.,Total,Hits,Raw.p,.log.p.,Holm.adjust,FDR,Impact,compounds,pathway,links,names
Pantothenate and CoA biosynthesis,12,1,0.033611,3.3929,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
beta-Alanine metabolism,12,1,0.033611,3.3929,1,1,0.025862,C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00750,mmu00410+C00750:Spermine
Glutathione metabolism,22,1,0.061037,2.7963,1,1,0.013986,C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00750,mmu00480+C00750:Spermine
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.061037,2.7963,1,1,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Nicotinate and nicotinamide metabolism,27,1,0.074554,2.5962,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Arginine and proline metabolism,35,1,0.095909,2.3444,1,1,0.019608,C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00750,mmu00330+C00750:Spermine
Bile secretion,52,1,0.14019,1.9647,1,1,0.0091743,C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00750,mmu04976+C00750:Spermine
Cholinergic synapse,4,1,0.018761,3.976,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.018761,3.976,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Bile secretion,52,2,0.021469,3.8412,1,1,0.018349,C00114;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00750,mmu04976+C00114:Choline;C00750:Spermine
Pantothenate and CoA biosynthesis,12,1,0.055439,2.8925,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
beta-Alanine metabolism,12,1,0.055439,2.8925,1,1,0.025862,C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00750,mmu00410+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.055439,2.8925,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.082221,2.4983,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Phenylalanine metabolism,22,1,0.099735,2.3052,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Glutathione metabolism,22,1,0.099735,2.3052,1,1,0.013986,C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00750,mmu00480+C00750:Spermine
Nicotinate and nicotinamide metabolism,27,1,0.12125,2.1099,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Arginine and proline metabolism,35,1,0.15482,1.8655,1,1,0.019608,C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00750,mmu00330+C00750:Spermine
Purine metabolism,51,1,0.21888,1.5192,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
ABC transporters,59,1,0.24942,1.3886,1,1,0.0072464,C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114,mmu02010+C00114:Choline
Cholinergic synapse,4,1,0.01503,4.1977,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.01503,4.1977,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Glycerophospholipid metabolism,12,1,0.044582,3.1104,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.066305,2.7135,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Phosphonate and phosphinate metabolism,22,1,0.08058,2.5185,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Nicotinate and nicotinamide metabolism,27,1,0.098193,2.3208,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Purine metabolism,51,1,0.17924,1.719,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Bile secretion,52,1,0.18249,1.701,1,1,0.0091743,C00114,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114,mmu04976+C00114:Choline
ABC transporters,59,1,0.205,1.5847,1,1,0.0072464,C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114,mmu02010+C00114:Choline
Metabolism of xenobiotics by cytochrome P450,43,2,0.021743,3.8285,1,1,0.015936,C19588;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588+C19594,"mmu00980+C19588:Aflatoxin B1 diol;C19594:Aflatoxin-M1-8,9-epoxide"
Cholinergic synapse,4,1,0.022482,3.7951,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.022482,3.7951,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Glycerophospholipid metabolism,12,1,0.066183,2.7153,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.097879,2.324,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Phenylalanine metabolism,22,1,0.11851,2.1328,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.11851,2.1328,1,1,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Nicotinate and nicotinamide metabolism,27,1,0.14374,1.9397,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Bile secretion,52,1,0.26106,1.343,1,1,0.0091743,C00114,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114,mmu04976+C00114:Choline
ABC transporters,59,1,0.29139,1.2331,1,1,0.0072464,C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114,mmu02010+C00114:Choline
Metabolism of xenobiotics by cytochrome P450,43,2,0.0047019,5.3598,1,1,0.015936,C19588;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588+C19594,"mmu00980+C19588:Aflatoxin B1 diol;C19594:Aflatoxin-M1-8,9-epoxide"
Pantothenate and CoA biosynthesis,12,1,0.033611,3.3929,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
beta-Alanine metabolism,12,1,0.033611,3.3929,1,1,0.025862,C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00750,mmu00410+C00750:Spermine
Glutathione metabolism,22,1,0.061037,2.7963,1,1,0.013986,C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00750,mmu00480+C00750:Spermine
Arginine and proline metabolism,35,1,0.095909,2.3444,1,1,0.019608,C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00750,mmu00330+C00750:Spermine
Bile secretion,52,1,0.14019,1.9647,1,1,0.0091743,C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00750,mmu04976+C00750:Spermine
Ferroptosis,19,1,0.017925,4.0216,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
beta-Alanine metabolism,12,1,0.011321,4.4811,1,1,0.025862,C00315,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315,mmu00410+C00315:Spermidine
Glutathione metabolism,22,1,0.020755,3.875,1,1,0.027972,C00315,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315,mmu00480+C00315:Spermidine
Arginine and proline metabolism,35,1,0.033019,3.4107,1,1,0.044118,C00315,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315,mmu00330+C00315:Spermidine
Bile secretion,52,1,0.049057,3.0148,1,1,0.0091743,C00315,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315,mmu04976+C00315:Spermidine
ABC transporters,59,1,0.05566,2.8885,1,1,0.0072464,C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00315,mmu02010+C00315:Spermidine
Bile secretion,52,2,0.013297,4.3202,1,1,0.018349,C00114;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00750,mmu04976+C00114:Choline;C00750:Spermine
Cholinergic synapse,4,1,0.01503,4.1977,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.01503,4.1977,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Pantothenate and CoA biosynthesis,12,1,0.044582,3.1104,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
beta-Alanine metabolism,12,1,0.044582,3.1104,1,1,0.025862,C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00750,mmu00410+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.044582,3.1104,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.066305,2.7135,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Phenylalanine metabolism,22,1,0.08058,2.5185,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Glutathione metabolism,22,1,0.08058,2.5185,1,1,0.013986,C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00750,mmu00480+C00750:Spermine
Arginine and proline metabolism,35,1,0.12585,2.0727,1,1,0.019608,C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00750,mmu00330+C00750:Spermine
Metabolism of xenobiotics by cytochrome P450,43,1,0.15286,1.8782,1,1,0.011952,C19588,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588,mmu00980+C19588:Aflatoxin B1 diol
ABC transporters,59,1,0.205,1.5847,1,1,0.0072464,C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114,mmu02010+C00114:Choline
Bile secretion,52,2,0.0068642,4.9814,1,0.8015,0.018349,C00114;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00750,mmu04976+C00114:Choline;C00750:Spermine
Cholinergic synapse,4,1,0.011289,4.484,1,0.8015,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.011289,4.484,1,0.8015,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Pantothenate and CoA biosynthesis,12,1,0.033611,3.3929,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
beta-Alanine metabolism,12,1,0.033611,3.3929,1,1,0.025862,C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00750,mmu00410+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.033611,3.3929,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.05013,2.9931,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Phenylalanine metabolism,22,1,0.061037,2.7963,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Glutathione metabolism,22,1,0.061037,2.7963,1,1,0.013986,C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00750,mmu00480+C00750:Spermine
Arginine and proline metabolism,35,1,0.095909,2.3444,1,1,0.019608,C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00750,mmu00330+C00750:Spermine
ABC transporters,59,1,0.158,1.8452,1,1,0.0072464,C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114,mmu02010+C00114:Choline
D-Arginine and D-ornithine metabolism,2,1,0.0094161,4.6653,1,0.60056,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Chagas disease,2,1,0.0094161,4.6653,1,0.60056,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Amyotrophic lateral sclerosis,3,1,0.014098,4.2618,1,0.60056,0.055556,C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00062,mmu05014+C00062:L-Arginine
Amoebiasis,3,1,0.014098,4.2618,1,0.60056,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
mTOR signaling pathway,3,1,0.014098,4.2618,1,0.60056,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
Pathways of neurodegeneration - multiple diseases,8,1,0.03724,3.2904,1,1,0.020833,C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00062,mmu05022+C00062:L-Arginine
Arginine biosynthesis,11,1,0.050915,2.9776,1,1,0.050314,C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00062,mmu00220+C00062:L-Arginine
Aminoacyl-tRNA biosynthesis,16,1,0.073362,2.6124,1,1,0.017857,C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00062,mmu00970+C00062:L-Arginine
Central carbon metabolism in cancer,17,1,0.0778,2.5536,1,1,0.018868,C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00062,mmu05230+C00062:L-Arginine
Ferroptosis,19,1,0.086625,2.4462,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Protein digestion and absorption,21,1,0.095382,2.3499,1,1,0.021277,C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00062,mmu04974+C00062:L-Arginine
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.099735,2.3052,1,1,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Arginine and proline metabolism,35,1,0.15482,1.8655,1,1,0.041667,C00062,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00062,mmu00330+C00062:L-Arginine
Metabolism of xenobiotics by cytochrome P450,43,1,0.18735,1.6748,1,1,0.011952,C19588,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588,mmu00980+C19588:Aflatoxin B1 diol
Purine metabolism,51,1,0.21888,1.5192,1,1,0.01083,C00360,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360,mmu00230+C00360:dAMP
ABC transporters,59,1,0.24942,1.3886,1,1,0.0072464,C00062,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00062,mmu02010+C00062:L-Arginine
D-Arginine and D-ornithine metabolism,2,1,0.015044,4.1967,1,0.9295,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Chagas disease,2,1,0.015044,4.1967,1,0.9295,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Amyotrophic lateral sclerosis,3,1,0.022492,3.7946,1,0.9295,0.055556,C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00062,mmu05014+C00062:L-Arginine
Amoebiasis,3,1,0.022492,3.7946,1,0.9295,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
mTOR signaling pathway,3,1,0.022492,3.7946,1,0.9295,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
Arginine and proline metabolism,35,2,0.026183,3.6426,1,0.9295,0.061275,C00062;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00062+C00750,mmu00330+C00062:L-Arginine;C00750:Spermine
Metabolism of xenobiotics by cytochrome P450,43,2,0.038541,3.256,1,1,0.015936,C19588;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588+C19594,"mmu00980+C19588:Aflatoxin B1 diol;C19594:Aflatoxin-M1-8,9-epoxide"
Pathways of neurodegeneration - multiple diseases,8,1,0.058996,2.8303,1,1,0.020833,C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00062,mmu05022+C00062:L-Arginine
Arginine biosynthesis,11,1,0.080321,2.5217,1,1,0.050314,C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00062,mmu00220+C00062:L-Arginine
Pantothenate and CoA biosynthesis,12,1,0.087335,2.438,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
beta-Alanine metabolism,12,1,0.087335,2.438,1,1,0.025862,C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00750,mmu00410+C00750:Spermine
Aminoacyl-tRNA biosynthesis,16,1,0.11492,2.1635,1,1,0.017857,C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00062,mmu00970+C00062:L-Arginine
Central carbon metabolism in cancer,17,1,0.12171,2.1061,1,1,0.018868,C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00062,mmu05230+C00062:L-Arginine
Protein digestion and absorption,21,1,0.14838,1.908,1,1,0.021277,C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00062,mmu04974+C00062:L-Arginine
Phenylalanine metabolism,22,1,0.15494,1.8647,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Glutathione metabolism,22,1,0.15494,1.8647,1,1,0.013986,C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00750,mmu00480+C00750:Spermine
Phosphonate and phosphinate metabolism,22,1,0.15494,1.8647,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Nicotinate and nicotinamide metabolism,27,1,0.18707,1.6763,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Purine metabolism,51,1,0.32687,1.1182,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Bile secretion,52,1,0.33221,1.102,1,1,0.0091743,C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00750,mmu04976+C00750:Spermine
ABC transporters,59,1,0.36854,0.99821,1,1,0.0072464,C00062,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00062,mmu02010+C00062:L-Arginine
Cholinergic synapse,4,1,0.011289,4.484,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.011289,4.484,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Glycerophospholipid metabolism,12,1,0.033611,3.3929,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.05013,2.9931,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Phenylalanine metabolism,22,1,0.061037,2.7963,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Nicotinate and nicotinamide metabolism,27,1,0.074554,2.5962,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Bile secretion,52,1,0.14019,1.9647,1,1,0.0091743,C00114,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114,mmu04976+C00114:Choline
ABC transporters,59,1,0.158,1.8452,1,1,0.0072464,C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114,mmu02010+C00114:Choline
Cholinergic synapse,4,1,0.018761,3.976,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.018761,3.976,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Glycerophospholipid metabolism,12,1,0.055439,2.8925,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.082221,2.4983,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Ferroptosis,19,1,0.086625,2.4462,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Phosphonate and phosphinate metabolism,22,1,0.099735,2.3052,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.099735,2.3052,1,1,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Purine metabolism,51,1,0.21888,1.5192,1,1,0.01083,C00360,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360,mmu00230+C00360:dAMP
Bile secretion,52,1,0.22275,1.5017,1,1,0.0091743,C00114,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114,mmu04976+C00114:Choline
ABC transporters,59,1,0.24942,1.3886,1,1,0.0072464,C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114,mmu02010+C00114:Choline
beta-Alanine metabolism,12,2,0.0017198,6.3655,0.36632,0.2139,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Bile secretion,52,3,0.0020084,6.2104,0.42579,0.2139,0.027523,C00114;C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00315+C00750,mmu04976+C00114:Choline;C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.0058685,5.1382,1,0.41667,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
Arginine and proline metabolism,35,2,0.014623,4.2251,1,0.77868,0.063725,C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315+C00750,mmu00330+C00315:Spermidine;C00750:Spermine
Cholinergic synapse,4,1,0.022482,3.7951,1,0.7981,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.022482,3.7951,1,0.7981,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
ABC transporters,59,2,0.039538,3.2305,1,1,0.014493,C00114;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114+C00315,mmu02010+C00114:Choline;C00315:Spermidine
Pantothenate and CoA biosynthesis,12,1,0.066183,2.7153,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.066183,2.7153,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.097879,2.324,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Phenylalanine metabolism,22,1,0.11851,2.1328,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Nicotinate and nicotinamide metabolism,27,1,0.14374,1.9397,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Purine metabolism,51,1,0.25664,1.3601,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Cholinergic synapse,4,1,0.022482,3.7951,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.022482,3.7951,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Bile secretion,52,2,0.031199,3.4674,1,1,0.018349,C00114;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00750,mmu04976+C00114:Choline;C00750:Spermine
Pantothenate and CoA biosynthesis,12,1,0.066183,2.7153,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
beta-Alanine metabolism,12,1,0.066183,2.7153,1,1,0.025862,C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00750,mmu00410+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.066183,2.7153,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.097879,2.324,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Phenylalanine metabolism,22,1,0.11851,2.1328,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Glutathione metabolism,22,1,0.11851,2.1328,1,1,0.013986,C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00750,mmu00480+C00750:Spermine
Nicotinate and nicotinamide metabolism,27,1,0.14374,1.9397,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Arginine and proline metabolism,35,1,0.18286,1.699,1,1,0.019608,C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00750,mmu00330+C00750:Spermine
Metabolism of xenobiotics by cytochrome P450,43,1,0.22048,1.512,1,1,0.011952,C19588,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588,mmu00980+C19588:Aflatoxin B1 diol
Purine metabolism,51,1,0.25664,1.3601,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
ABC transporters,59,1,0.29139,1.2331,1,1,0.0072464,C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114,mmu02010+C00114:Choline
Bile secretion,52,2,0.013297,4.3202,1,1,0.018349,C00114;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00750,mmu04976+C00114:Choline;C00750:Spermine
Cholinergic synapse,4,1,0.01503,4.1977,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.01503,4.1977,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Pantothenate and CoA biosynthesis,12,1,0.044582,3.1104,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
beta-Alanine metabolism,12,1,0.044582,3.1104,1,1,0.025862,C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00750,mmu00410+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.044582,3.1104,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.066305,2.7135,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Glutathione metabolism,22,1,0.08058,2.5185,1,1,0.013986,C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00750,mmu00480+C00750:Spermine
Nicotinate and nicotinamide metabolism,27,1,0.098193,2.3208,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Arginine and proline metabolism,35,1,0.12585,2.0727,1,1,0.019608,C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00750,mmu00330+C00750:Spermine
Purine metabolism,51,1,0.17924,1.719,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
ABC transporters,59,1,0.205,1.5847,1,1,0.0072464,C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114,mmu02010+C00114:Choline
Ferroptosis,19,1,0.017925,4.0216,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Arginine and proline metabolism,35,4,0.00027975,8.1816,0.059586,0.031131,0.15441,C00025;C00062;C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00062+C00315+C00750,mmu00330+C00025:L-Glutamate;C00062:L-Arginine;C00315:Spermidine;C00750:Spermine
Amyotrophic lateral sclerosis,3,2,0.00029231,8.1377,0.06197,0.031131,0.11111,C00025;C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025+C00062,mmu05014+C00025:L-Glutamate;C00062:L-Arginine
Glutathione metabolism,22,3,0.0011517,6.7665,0.24301,0.08177,0.083916,C00025;C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00315+C00750,mmu00480+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
Pathways of neurodegeneration - multiple diseases,8,2,0.0026517,5.9325,0.55686,0.1412,0.041667,C00025;C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025+C00062,mmu05022+C00025:L-Glutamate;C00062:L-Arginine
Arginine biosynthesis,11,2,0.0051207,5.2745,1,0.2169,0.13208,C00025;C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025+C00062,mmu00220+C00025:L-Glutamate;C00062:L-Arginine
beta-Alanine metabolism,12,2,0.0061099,5.0978,1,0.2169,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Spinocerebellar ataxia,1,1,0.010377,4.5681,1,0.24328,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.010377,4.5681,1,0.24328,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Aminoacyl-tRNA biosynthesis,16,2,0.010859,4.5227,1,0.24328,0.035714,C00025;C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025+C00062,mmu00970+C00025:L-Glutamate;C00062:L-Arginine
Central carbon metabolism in cancer,17,2,0.012237,4.4033,1,0.24328,0.056604,C00025;C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025+C00062,mmu05230+C00025:L-Glutamate;C00062:L-Arginine
Protein digestion and absorption,21,2,0.018471,3.9916,1,0.24328,0.042553,C00025;C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025+C00062,mmu04974+C00025:L-Glutamate;C00062:L-Arginine
ABC transporters,59,3,0.019639,3.9302,1,0.24328,0.021739,C00025;C00062;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00062+C00315,mmu02010+C00025:L-Glutamate;C00062:L-Arginine;C00315:Spermidine
D-Arginine and D-ornithine metabolism,2,1,0.020657,3.8797,1,0.24328,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Long-term potentiation,2,1,0.020657,3.8797,1,0.24328,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Chagas disease,2,1,0.020657,3.8797,1,0.24328,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Proximal tubule bicarbonate reclamation,3,1,0.030839,3.479,1,0.24328,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amoebiasis,3,1,0.030839,3.479,1,0.24328,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
Amphetamine addiction,3,1,0.030839,3.479,1,0.24328,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.030839,3.479,1,0.24328,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.030839,3.479,1,0.24328,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.030839,3.479,1,0.24328,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.030839,3.479,1,0.24328,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.030839,3.479,1,0.24328,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.030839,3.479,1,0.24328,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.030839,3.479,1,0.24328,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.030839,3.479,1,0.24328,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
mTOR signaling pathway,3,1,0.030839,3.479,1,0.24328,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
Phospholipase D signaling pathway,4,1,0.040925,3.196,1,0.28119,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.040925,3.196,1,0.28119,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.040925,3.196,1,0.28119,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Pertussis,4,1,0.040925,3.196,1,0.28119,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Synaptic vesicle cycle,5,1,0.050915,2.9776,1,0.32863,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.050915,2.9776,1,0.32863,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Metabolism of xenobiotics by cytochrome P450,43,2,0.070094,2.6579,1,0.43912,0.0079681,C19591;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19591+C19594,"mmu00980+C19591:1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal;C19594:Aflatoxin-M1-8,9-epoxide"
Retrograde endocannabinoid signaling,8,1,0.080321,2.5217,1,0.48881,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Bile secretion,52,2,0.097806,2.3248,1,0.57868,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
Butanoate metabolism,11,1,0.1089,2.2174,1,0.6104,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.1089,2.2174,1,0.6104,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Pantothenate and CoA biosynthesis,12,1,0.11824,2.135,1,0.64578,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Taste transduction,14,1,0.13666,1.9902,1,0.70998,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.13666,1.9902,1,0.70998,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Glyoxylate and dicarboxylate metabolism,18,1,0.17246,1.7576,1,0.87462,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Terpenoid backbone biosynthesis,19,1,0.1812,1.7082,1,0.87716,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Ferroptosis,19,1,0.1812,1.7082,1,0.87716,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
Phenylalanine metabolism,22,1,0.2069,1.5755,1,0.97935,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Histidine metabolism,23,1,0.21531,1.5357,1,0.99697,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.24004,1.427,1,1,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
Nicotinate and nicotinamide metabolism,27,1,0.24812,1.3938,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.30256,1.1955,1,1,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Purine metabolism,51,1,0.42018,0.86707,1,1,0.01083,C00360,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360,mmu00230+C00360:dAMP
Porphyrin and chlorophyll metabolism,54,1,0.43896,0.82335,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
Pertussis,4,1,0.022482,3.7951,1,1,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Phosphonate and phosphinate metabolism,22,1,0.11851,2.1328,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.11851,2.1328,1,1,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Drug metabolism - cytochrome P450,32,1,0.16837,1.7816,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Metabolism of xenobiotics by cytochrome P450,43,1,0.22048,1.512,1,1,0.011952,C19588,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588,mmu00980+C19588:Aflatoxin B1 diol
Purine metabolism,51,1,0.25664,1.3601,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Spinocerebellar ataxia,1,1,0.004717,5.3566,1,0.21448,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.004717,5.3566,1,0.21448,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Long-term potentiation,2,1,0.0094161,4.6653,1,0.21448,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Amyotrophic lateral sclerosis,3,1,0.014098,4.2618,1,0.21448,0.055556,C00025,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025,mmu05014+C00025:L-Glutamate
Proximal tubule bicarbonate reclamation,3,1,0.014098,4.2618,1,0.21448,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amphetamine addiction,3,1,0.014098,4.2618,1,0.21448,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.014098,4.2618,1,0.21448,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.014098,4.2618,1,0.21448,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.014098,4.2618,1,0.21448,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.014098,4.2618,1,0.21448,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.014098,4.2618,1,0.21448,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.014098,4.2618,1,0.21448,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.014098,4.2618,1,0.21448,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.014098,4.2618,1,0.21448,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
Phospholipase D signaling pathway,4,1,0.018761,3.976,1,0.23507,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.018761,3.976,1,0.23507,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.018761,3.976,1,0.23507,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Synaptic vesicle cycle,5,1,0.023407,3.7547,1,0.26241,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.023407,3.7547,1,0.26241,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Pathways of neurodegeneration - multiple diseases,8,1,0.03724,3.2904,1,0.36055,0.020833,C00025,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025,mmu05022+C00025:L-Glutamate
Glycolysis / Gluconeogenesis,8,1,0.03724,3.2904,1,0.36055,0.037344,C00236,mmu00010,http://www.kegg.jp/pathway/mmu00010+C00236,mmu00010+C00236:3-Phospho-D-glyceroyl phosphate
Retrograde endocannabinoid signaling,8,1,0.03724,3.2904,1,0.36055,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Butanoate metabolism,11,1,0.050915,2.9776,1,0.4338,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
Arginine biosynthesis,11,1,0.050915,2.9776,1,0.4338,0.081761,C00025,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025,mmu00220+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.050915,2.9776,1,0.4338,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Taste transduction,14,1,0.064435,2.7421,1,0.50832,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.064435,2.7421,1,0.50832,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Aminoacyl-tRNA biosynthesis,16,1,0.073362,2.6124,1,0.55807,0.017857,C00025,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025,mmu00970+C00025:L-Glutamate
Central carbon metabolism in cancer,17,1,0.0778,2.5536,1,0.57143,0.037736,C00025,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025,mmu05230+C00025:L-Glutamate
Glyoxylate and dicarboxylate metabolism,18,1,0.082221,2.4983,1,0.58377,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Ferroptosis,19,1,0.086625,2.4462,1,0.59519,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
Protein digestion and absorption,21,1,0.095382,2.3499,1,0.62481,0.021277,C00025,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025,mmu04974+C00025:L-Glutamate
Phosphonate and phosphinate metabolism,22,1,0.099735,2.3052,1,0.62481,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Glutathione metabolism,22,1,0.099735,2.3052,1,0.62481,0.041958,C00025,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025,mmu00480+C00025:L-Glutamate
Histidine metabolism,23,1,0.10407,2.2627,1,0.63335,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.11698,2.1457,1,0.69214,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.15068,1.8926,1,0.86743,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Arginine and proline metabolism,35,1,0.15482,1.8655,1,0.8678,0.04902,C00025,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025,mmu00330+C00025:L-Glutamate
Metabolism of xenobiotics by cytochrome P450,43,1,0.18735,1.6748,1,1,0.0039841,C19591,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19591,"mmu00980+C19591:1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal"
Purine metabolism,51,1,0.21888,1.5192,1,1,0.01083,C00360,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360,mmu00230+C00360:dAMP
Porphyrin and chlorophyll metabolism,54,1,0.23044,1.4677,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
ABC transporters,59,1,0.24942,1.3886,1,1,0.0072464,C00025,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025,mmu02010+C00025:L-Glutamate
Nicotinate and nicotinamide metabolism,27,1,0.050318,2.9894,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Metabolism of xenobiotics by cytochrome P450,43,1,0.079523,2.5317,1,1,0.0039841,C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19594,"mmu00980+C19594:Aflatoxin-M1-8,9-epoxide"
Phosphonate and phosphinate metabolism,22,1,0.041098,3.1918,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.041098,3.1918,1,1,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Spinocerebellar ataxia,1,1,0.0075472,4.8866,1,0.30317,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.0075472,4.8866,1,0.30317,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Glutathione metabolism,22,2,0.010681,4.5393,1,0.30317,0.055944,C00025;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00750,mmu00480+C00025:L-Glutamate;C00750:Spermine
Long-term potentiation,2,1,0.015044,4.1967,1,0.30317,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Amyotrophic lateral sclerosis,3,1,0.022492,3.7946,1,0.30317,0.055556,C00025,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025,mmu05014+C00025:L-Glutamate
Proximal tubule bicarbonate reclamation,3,1,0.022492,3.7946,1,0.30317,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amphetamine addiction,3,1,0.022492,3.7946,1,0.30317,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.022492,3.7946,1,0.30317,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.022492,3.7946,1,0.30317,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.022492,3.7946,1,0.30317,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.022492,3.7946,1,0.30317,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.022492,3.7946,1,0.30317,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.022492,3.7946,1,0.30317,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.022492,3.7946,1,0.30317,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.022492,3.7946,1,0.30317,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
Arginine and proline metabolism,35,2,0.026183,3.6426,1,0.30317,0.068627,C00025;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00750,mmu00330+C00025:L-Glutamate;C00750:Spermine
Phospholipase D signaling pathway,4,1,0.02989,3.5102,1,0.30317,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.02989,3.5102,1,0.30317,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.02989,3.5102,1,0.30317,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Cholinergic synapse,4,1,0.02989,3.5102,1,0.30317,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.02989,3.5102,1,0.30317,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Synaptic vesicle cycle,5,1,0.03724,3.2904,1,0.34487,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.03724,3.2904,1,0.34487,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Bile secretion,52,2,0.054681,2.9062,1,0.48332,0.018349,C00114;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00750,mmu04976+C00114:Choline;C00750:Spermine
Pathways of neurodegeneration - multiple diseases,8,1,0.058996,2.8303,1,0.48332,0.020833,C00025,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025,mmu05022+C00025:L-Glutamate
Retrograde endocannabinoid signaling,8,1,0.058996,2.8303,1,0.48332,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
ABC transporters,59,2,0.068691,2.6781,1,0.5419,0.014493,C00025;C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00114,mmu02010+C00025:L-Glutamate;C00114:Choline
Butanoate metabolism,11,1,0.080321,2.5217,1,0.56371,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
Arginine biosynthesis,11,1,0.080321,2.5217,1,0.56371,0.081761,C00025,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025,mmu00220+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.080321,2.5217,1,0.56371,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Pantothenate and CoA biosynthesis,12,1,0.087335,2.438,1,0.56371,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
beta-Alanine metabolism,12,1,0.087335,2.438,1,0.56371,0.025862,C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00750,mmu00410+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.087335,2.438,1,0.56371,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
Taste transduction,14,1,0.10122,2.2904,1,0.61601,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.10122,2.2904,1,0.61601,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Aminoacyl-tRNA biosynthesis,16,1,0.11492,2.1635,1,0.67997,0.017857,C00025,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025,mmu00970+C00025:L-Glutamate
Central carbon metabolism in cancer,17,1,0.12171,2.1061,1,0.70063,0.037736,C00025,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025,mmu05230+C00025:L-Glutamate
"Glycine, serine and threonine metabolism",18,1,0.12844,2.0523,1,0.7015,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Glyoxylate and dicarboxylate metabolism,18,1,0.12844,2.0523,1,0.7015,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Ferroptosis,19,1,0.13513,2.0015,1,0.71959,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
Protein digestion and absorption,21,1,0.14838,1.908,1,0.76749,0.021277,C00025,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025,mmu04974+C00025:L-Glutamate
Phenylalanine metabolism,22,1,0.15494,1.8647,1,0.76749,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Phosphonate and phosphinate metabolism,22,1,0.15494,1.8647,1,0.76749,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Histidine metabolism,23,1,0.16145,1.8235,1,0.78158,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.18073,1.7108,1,0.85545,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
Nicotinate and nicotinamide metabolism,27,1,0.18707,1.6763,1,0.8662,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.23025,1.4686,1,1,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Metabolism of xenobiotics by cytochrome P450,43,1,0.28281,1.263,1,1,0.0039841,C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19594,"mmu00980+C19594:Aflatoxin-M1-8,9-epoxide"
Purine metabolism,51,1,0.32687,1.1182,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Porphyrin and chlorophyll metabolism,54,1,0.34277,1.0707,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
Cholinergic synapse,4,1,0.01503,4.1977,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.01503,4.1977,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Glycerophospholipid metabolism,12,1,0.044582,3.1104,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.066305,2.7135,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Phenylalanine metabolism,22,1,0.08058,2.5185,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Phosphonate and phosphinate metabolism,22,1,0.08058,2.5185,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Nicotinate and nicotinamide metabolism,27,1,0.098193,2.3208,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Bile secretion,52,1,0.18249,1.701,1,1,0.0091743,C00114,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114,mmu04976+C00114:Choline
ABC transporters,59,1,0.205,1.5847,1,1,0.0072464,C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114,mmu02010+C00114:Choline
Cholinergic synapse,4,1,0.026191,3.6423,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.026191,3.6423,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Caffeine metabolism,7,1,0.045447,3.0912,1,1,0.029412,C07481,mmu00232,http://www.kegg.jp/pathway/mmu00232+C07481,mmu00232+C07481:Caffeine
Glycerophospholipid metabolism,12,1,0.076814,2.5664,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.11329,2.1778,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Phenylalanine metabolism,22,1,0.13691,1.9884,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Phosphonate and phosphinate metabolism,22,1,0.13691,1.9884,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.13691,1.9884,1,1,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Nicotinate and nicotinamide metabolism,27,1,0.16567,1.7977,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Metabolism of xenobiotics by cytochrome P450,43,1,0.25228,1.3772,1,1,0.0039841,C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19594,"mmu00980+C19594:Aflatoxin-M1-8,9-epoxide"
Bile secretion,52,1,0.29752,1.2123,1,1,0.0091743,C00114,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114,mmu04976+C00114:Choline
ABC transporters,59,1,0.33106,1.1055,1,1,0.0072464,C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114,mmu02010+C00114:Choline
Metabolism of xenobiotics by cytochrome P450,43,2,0.0047019,5.3598,1,1,0.015936,C19588;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588+C19594,"mmu00980+C19588:Aflatoxin B1 diol;C19594:Aflatoxin-M1-8,9-epoxide"
Phosphonate and phosphinate metabolism,22,1,0.061037,2.7963,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Cholinergic synapse,4,1,0.0075365,4.888,1,0.80264,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.0075365,4.888,1,0.80264,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Glycerophospholipid metabolism,12,1,0.022524,3.7932,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.03369,3.3906,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Ferroptosis,19,1,0.035544,3.337,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Bile secretion,52,1,0.095751,2.346,1,1,0.0091743,C00114,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114,mmu04976+C00114:Choline
ABC transporters,59,1,0.10827,2.2231,1,1,0.0072464,C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114,mmu02010+C00114:Choline
Glycolysis / Gluconeogenesis,8,1,0.022492,3.7946,1,1,0.037344,C00236,mmu00010,http://www.kegg.jp/pathway/mmu00010+C00236,mmu00010+C00236:3-Phospho-D-glyceroyl phosphate
beta-Alanine metabolism,12,1,0.033611,3.3929,1,1,0.025862,C00315,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315,mmu00410+C00315:Spermidine
Terpenoid backbone biosynthesis,19,1,0.052864,2.94,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Glutathione metabolism,22,1,0.061037,2.7963,1,1,0.027972,C00315,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315,mmu00480+C00315:Spermidine
Arginine and proline metabolism,35,1,0.095909,2.3444,1,1,0.044118,C00315,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315,mmu00330+C00315:Spermidine
Bile secretion,52,1,0.14019,1.9647,1,1,0.0091743,C00315,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315,mmu04976+C00315:Spermidine
ABC transporters,59,1,0.158,1.8452,1,1,0.0072464,C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00315,mmu02010+C00315:Spermidine
Cholinergic synapse,4,1,0.011289,4.484,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.011289,4.484,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Glycerophospholipid metabolism,12,1,0.033611,3.3929,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.05013,2.9931,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Phosphonate and phosphinate metabolism,22,1,0.061037,2.7963,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Nicotinate and nicotinamide metabolism,27,1,0.074554,2.5962,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Bile secretion,52,1,0.14019,1.9647,1,1,0.0091743,C00114,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114,mmu04976+C00114:Choline
ABC transporters,59,1,0.158,1.8452,1,1,0.0072464,C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114,mmu02010+C00114:Choline
Cholinergic synapse,4,1,0.011289,4.484,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.011289,4.484,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Glycerophospholipid metabolism,12,1,0.033611,3.3929,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.05013,2.9931,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Phenylalanine metabolism,22,1,0.061037,2.7963,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Nicotinate and nicotinamide metabolism,27,1,0.074554,2.5962,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Bile secretion,52,1,0.14019,1.9647,1,1,0.0091743,C00114,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114,mmu04976+C00114:Choline
ABC transporters,59,1,0.158,1.8452,1,1,0.0072464,C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114,mmu02010+C00114:Choline
Pertussis,4,1,0.033579,3.3939,1,1,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Metabolism of xenobiotics by cytochrome P450,43,2,0.048294,3.0305,1,1,0.0079681,C19591;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19591+C19594,"mmu00980+C19591:1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal;C19594:Aflatoxin-M1-8,9-epoxide"
Ferroptosis,19,1,0.15075,1.8921,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Terpenoid backbone biosynthesis,19,1,0.15075,1.8921,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phenylalanine metabolism,22,1,0.17261,1.7567,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.17261,1.7567,1,1,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Nicotinate and nicotinamide metabolism,27,1,0.20793,1.5705,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Purine metabolism,51,1,0.3595,1.023,1,1,0.01083,C00360,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360,mmu00230+C00360:dAMP
Cholinergic synapse,4,1,0.0037736,5.5797,0.80377,0.40189,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.0037736,5.5797,0.80377,0.40189,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Glycerophospholipid metabolism,12,1,0.011321,4.4811,1,0.80377,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.016981,4.0757,1,0.90425,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Bile secretion,52,1,0.049057,3.0148,1,1,0.0091743,C00114,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114,mmu04976+C00114:Choline
ABC transporters,59,1,0.05566,2.8885,1,1,0.0072464,C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114,mmu02010+C00114:Choline
Cholinergic synapse,4,1,0.018761,3.976,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.018761,3.976,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Glycerophospholipid metabolism,12,1,0.055439,2.8925,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.082221,2.4983,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Terpenoid backbone biosynthesis,19,1,0.086625,2.4462,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phenylalanine metabolism,22,1,0.099735,2.3052,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Nicotinate and nicotinamide metabolism,27,1,0.12125,2.1099,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Metabolism of xenobiotics by cytochrome P450,43,1,0.18735,1.6748,1,1,0.0039841,C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19594,"mmu00980+C19594:Aflatoxin-M1-8,9-epoxide"
Bile secretion,52,1,0.22275,1.5017,1,1,0.0091743,C00114,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114,mmu04976+C00114:Choline
ABC transporters,59,1,0.24942,1.3886,1,1,0.0072464,C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114,mmu02010+C00114:Choline
Pertussis,4,1,0.026191,3.6423,1,1,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Cholinergic synapse,4,1,0.026191,3.6423,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.026191,3.6423,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Glycolysis / Gluconeogenesis,8,1,0.051792,2.9605,1,1,0.037344,C00236,mmu00010,http://www.kegg.jp/pathway/mmu00010+C00236,mmu00010+C00236:3-Phospho-D-glyceroyl phosphate
Glycerophospholipid metabolism,12,1,0.076814,2.5664,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.11329,2.1778,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Ferroptosis,19,1,0.11924,2.1266,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.13691,1.9884,1,1,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Metabolism of xenobiotics by cytochrome P450,43,1,0.25228,1.3772,1,1,0.0039841,C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19594,"mmu00980+C19594:Aflatoxin-M1-8,9-epoxide"
Purine metabolism,51,1,0.29261,1.2289,1,1,0.01083,C00360,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360,mmu00230+C00360:dAMP
Bile secretion,52,1,0.29752,1.2123,1,1,0.0091743,C00114,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114,mmu04976+C00114:Choline
ABC transporters,59,1,0.33106,1.1055,1,1,0.0072464,C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114,mmu02010+C00114:Choline
beta-Alanine metabolism,12,2,0.0023926,6.0354,0.50962,0.36137,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Bile secretion,52,3,0.0033932,5.686,0.71935,0.36137,0.027523,C00114;C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00315+C00750,mmu04976+C00114:Choline;C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.0081128,4.8143,1,0.57601,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
Arginine and proline metabolism,35,2,0.02005,3.9095,1,0.92979,0.063725,C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315+C00750,mmu00330+C00315:Spermidine;C00750:Spermine
Cholinergic synapse,4,1,0.026191,3.6423,1,0.92979,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.026191,3.6423,1,0.92979,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
ABC transporters,59,2,0.053397,2.93,1,1,0.014493,C00114;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114+C00315,mmu02010+C00114:Choline;C00315:Spermidine
Pantothenate and CoA biosynthesis,12,1,0.076814,2.5664,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.076814,2.5664,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.11329,2.1778,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Terpenoid backbone biosynthesis,19,1,0.11924,2.1266,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phenylalanine metabolism,22,1,0.13691,1.9884,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Phosphonate and phosphinate metabolism,22,1,0.13691,1.9884,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Nicotinate and nicotinamide metabolism,27,1,0.16567,1.7977,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Nicotinate and nicotinamide metabolism,27,1,0.025472,3.6702,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Cholinergic synapse,4,1,0.02989,3.5102,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.02989,3.5102,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Bile secretion,52,2,0.054681,2.9062,1,1,0.018349,C00114;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00750,mmu04976+C00114:Choline;C00750:Spermine
Pantothenate and CoA biosynthesis,12,1,0.087335,2.438,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
beta-Alanine metabolism,12,1,0.087335,2.438,1,1,0.025862,C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00750,mmu00410+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.087335,2.438,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.12844,2.0523,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Terpenoid backbone biosynthesis,19,1,0.13513,2.0015,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phenylalanine metabolism,22,1,0.15494,1.8647,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Glutathione metabolism,22,1,0.15494,1.8647,1,1,0.013986,C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00750,mmu00480+C00750:Spermine
Phosphonate and phosphinate metabolism,22,1,0.15494,1.8647,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Nicotinate and nicotinamide metabolism,27,1,0.18707,1.6763,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Arginine and proline metabolism,35,1,0.23625,1.4429,1,1,0.019608,C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00750,mmu00330+C00750:Spermine
Metabolism of xenobiotics by cytochrome P450,43,1,0.28281,1.263,1,1,0.0039841,C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19594,"mmu00980+C19594:Aflatoxin-M1-8,9-epoxide"
Purine metabolism,51,1,0.32687,1.1182,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
ABC transporters,59,1,0.36854,0.99821,1,1,0.0072464,C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114,mmu02010+C00114:Choline
Cholinergic synapse,4,1,0.01503,4.1977,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.01503,4.1977,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Glycerophospholipid metabolism,12,1,0.044582,3.1104,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.066305,2.7135,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Terpenoid backbone biosynthesis,19,1,0.06989,2.6608,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phenylalanine metabolism,22,1,0.08058,2.5185,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Nicotinate and nicotinamide metabolism,27,1,0.098193,2.3208,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Bile secretion,52,1,0.18249,1.701,1,1,0.0091743,C00114,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114,mmu04976+C00114:Choline
ABC transporters,59,1,0.205,1.5847,1,1,0.0072464,C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114,mmu02010+C00114:Choline
Glutathione metabolism,22,3,0.00040711,7.8064,0.086714,0.086714,0.083916,C00025;C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00315+C00750,mmu00480+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
Arginine and proline metabolism,35,3,0.0016511,6.4063,0.35003,0.17584,0.11275,C00025;C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00315+C00750,mmu00330+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
beta-Alanine metabolism,12,2,0.00317,5.754,0.66887,0.22507,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Bile secretion,52,3,0.0052416,5.2511,1,0.22965,0.027523,C00114;C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00315+C00750,mmu04976+C00114:Choline;C00315:Spermidine;C00750:Spermine
ABC transporters,59,3,0.0075159,4.8907,1,0.22965,0.021739,C00025;C00114;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00114+C00315,mmu02010+C00025:L-Glutamate;C00114:Choline;C00315:Spermidine
Spinocerebellar ataxia,1,1,0.0075472,4.8866,1,0.22965,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.0075472,4.8866,1,0.22965,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Long-term potentiation,2,1,0.015044,4.1967,1,0.25215,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Amyotrophic lateral sclerosis,3,1,0.022492,3.7946,1,0.25215,0.055556,C00025,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025,mmu05014+C00025:L-Glutamate
Proximal tubule bicarbonate reclamation,3,1,0.022492,3.7946,1,0.25215,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amphetamine addiction,3,1,0.022492,3.7946,1,0.25215,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.022492,3.7946,1,0.25215,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.022492,3.7946,1,0.25215,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.022492,3.7946,1,0.25215,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.022492,3.7946,1,0.25215,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.022492,3.7946,1,0.25215,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.022492,3.7946,1,0.25215,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.022492,3.7946,1,0.25215,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.022492,3.7946,1,0.25215,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
Phospholipase D signaling pathway,4,1,0.02989,3.5102,1,0.26528,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.02989,3.5102,1,0.26528,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.02989,3.5102,1,0.26528,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Cholinergic synapse,4,1,0.02989,3.5102,1,0.26528,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.02989,3.5102,1,0.26528,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Synaptic vesicle cycle,5,1,0.03724,3.2904,1,0.30508,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.03724,3.2904,1,0.30508,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Pathways of neurodegeneration - multiple diseases,8,1,0.058996,2.8303,1,0.44879,0.020833,C00025,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025,mmu05022+C00025:L-Glutamate
Retrograde endocannabinoid signaling,8,1,0.058996,2.8303,1,0.44879,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Butanoate metabolism,11,1,0.080321,2.5217,1,0.55189,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
Arginine biosynthesis,11,1,0.080321,2.5217,1,0.55189,0.081761,C00025,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025,mmu00220+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.080321,2.5217,1,0.55189,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Pantothenate and CoA biosynthesis,12,1,0.087335,2.438,1,0.56371,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.087335,2.438,1,0.56371,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
Taste transduction,14,1,0.10122,2.2904,1,0.61601,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.10122,2.2904,1,0.61601,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Aminoacyl-tRNA biosynthesis,16,1,0.11492,2.1635,1,0.67997,0.017857,C00025,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025,mmu00970+C00025:L-Glutamate
Central carbon metabolism in cancer,17,1,0.12171,2.1061,1,0.70063,0.037736,C00025,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025,mmu05230+C00025:L-Glutamate
"Glycine, serine and threonine metabolism",18,1,0.12844,2.0523,1,0.7015,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Glyoxylate and dicarboxylate metabolism,18,1,0.12844,2.0523,1,0.7015,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Ferroptosis,19,1,0.13513,2.0015,1,0.71959,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
Protein digestion and absorption,21,1,0.14838,1.908,1,0.77087,0.021277,C00025,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025,mmu04974+C00025:L-Glutamate
Phenylalanine metabolism,22,1,0.15494,1.8647,1,0.78577,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Histidine metabolism,23,1,0.16145,1.8235,1,0.79975,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.18073,1.7108,1,0.87489,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
Nicotinate and nicotinamide metabolism,27,1,0.18707,1.6763,1,0.88545,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.23025,1.4686,1,1,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Metabolism of xenobiotics by cytochrome P450,43,1,0.28281,1.263,1,1,0.0039841,C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19594,"mmu00980+C19594:Aflatoxin-M1-8,9-epoxide"
Purine metabolism,51,1,0.32687,1.1182,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Porphyrin and chlorophyll metabolism,54,1,0.34277,1.0707,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
Cholinergic synapse,4,1,0.018761,3.976,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.018761,3.976,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Bile secretion,52,2,0.021469,3.8412,1,1,0.018349,C00114;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00750,mmu04976+C00114:Choline;C00750:Spermine
Pantothenate and CoA biosynthesis,12,1,0.055439,2.8925,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
beta-Alanine metabolism,12,1,0.055439,2.8925,1,1,0.025862,C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00750,mmu00410+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.055439,2.8925,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.082221,2.4983,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Phenylalanine metabolism,22,1,0.099735,2.3052,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Glutathione metabolism,22,1,0.099735,2.3052,1,1,0.013986,C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00750,mmu00480+C00750:Spermine
Nicotinate and nicotinamide metabolism,27,1,0.12125,2.1099,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Arginine and proline metabolism,35,1,0.15482,1.8655,1,1,0.019608,C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00750,mmu00330+C00750:Spermine
Purine metabolism,51,1,0.21888,1.5192,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
ABC transporters,59,1,0.24942,1.3886,1,1,0.0072464,C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114,mmu02010+C00114:Choline
Cholinergic synapse,4,1,0.018761,3.976,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.018761,3.976,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Glycerophospholipid metabolism,12,1,0.055439,2.8925,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.082221,2.4983,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Phenylalanine metabolism,22,1,0.099735,2.3052,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Nicotinate and nicotinamide metabolism,27,1,0.12125,2.1099,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Metabolism of xenobiotics by cytochrome P450,43,1,0.18735,1.6748,1,1,0.011952,C19588,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588,mmu00980+C19588:Aflatoxin B1 diol
Purine metabolism,51,1,0.21888,1.5192,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Bile secretion,52,1,0.22275,1.5017,1,1,0.0091743,C00114,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114,mmu04976+C00114:Choline
ABC transporters,59,1,0.24942,1.3886,1,1,0.0072464,C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114,mmu02010+C00114:Choline
Glutathione metabolism,22,3,0.00060243,7.4145,0.12832,0.12832,0.083916,C00025;C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00315+C00750,mmu00480+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
Arginine and proline metabolism,35,3,0.0024206,6.0237,0.51317,0.2578,0.11275,C00025;C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00315+C00750,mmu00330+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
beta-Alanine metabolism,12,2,0.0040501,5.509,0.85457,0.28756,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Spinocerebellar ataxia,1,1,0.0084906,4.7688,1,0.31674,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.0084906,4.7688,1,0.31674,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Long-term potentiation,2,1,0.016917,4.0794,1,0.31674,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Amyotrophic lateral sclerosis,3,1,0.02528,3.6778,1,0.31674,0.055556,C00025,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025,mmu05014+C00025:L-Glutamate
Proximal tubule bicarbonate reclamation,3,1,0.02528,3.6778,1,0.31674,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amphetamine addiction,3,1,0.02528,3.6778,1,0.31674,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.02528,3.6778,1,0.31674,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.02528,3.6778,1,0.31674,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.02528,3.6778,1,0.31674,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.02528,3.6778,1,0.31674,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.02528,3.6778,1,0.31674,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.02528,3.6778,1,0.31674,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.02528,3.6778,1,0.31674,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.02528,3.6778,1,0.31674,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
Phospholipase D signaling pathway,4,1,0.033579,3.3939,1,0.35762,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.033579,3.3939,1,0.35762,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.033579,3.3939,1,0.35762,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Synaptic vesicle cycle,5,1,0.041816,3.1745,1,0.40485,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.041816,3.1745,1,0.40485,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Metabolism of xenobiotics by cytochrome P450,43,2,0.048294,3.0305,1,0.44724,0.015936,C19588;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588+C19594,"mmu00980+C19588:Aflatoxin B1 diol;C19594:Aflatoxin-M1-8,9-epoxide"
Pathways of neurodegeneration - multiple diseases,8,1,0.066152,2.7158,1,0.55818,0.020833,C00025,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025,mmu05022+C00025:L-Glutamate
Retrograde endocannabinoid signaling,8,1,0.066152,2.7158,1,0.55818,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Bile secretion,52,2,0.068135,2.6863,1,0.55818,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
ABC transporters,59,2,0.085223,2.4625,1,0.63856,0.014493,C00025;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00315,mmu02010+C00025:L-Glutamate;C00315:Spermidine
Butanoate metabolism,11,1,0.089938,2.4086,1,0.63856,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
Arginine biosynthesis,11,1,0.089938,2.4086,1,0.63856,0.081761,C00025,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025,mmu00220+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.089938,2.4086,1,0.63856,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Pantothenate and CoA biosynthesis,12,1,0.097746,2.3254,1,0.67161,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Taste transduction,14,1,0.11318,2.1787,1,0.73055,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.11318,2.1787,1,0.73055,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Aminoacyl-tRNA biosynthesis,16,1,0.12839,2.0527,1,0.8043,0.017857,C00025,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025,mmu00970+C00025:L-Glutamate
Central carbon metabolism in cancer,17,1,0.1359,1.9958,1,0.82705,0.037736,C00025,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025,mmu05230+C00025:L-Glutamate
Glyoxylate and dicarboxylate metabolism,18,1,0.14336,1.9424,1,0.84819,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Ferroptosis,19,1,0.15075,1.8921,1,0.86786,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
Protein digestion and absorption,21,1,0.16538,1.7995,1,0.91916,0.021277,C00025,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025,mmu04974+C00025:L-Glutamate
Phenylalanine metabolism,22,1,0.17261,1.7567,1,0.91916,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Phosphonate and phosphinate metabolism,22,1,0.17261,1.7567,1,0.91916,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Histidine metabolism,23,1,0.17979,1.716,1,0.93401,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.20098,1.6046,1,1,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
Nicotinate and nicotinamide metabolism,27,1,0.20793,1.5705,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.25513,1.366,1,1,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Purine metabolism,51,1,0.3595,1.023,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Porphyrin and chlorophyll metabolism,54,1,0.37651,0.97682,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
Spinocerebellar ataxia,1,1,0.0028302,5.8674,0.60283,0.12893,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.0028302,5.8674,0.60283,0.12893,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Long-term potentiation,2,1,0.005655,5.1752,1,0.12893,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Amyotrophic lateral sclerosis,3,1,0.0084745,4.7707,1,0.12893,0.055556,C00025,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025,mmu05014+C00025:L-Glutamate
Proximal tubule bicarbonate reclamation,3,1,0.0084745,4.7707,1,0.12893,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amphetamine addiction,3,1,0.0084745,4.7707,1,0.12893,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.0084745,4.7707,1,0.12893,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.0084745,4.7707,1,0.12893,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.0084745,4.7707,1,0.12893,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.0084745,4.7707,1,0.12893,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.0084745,4.7707,1,0.12893,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.0084745,4.7707,1,0.12893,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.0084745,4.7707,1,0.12893,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.0084745,4.7707,1,0.12893,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
Phospholipase D signaling pathway,4,1,0.011289,4.484,1,0.14144,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.011289,4.484,1,0.14144,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.011289,4.484,1,0.14144,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Synaptic vesicle cycle,5,1,0.014098,4.2618,1,0.15804,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.014098,4.2618,1,0.15804,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Pathways of neurodegeneration - multiple diseases,8,1,0.022492,3.7946,1,0.21776,0.020833,C00025,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025,mmu05022+C00025:L-Glutamate
Glycolysis / Gluconeogenesis,8,1,0.022492,3.7946,1,0.21776,0.037344,C00236,mmu00010,http://www.kegg.jp/pathway/mmu00010+C00236,mmu00010+C00236:3-Phospho-D-glyceroyl phosphate
Retrograde endocannabinoid signaling,8,1,0.022492,3.7946,1,0.21776,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Butanoate metabolism,11,1,0.030839,3.479,1,0.26275,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
Arginine biosynthesis,11,1,0.030839,3.479,1,0.26275,0.081761,C00025,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025,mmu00220+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.030839,3.479,1,0.26275,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Taste transduction,14,1,0.039138,3.2407,1,0.30876,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.039138,3.2407,1,0.30876,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Aminoacyl-tRNA biosynthesis,16,1,0.044644,3.109,1,0.33962,0.017857,C00025,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025,mmu00970+C00025:L-Glutamate
Central carbon metabolism in cancer,17,1,0.04739,3.0493,1,0.34807,0.037736,C00025,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025,mmu05230+C00025:L-Glutamate
Glyoxylate and dicarboxylate metabolism,18,1,0.05013,2.9931,1,0.35592,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Ferroptosis,19,1,0.052864,2.94,1,0.36323,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
Protein digestion and absorption,21,1,0.058318,2.8418,1,0.38238,0.021277,C00025,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025,mmu04974+C00025:L-Glutamate
Phosphonate and phosphinate metabolism,22,1,0.061037,2.7963,1,0.38238,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Glutathione metabolism,22,1,0.061037,2.7963,1,0.38238,0.041958,C00025,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025,mmu00480+C00025:L-Glutamate
Histidine metabolism,23,1,0.063751,2.7528,1,0.38797,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.071861,2.633,1,0.42518,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.093258,2.3724,1,0.53686,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Arginine and proline metabolism,35,1,0.095909,2.3444,1,0.5376,0.04902,C00025,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025,mmu00330+C00025:L-Glutamate
Porphyrin and chlorophyll metabolism,54,1,0.14531,1.9289,1,0.7936,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
ABC transporters,59,1,0.158,1.8452,1,0.84135,0.0072464,C00025,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025,mmu02010+C00025:L-Glutamate
Cholinergic synapse,4,1,0.022482,3.7951,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.022482,3.7951,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Glycerophospholipid metabolism,12,1,0.066183,2.7153,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.097879,2.324,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Terpenoid backbone biosynthesis,19,1,0.10307,2.2723,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phenylalanine metabolism,22,1,0.11851,2.1328,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Nicotinate and nicotinamide metabolism,27,1,0.14374,1.9397,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Drug metabolism - cytochrome P450,32,1,0.16837,1.7816,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Purine metabolism,51,1,0.25664,1.3601,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Bile secretion,52,1,0.26106,1.343,1,1,0.0091743,C00114,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114,mmu04976+C00114:Choline
ABC transporters,59,1,0.29139,1.2331,1,1,0.0072464,C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114,mmu02010+C00114:Choline
Glutathione metabolism,22,2,0.0024076,6.0291,0.51281,0.14552,0.055944,C00025;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00750,mmu00480+C00025:L-Glutamate;C00750:Spermine
Spinocerebellar ataxia,1,1,0.0037736,5.5797,0.8,0.14552,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.0037736,5.5797,0.8,0.14552,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Arginine and proline metabolism,35,2,0.0060991,5.0996,1,0.14552,0.068627,C00025;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00750,mmu00330+C00025:L-Glutamate;C00750:Spermine
Long-term potentiation,2,1,0.0075365,4.888,1,0.14552,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Amyotrophic lateral sclerosis,3,1,0.011289,4.484,1,0.14552,0.055556,C00025,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025,mmu05014+C00025:L-Glutamate
Proximal tubule bicarbonate reclamation,3,1,0.011289,4.484,1,0.14552,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amphetamine addiction,3,1,0.011289,4.484,1,0.14552,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.011289,4.484,1,0.14552,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.011289,4.484,1,0.14552,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.011289,4.484,1,0.14552,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.011289,4.484,1,0.14552,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.011289,4.484,1,0.14552,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.011289,4.484,1,0.14552,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.011289,4.484,1,0.14552,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.011289,4.484,1,0.14552,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
Bile secretion,52,2,0.013297,4.3202,1,0.14552,0.018349,C00114;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00750,mmu04976+C00114:Choline;C00750:Spermine
Phospholipase D signaling pathway,4,1,0.01503,4.1977,1,0.14552,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.01503,4.1977,1,0.14552,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.01503,4.1977,1,0.14552,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Cholinergic synapse,4,1,0.01503,4.1977,1,0.14552,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.01503,4.1977,1,0.14552,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
ABC transporters,59,2,0.017003,4.0744,1,0.15746,0.014493,C00025;C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00114,mmu02010+C00025:L-Glutamate;C00114:Choline
Synaptic vesicle cycle,5,1,0.018761,3.976,1,0.15985,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.018761,3.976,1,0.15985,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Pathways of neurodegeneration - multiple diseases,8,1,0.02989,3.5102,1,0.2358,0.020833,C00025,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025,mmu05022+C00025:L-Glutamate
Retrograde endocannabinoid signaling,8,1,0.02989,3.5102,1,0.2358,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Butanoate metabolism,11,1,0.040925,3.196,1,0.28776,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
Arginine biosynthesis,11,1,0.040925,3.196,1,0.28776,0.081761,C00025,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025,mmu00220+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.040925,3.196,1,0.28776,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Pantothenate and CoA biosynthesis,12,1,0.044582,3.1104,1,0.28776,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
beta-Alanine metabolism,12,1,0.044582,3.1104,1,0.28776,0.025862,C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00750,mmu00410+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.044582,3.1104,1,0.28776,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
Taste transduction,14,1,0.051865,2.9591,1,0.31563,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.051865,2.9591,1,0.31563,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Aminoacyl-tRNA biosynthesis,16,1,0.059106,2.8284,1,0.34971,0.017857,C00025,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025,mmu00970+C00025:L-Glutamate
Central carbon metabolism in cancer,17,1,0.062711,2.7692,1,0.36101,0.037736,C00025,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025,mmu05230+C00025:L-Glutamate
"Glycine, serine and threonine metabolism",18,1,0.066305,2.7135,1,0.36213,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Glyoxylate and dicarboxylate metabolism,18,1,0.066305,2.7135,1,0.36213,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Ferroptosis,19,1,0.06989,2.6608,1,0.37216,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
Protein digestion and absorption,21,1,0.077027,2.5636,1,0.40017,0.021277,C00025,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025,mmu04974+C00025:L-Glutamate
Phenylalanine metabolism,22,1,0.08058,2.5185,1,0.40866,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Histidine metabolism,23,1,0.084123,2.4755,1,0.4167,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.094691,2.3571,1,0.45839,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.12242,2.1003,1,0.57948,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Porphyrin and chlorophyll metabolism,54,1,0.18897,1.6662,1,0.87502,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
Phosphonate and phosphinate metabolism,22,1,0.061037,2.7963,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Drug metabolism - cytochrome P450,32,1,0.08794,2.4311,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Purine metabolism,51,1,0.13763,1.9832,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Purine metabolism,51,1,0.048113,3.0342,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Terpenoid backbone biosynthesis,19,1,0.10307,2.2723,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phenylalanine metabolism,22,1,0.11851,2.1328,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Phosphonate and phosphinate metabolism,22,1,0.11851,2.1328,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Nicotinate and nicotinamide metabolism,27,1,0.14374,1.9397,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Metabolism of xenobiotics by cytochrome P450,43,1,0.22048,1.512,1,1,0.011952,C19588,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588,mmu00980+C19588:Aflatoxin B1 diol
Purine metabolism,51,1,0.25664,1.3601,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Glycolysis / Gluconeogenesis,8,1,0.022492,3.7946,1,1,0.037344,C00236,mmu00010,http://www.kegg.jp/pathway/mmu00010+C00236,mmu00010+C00236:3-Phospho-D-glyceroyl phosphate
Phosphonate and phosphinate metabolism,22,1,0.061037,2.7963,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Drug metabolism - cytochrome P450,32,1,0.08794,2.4311,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Spinocerebellar ataxia,1,1,0.010377,4.5681,1,0.41509,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.010377,4.5681,1,0.41509,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Glutathione metabolism,22,2,0.020203,3.9019,1,0.41509,0.055944,C00025;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00750,mmu00480+C00025:L-Glutamate;C00750:Spermine
Long-term potentiation,2,1,0.020657,3.8797,1,0.41509,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Amyotrophic lateral sclerosis,3,1,0.030839,3.479,1,0.41509,0.055556,C00025,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025,mmu05014+C00025:L-Glutamate
Proximal tubule bicarbonate reclamation,3,1,0.030839,3.479,1,0.41509,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amphetamine addiction,3,1,0.030839,3.479,1,0.41509,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.030839,3.479,1,0.41509,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.030839,3.479,1,0.41509,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.030839,3.479,1,0.41509,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.030839,3.479,1,0.41509,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.030839,3.479,1,0.41509,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.030839,3.479,1,0.41509,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.030839,3.479,1,0.41509,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.030839,3.479,1,0.41509,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
Phospholipase D signaling pathway,4,1,0.040925,3.196,1,0.41509,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.040925,3.196,1,0.41509,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.040925,3.196,1,0.41509,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Pertussis,4,1,0.040925,3.196,1,0.41509,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Cholinergic synapse,4,1,0.040925,3.196,1,0.41509,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.040925,3.196,1,0.41509,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Arginine and proline metabolism,35,2,0.048332,3.0297,1,0.45187,0.068627,C00025;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00750,mmu00330+C00025:L-Glutamate;C00750:Spermine
Synaptic vesicle cycle,5,1,0.050915,2.9776,1,0.45187,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.050915,2.9776,1,0.45187,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Pathways of neurodegeneration - multiple diseases,8,1,0.080321,2.5217,1,0.65802,0.020833,C00025,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025,mmu05022+C00025:L-Glutamate
Retrograde endocannabinoid signaling,8,1,0.080321,2.5217,1,0.65802,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Purine metabolism,51,2,0.094579,2.3583,1,0.73816,0.013409,C00360;C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360+C01345,mmu00230+C00360:dAMP;C01345:dITP
Bile secretion,52,2,0.097806,2.3248,1,0.73816,0.018349,C00114;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00750,mmu04976+C00114:Choline;C00750:Spermine
Butanoate metabolism,11,1,0.1089,2.2174,1,0.73816,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
Arginine biosynthesis,11,1,0.1089,2.2174,1,0.73816,0.081761,C00025,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025,mmu00220+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.1089,2.2174,1,0.73816,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Pantothenate and CoA biosynthesis,12,1,0.11824,2.135,1,0.73816,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
beta-Alanine metabolism,12,1,0.11824,2.135,1,0.73816,0.025862,C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00750,mmu00410+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.11824,2.135,1,0.73816,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
ABC transporters,59,2,0.12129,2.1095,1,0.73816,0.014493,C00025;C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00114,mmu02010+C00025:L-Glutamate;C00114:Choline
Taste transduction,14,1,0.13666,1.9902,1,0.78674,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.13666,1.9902,1,0.78674,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Aminoacyl-tRNA biosynthesis,16,1,0.15473,1.866,1,0.86733,0.017857,C00025,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025,mmu00970+C00025:L-Glutamate
Central carbon metabolism in cancer,17,1,0.16364,1.8101,1,0.89373,0.037736,C00025,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025,mmu05230+C00025:L-Glutamate
"Glycine, serine and threonine metabolism",18,1,0.17246,1.7576,1,0.89596,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Glyoxylate and dicarboxylate metabolism,18,1,0.17246,1.7576,1,0.89596,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Terpenoid backbone biosynthesis,19,1,0.1812,1.7082,1,0.89756,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Ferroptosis,19,1,0.1812,1.7082,1,0.89756,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
Protein digestion and absorption,21,1,0.19842,1.6174,1,0.96052,0.021277,C00025,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025,mmu04974+C00025:L-Glutamate
Phenylalanine metabolism,22,1,0.2069,1.5755,1,0.97935,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Histidine metabolism,23,1,0.21531,1.5357,1,0.99697,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.24004,1.427,1,1,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
Nicotinate and nicotinamide metabolism,27,1,0.24812,1.3938,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Drug metabolism - cytochrome P450,32,1,0.28739,1.2469,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.30256,1.1955,1,1,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Metabolism of xenobiotics by cytochrome P450,43,1,0.36729,1.0016,1,1,0.0039841,C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19594,"mmu00980+C19594:Aflatoxin-M1-8,9-epoxide"
Porphyrin and chlorophyll metabolism,54,1,0.43896,0.82335,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
Glutathione metabolism,22,3,0.00040711,7.8064,0.086714,0.086714,0.083916,C00025;C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00315+C00750,mmu00480+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
Arginine and proline metabolism,35,3,0.0016511,6.4063,0.35003,0.17584,0.11275,C00025;C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00315+C00750,mmu00330+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
beta-Alanine metabolism,12,2,0.00317,5.754,0.66887,0.22507,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Bile secretion,52,3,0.0052416,5.2511,1,0.22965,0.027523,C00114;C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00315+C00750,mmu04976+C00114:Choline;C00315:Spermidine;C00750:Spermine
ABC transporters,59,3,0.0075159,4.8907,1,0.22965,0.021739,C00025;C00114;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00114+C00315,mmu02010+C00025:L-Glutamate;C00114:Choline;C00315:Spermidine
Spinocerebellar ataxia,1,1,0.0075472,4.8866,1,0.22965,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.0075472,4.8866,1,0.22965,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Long-term potentiation,2,1,0.015044,4.1967,1,0.25215,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Amyotrophic lateral sclerosis,3,1,0.022492,3.7946,1,0.25215,0.055556,C00025,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025,mmu05014+C00025:L-Glutamate
Proximal tubule bicarbonate reclamation,3,1,0.022492,3.7946,1,0.25215,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amphetamine addiction,3,1,0.022492,3.7946,1,0.25215,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.022492,3.7946,1,0.25215,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.022492,3.7946,1,0.25215,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.022492,3.7946,1,0.25215,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.022492,3.7946,1,0.25215,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.022492,3.7946,1,0.25215,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.022492,3.7946,1,0.25215,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.022492,3.7946,1,0.25215,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.022492,3.7946,1,0.25215,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
Phospholipase D signaling pathway,4,1,0.02989,3.5102,1,0.26528,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.02989,3.5102,1,0.26528,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.02989,3.5102,1,0.26528,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Cholinergic synapse,4,1,0.02989,3.5102,1,0.26528,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.02989,3.5102,1,0.26528,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Synaptic vesicle cycle,5,1,0.03724,3.2904,1,0.30508,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.03724,3.2904,1,0.30508,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Pathways of neurodegeneration - multiple diseases,8,1,0.058996,2.8303,1,0.44879,0.020833,C00025,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025,mmu05022+C00025:L-Glutamate
Retrograde endocannabinoid signaling,8,1,0.058996,2.8303,1,0.44879,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Butanoate metabolism,11,1,0.080321,2.5217,1,0.55189,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
Arginine biosynthesis,11,1,0.080321,2.5217,1,0.55189,0.081761,C00025,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025,mmu00220+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.080321,2.5217,1,0.55189,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Pantothenate and CoA biosynthesis,12,1,0.087335,2.438,1,0.56371,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.087335,2.438,1,0.56371,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
Taste transduction,14,1,0.10122,2.2904,1,0.61601,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.10122,2.2904,1,0.61601,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Aminoacyl-tRNA biosynthesis,16,1,0.11492,2.1635,1,0.67997,0.017857,C00025,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025,mmu00970+C00025:L-Glutamate
Central carbon metabolism in cancer,17,1,0.12171,2.1061,1,0.70063,0.037736,C00025,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025,mmu05230+C00025:L-Glutamate
"Glycine, serine and threonine metabolism",18,1,0.12844,2.0523,1,0.7015,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Glyoxylate and dicarboxylate metabolism,18,1,0.12844,2.0523,1,0.7015,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Ferroptosis,19,1,0.13513,2.0015,1,0.71959,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
Protein digestion and absorption,21,1,0.14838,1.908,1,0.77087,0.021277,C00025,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025,mmu04974+C00025:L-Glutamate
Phenylalanine metabolism,22,1,0.15494,1.8647,1,0.78577,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Histidine metabolism,23,1,0.16145,1.8235,1,0.79975,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.18073,1.7108,1,0.87489,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
Nicotinate and nicotinamide metabolism,27,1,0.18707,1.6763,1,0.88545,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.23025,1.4686,1,1,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Metabolism of xenobiotics by cytochrome P450,43,1,0.28281,1.263,1,1,0.011952,C19588,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588,mmu00980+C19588:Aflatoxin B1 diol
Purine metabolism,51,1,0.32687,1.1182,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Porphyrin and chlorophyll metabolism,54,1,0.34277,1.0707,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
Cholinergic synapse,4,1,0.0037736,5.5797,0.80377,0.40189,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.0037736,5.5797,0.80377,0.40189,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Glycerophospholipid metabolism,12,1,0.011321,4.4811,1,0.80377,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.016981,4.0757,1,0.90425,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Bile secretion,52,1,0.049057,3.0148,1,1,0.0091743,C00114,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114,mmu04976+C00114:Choline
ABC transporters,59,1,0.05566,2.8885,1,1,0.0072464,C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114,mmu02010+C00114:Choline
Ferroptosis,19,1,0.052864,2.94,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Phenylalanine metabolism,22,1,0.061037,2.7963,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Drug metabolism - cytochrome P450,32,1,0.08794,2.4311,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Metabolism of xenobiotics by cytochrome P450,43,2,0.029662,3.5179,1,1,0.015936,C19588;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588+C19594,"mmu00980+C19588:Aflatoxin B1 diol;C19594:Aflatoxin-M1-8,9-epoxide"
Glycolysis / Gluconeogenesis,8,1,0.051792,2.9605,1,1,0.037344,C00236,mmu00010,http://www.kegg.jp/pathway/mmu00010+C00236,mmu00010+C00236:3-Phospho-D-glyceroyl phosphate
beta-Alanine metabolism,12,1,0.076814,2.5664,1,1,0.025862,C00315,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315,mmu00410+C00315:Spermidine
Terpenoid backbone biosynthesis,19,1,0.11924,2.1266,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phosphonate and phosphinate metabolism,22,1,0.13691,1.9884,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Glutathione metabolism,22,1,0.13691,1.9884,1,1,0.027972,C00315,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315,mmu00480+C00315:Spermidine
Drug metabolism - cytochrome P450,32,1,0.19362,1.6419,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Arginine and proline metabolism,35,1,0.20999,1.5607,1,1,0.044118,C00315,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315,mmu00330+C00315:Spermidine
Bile secretion,52,1,0.29752,1.2123,1,1,0.0091743,C00315,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315,mmu04976+C00315:Spermidine
ABC transporters,59,1,0.33106,1.1055,1,1,0.0072464,C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00315,mmu02010+C00315:Spermidine
Spinocerebellar ataxia,1,1,0.0066038,5.0201,1,0.26692,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.0066038,5.0201,1,0.26692,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Glutathione metabolism,22,2,0.0081128,4.8143,1,0.26692,0.055944,C00025;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00750,mmu00480+C00025:L-Glutamate;C00750:Spermine
Long-term potentiation,2,1,0.01317,4.3298,1,0.26692,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Amyotrophic lateral sclerosis,3,1,0.019699,3.9272,1,0.26692,0.055556,C00025,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025,mmu05014+C00025:L-Glutamate
Proximal tubule bicarbonate reclamation,3,1,0.019699,3.9272,1,0.26692,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amphetamine addiction,3,1,0.019699,3.9272,1,0.26692,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.019699,3.9272,1,0.26692,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.019699,3.9272,1,0.26692,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.019699,3.9272,1,0.26692,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.019699,3.9272,1,0.26692,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.019699,3.9272,1,0.26692,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.019699,3.9272,1,0.26692,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.019699,3.9272,1,0.26692,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.019699,3.9272,1,0.26692,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
Arginine and proline metabolism,35,2,0.02005,3.9095,1,0.26692,0.068627,C00025;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00750,mmu00330+C00025:L-Glutamate;C00750:Spermine
Phospholipase D signaling pathway,4,1,0.026191,3.6423,1,0.29362,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.026191,3.6423,1,0.29362,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.026191,3.6423,1,0.29362,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Synaptic vesicle cycle,5,1,0.032646,3.422,1,0.33113,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.032646,3.422,1,0.33113,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Pathways of neurodegeneration - multiple diseases,8,1,0.051792,2.9605,1,0.47964,0.020833,C00025,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025,mmu05022+C00025:L-Glutamate
Retrograde endocannabinoid signaling,8,1,0.051792,2.9605,1,0.47964,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Butanoate metabolism,11,1,0.070613,2.6505,1,0.57848,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
Arginine biosynthesis,11,1,0.070613,2.6505,1,0.57848,0.081761,C00025,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025,mmu00220+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.070613,2.6505,1,0.57848,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Pantothenate and CoA biosynthesis,12,1,0.076814,2.5664,1,0.58434,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
beta-Alanine metabolism,12,1,0.076814,2.5664,1,0.58434,0.025862,C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00750,mmu00410+C00750:Spermine
Taste transduction,14,1,0.089112,2.4179,1,0.63269,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.089112,2.4179,1,0.63269,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Aminoacyl-tRNA biosynthesis,16,1,0.10127,2.29,1,0.69581,0.017857,C00025,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025,mmu00970+C00025:L-Glutamate
Central carbon metabolism in cancer,17,1,0.10729,2.2322,1,0.71418,0.037736,C00025,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025,mmu05230+C00025:L-Glutamate
Glyoxylate and dicarboxylate metabolism,18,1,0.11329,2.1778,1,0.72568,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Terpenoid backbone biosynthesis,19,1,0.11924,2.1266,1,0.72568,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Ferroptosis,19,1,0.11924,2.1266,1,0.72568,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
Protein digestion and absorption,21,1,0.13105,2.0322,1,0.7674,0.021277,C00025,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025,mmu04974+C00025:L-Glutamate
Phenylalanine metabolism,22,1,0.13691,1.9884,1,0.7674,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.13691,1.9884,1,0.7674,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Histidine metabolism,23,1,0.14273,1.9468,1,0.77951,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.15999,1.8327,1,0.85194,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
Drug metabolism - cytochrome P450,32,1,0.19362,1.6419,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.20457,1.5869,1,1,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Purine metabolism,51,1,0.29261,1.2289,1,1,0.01083,C00360,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360,mmu00230+C00360:dAMP
Bile secretion,52,1,0.29752,1.2123,1,1,0.0091743,C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00750,mmu04976+C00750:Spermine
Porphyrin and chlorophyll metabolism,54,1,0.30724,1.1801,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
ABC transporters,59,1,0.33106,1.1055,1,1,0.0072464,C00025,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025,mmu02010+C00025:L-Glutamate
beta-Alanine metabolism,12,2,0.0023926,6.0354,0.50962,0.50962,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.0081128,4.8143,1,0.86401,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
Arginine and proline metabolism,35,2,0.02005,3.9095,1,1,0.063725,C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315+C00750,mmu00330+C00315:Spermidine;C00750:Spermine
Bile secretion,52,2,0.042321,3.1625,1,1,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
Pantothenate and CoA biosynthesis,12,1,0.076814,2.5664,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Ferroptosis,19,1,0.11924,2.1266,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.13691,1.9884,1,1,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Drug metabolism - cytochrome P450,32,1,0.19362,1.6419,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Metabolism of xenobiotics by cytochrome P450,43,1,0.25228,1.3772,1,1,0.0039841,C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19594,"mmu00980+C19594:Aflatoxin-M1-8,9-epoxide"
Purine metabolism,51,1,0.29261,1.2289,1,1,0.01083,C00360,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360,mmu00230+C00360:dAMP
ABC transporters,59,1,0.33106,1.1055,1,1,0.0072464,C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00315,mmu02010+C00315:Spermidine
Amyotrophic lateral sclerosis,3,2,0.00011189,9.098,0.023721,0.011916,0.11111,C00025;C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025+C00062,mmu05014+C00025:L-Glutamate;C00062:L-Arginine
Glutathione metabolism,22,3,0.00025792,8.2629,0.05442,0.018312,0.083916,C00025;C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00315+C00750,mmu00480+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
Pathways of neurodegeneration - multiple diseases,8,2,0.001028,6.8802,0.21587,0.054739,0.041667,C00025;C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025+C00062,mmu05022+C00025:L-Glutamate;C00062:L-Arginine
Arginine biosynthesis,11,2,0.0020001,6.2145,0.41803,0.084937,0.13208,C00025;C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025+C00062,mmu00220+C00025:L-Glutamate;C00062:L-Arginine
beta-Alanine metabolism,12,2,0.0023926,6.0354,0.49766,0.084937,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Aminoacyl-tRNA biosynthesis,16,2,0.0042954,5.4502,0.88915,0.11573,0.035714,C00025;C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025+C00062,mmu00970+C00025:L-Glutamate;C00062:L-Arginine
Central carbon metabolism in cancer,17,2,0.0048527,5.3282,0.99966,0.11573,0.056604,C00025;C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025+C00062,mmu05230+C00025:L-Glutamate;C00062:L-Arginine
ABC transporters,59,3,0.0048901,5.3205,1,0.11573,0.021739,C00025;C00062;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00062+C00315,mmu02010+C00025:L-Glutamate;C00062:L-Arginine;C00315:Spermidine
Ether lipid metabolism,1,1,0.0066038,5.0201,1,0.11722,0.024096,C00670,mmu00565,http://www.kegg.jp/pathway/mmu00565+C00670,mmu00565+C00670:sn-Glycero-3-phosphocholine
Spinocerebellar ataxia,1,1,0.0066038,5.0201,1,0.11722,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.0066038,5.0201,1,0.11722,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Protein digestion and absorption,21,2,0.0073987,4.9065,1,0.12122,0.042553,C00025;C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025+C00062,mmu04974+C00025:L-Glutamate;C00062:L-Arginine
D-Arginine and D-ornithine metabolism,2,1,0.01317,4.3298,1,0.14986,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Long-term potentiation,2,1,0.01317,4.3298,1,0.14986,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Chagas disease,2,1,0.01317,4.3298,1,0.14986,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Proximal tubule bicarbonate reclamation,3,1,0.019699,3.9272,1,0.14986,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amoebiasis,3,1,0.019699,3.9272,1,0.14986,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
Amphetamine addiction,3,1,0.019699,3.9272,1,0.14986,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.019699,3.9272,1,0.14986,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.019699,3.9272,1,0.14986,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.019699,3.9272,1,0.14986,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.019699,3.9272,1,0.14986,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.019699,3.9272,1,0.14986,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.019699,3.9272,1,0.14986,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.019699,3.9272,1,0.14986,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.019699,3.9272,1,0.14986,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
mTOR signaling pathway,3,1,0.019699,3.9272,1,0.14986,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
Phospholipase D signaling pathway,4,1,0.026191,3.6423,1,0.16905,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.026191,3.6423,1,0.16905,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.026191,3.6423,1,0.16905,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Pertussis,4,1,0.026191,3.6423,1,0.16905,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Choline metabolism in cancer,4,1,0.026191,3.6423,1,0.16905,0.11236,C00670,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00670,mmu05231+C00670:sn-Glycero-3-phosphocholine
Synaptic vesicle cycle,5,1,0.032646,3.422,1,0.19868,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.032646,3.422,1,0.19868,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Bile secretion,52,2,0.042321,3.1625,1,0.2504,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
Retrograde endocannabinoid signaling,8,1,0.051792,2.9605,1,0.29816,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Butanoate metabolism,11,1,0.070613,2.6505,1,0.38565,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.070613,2.6505,1,0.38565,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Pantothenate and CoA biosynthesis,12,1,0.076814,2.5664,1,0.39906,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.076814,2.5664,1,0.39906,0.025926,C00670,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00670,mmu00564+C00670:sn-Glycero-3-phosphocholine
Taste transduction,14,1,0.089112,2.4179,1,0.44141,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.089112,2.4179,1,0.44141,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Glyoxylate and dicarboxylate metabolism,18,1,0.11329,2.1778,1,0.54841,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Ferroptosis,19,1,0.11924,2.1266,1,0.56441,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
Histidine metabolism,23,1,0.14273,1.9468,1,0.66089,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.15999,1.8327,1,0.72505,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.20457,1.5869,1,0.90776,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Purine metabolism,51,1,0.29261,1.2289,1,1,0.01083,C00360,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360,mmu00230+C00360:dAMP
Porphyrin and chlorophyll metabolism,54,1,0.30724,1.1801,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
Arginine and proline metabolism,35,4,3.2626E-05,10.33,0.0069493,0.0069493,0.15441,C00025;C00062;C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00062+C00315+C00750,mmu00330+C00025:L-Glutamate;C00062:L-Arginine;C00315:Spermidine;C00750:Spermine
Amyotrophic lateral sclerosis,3,2,0.00023931,8.3377,0.050974,0.050974,0.11111,C00025;C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025+C00062,mmu05014+C00025:L-Glutamate;C00062:L-Arginine
Pathways of neurodegeneration - multiple diseases,8,2,0.0021778,6.1294,0.4617,0.22437,0.041667,C00025;C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025+C00062,mmu05022+C00025:L-Glutamate;C00062:L-Arginine
Arginine and proline metabolism,35,3,0.0033799,5.6899,0.71316,0.22437,0.11029,C00025;C00062;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00062+C00750,mmu00330+C00025:L-Glutamate;C00062:L-Arginine;C00750:Spermine
Arginine biosynthesis,11,2,0.0042135,5.4695,0.88484,0.22437,0.13208,C00025;C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025+C00062,mmu00220+C00025:L-Glutamate;C00062:L-Arginine
Aminoacyl-tRNA biosynthesis,16,2,0.0089636,4.7146,1,0.23909,0.035714,C00025;C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025+C00062,mmu00970+C00025:L-Glutamate;C00062:L-Arginine
Spinocerebellar ataxia,1,1,0.009434,4.6634,1,0.23909,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.009434,4.6634,1,0.23909,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Central carbon metabolism in cancer,17,2,0.010107,4.5945,1,0.23909,0.056604,C00025;C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025+C00062,mmu05230+C00025:L-Glutamate;C00062:L-Arginine
Protein digestion and absorption,21,2,0.015294,4.1803,1,0.23909,0.042553,C00025;C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025+C00062,mmu04974+C00025:L-Glutamate;C00062:L-Arginine
Glutathione metabolism,22,2,0.016739,4.09,1,0.23909,0.055944,C00025;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00750,mmu00480+C00025:L-Glutamate;C00750:Spermine
D-Arginine and D-ornithine metabolism,2,1,0.018788,3.9746,1,0.23909,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Long-term potentiation,2,1,0.018788,3.9746,1,0.23909,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Chagas disease,2,1,0.018788,3.9746,1,0.23909,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Proximal tubule bicarbonate reclamation,3,1,0.028062,3.5733,1,0.23909,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amoebiasis,3,1,0.028062,3.5733,1,0.23909,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
Amphetamine addiction,3,1,0.028062,3.5733,1,0.23909,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.028062,3.5733,1,0.23909,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.028062,3.5733,1,0.23909,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.028062,3.5733,1,0.23909,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.028062,3.5733,1,0.23909,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.028062,3.5733,1,0.23909,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.028062,3.5733,1,0.23909,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.028062,3.5733,1,0.23909,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.028062,3.5733,1,0.23909,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
mTOR signaling pathway,3,1,0.028062,3.5733,1,0.23909,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
Phospholipase D signaling pathway,4,1,0.037257,3.2899,1,0.28342,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.037257,3.2899,1,0.28342,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.037257,3.2899,1,0.28342,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Synaptic vesicle cycle,5,1,0.046374,3.071,1,0.32926,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.046374,3.071,1,0.32926,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Metabolism of xenobiotics by cytochrome P450,43,2,0.058837,2.833,1,0.40427,0.015936,C19588;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588+C19594,"mmu00980+C19588:Aflatoxin B1 diol;C19594:Aflatoxin-M1-8,9-epoxide"
Retrograde endocannabinoid signaling,8,1,0.07326,2.6137,1,0.48764,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Butanoate metabolism,11,1,0.099463,2.308,1,0.622,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.099463,2.308,1,0.622,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
ABC transporters,59,2,0.10281,2.2749,1,0.622,0.014493,C00025;C00062,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00062,mmu02010+C00025:L-Glutamate;C00062:L-Arginine
Pantothenate and CoA biosynthesis,12,1,0.10805,2.2252,1,0.622,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
beta-Alanine metabolism,12,1,0.10805,2.2252,1,0.622,0.025862,C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00750,mmu00410+C00750:Spermine
Taste transduction,14,1,0.125,2.0795,1,0.68267,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.125,2.0795,1,0.68267,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Glyoxylate and dicarboxylate metabolism,18,1,0.15803,1.845,1,0.84149,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Ferroptosis,19,1,0.16611,1.7951,1,0.86295,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
Phenylalanine metabolism,22,1,0.18993,1.6611,1,0.91944,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Phosphonate and phosphinate metabolism,22,1,0.18993,1.6611,1,0.91944,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.18993,1.6611,1,0.91944,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Histidine metabolism,23,1,0.19774,1.6208,1,0.93595,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.22074,1.5108,1,1,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
Nicotinate and nicotinamide metabolism,27,1,0.22828,1.4772,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.27922,1.2757,1,1,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Purine metabolism,51,1,0.39058,0.94012,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Bile secretion,52,1,0.39662,0.92477,1,1,0.0091743,C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00750,mmu04976+C00750:Spermine
Porphyrin and chlorophyll metabolism,54,1,0.40854,0.89517,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
Ether lipid metabolism,1,1,0.0066038,5.0201,1,0.27894,0.024096,C00670,mmu00565,http://www.kegg.jp/pathway/mmu00565+C00670,mmu00565+C00670:sn-Glycero-3-phosphocholine
Spinocerebellar ataxia,1,1,0.0066038,5.0201,1,0.27894,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.0066038,5.0201,1,0.27894,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Long-term potentiation,2,1,0.01317,4.3298,1,0.27894,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Amyotrophic lateral sclerosis,3,1,0.019699,3.9272,1,0.27894,0.055556,C00025,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025,mmu05014+C00025:L-Glutamate
Proximal tubule bicarbonate reclamation,3,1,0.019699,3.9272,1,0.27894,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amphetamine addiction,3,1,0.019699,3.9272,1,0.27894,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.019699,3.9272,1,0.27894,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.019699,3.9272,1,0.27894,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.019699,3.9272,1,0.27894,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.019699,3.9272,1,0.27894,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.019699,3.9272,1,0.27894,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.019699,3.9272,1,0.27894,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.019699,3.9272,1,0.27894,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.019699,3.9272,1,0.27894,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
Phospholipase D signaling pathway,4,1,0.026191,3.6423,1,0.27894,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.026191,3.6423,1,0.27894,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.026191,3.6423,1,0.27894,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Pertussis,4,1,0.026191,3.6423,1,0.27894,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Choline metabolism in cancer,4,1,0.026191,3.6423,1,0.27894,0.11236,C00670,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00670,mmu05231+C00670:sn-Glycero-3-phosphocholine
Synaptic vesicle cycle,5,1,0.032646,3.422,1,0.31608,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.032646,3.422,1,0.31608,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Caffeine metabolism,7,1,0.045447,3.0912,1,0.42088,0.029412,C07481,mmu00232,http://www.kegg.jp/pathway/mmu00232+C07481,mmu00232+C07481:Caffeine
Pathways of neurodegeneration - multiple diseases,8,1,0.051792,2.9605,1,0.4243,0.020833,C00025,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025,mmu05022+C00025:L-Glutamate
Glycolysis / Gluconeogenesis,8,1,0.051792,2.9605,1,0.4243,0.037344,C00236,mmu00010,http://www.kegg.jp/pathway/mmu00010+C00236,mmu00010+C00236:3-Phospho-D-glyceroyl phosphate
Retrograde endocannabinoid signaling,8,1,0.051792,2.9605,1,0.4243,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Butanoate metabolism,11,1,0.070613,2.6505,1,0.51864,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
Arginine biosynthesis,11,1,0.070613,2.6505,1,0.51864,0.081761,C00025,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025,mmu00220+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.070613,2.6505,1,0.51864,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Glycerophospholipid metabolism,12,1,0.076814,2.5664,1,0.54538,0.025926,C00670,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00670,mmu00564+C00670:sn-Glycero-3-phosphocholine
Taste transduction,14,1,0.089112,2.4179,1,0.59315,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.089112,2.4179,1,0.59315,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Aminoacyl-tRNA biosynthesis,16,1,0.10127,2.29,1,0.65364,0.017857,C00025,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025,mmu00970+C00025:L-Glutamate
Central carbon metabolism in cancer,17,1,0.10729,2.2322,1,0.67217,0.037736,C00025,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025,mmu05230+C00025:L-Glutamate
Glyoxylate and dicarboxylate metabolism,18,1,0.11329,2.1778,1,0.68942,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Ferroptosis,19,1,0.11924,2.1266,1,0.70552,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
Protein digestion and absorption,21,1,0.13105,2.0322,1,0.74773,0.021277,C00025,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025,mmu04974+C00025:L-Glutamate
Phosphonate and phosphinate metabolism,22,1,0.13691,1.9884,1,0.74773,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Glutathione metabolism,22,1,0.13691,1.9884,1,0.74773,0.041958,C00025,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025,mmu00480+C00025:L-Glutamate
Histidine metabolism,23,1,0.14273,1.9468,1,0.76003,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.15999,1.8327,1,0.83116,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
Drug metabolism - cytochrome P450,32,1,0.19362,1.6419,1,0.98191,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.20457,1.5869,1,1,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Arginine and proline metabolism,35,1,0.20999,1.5607,1,1,0.04902,C00025,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025,mmu00330+C00025:L-Glutamate
Porphyrin and chlorophyll metabolism,54,1,0.30724,1.1801,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
ABC transporters,59,1,0.33106,1.1055,1,1,0.0072464,C00025,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025,mmu02010+C00025:L-Glutamate
Choline metabolism in cancer,4,2,0.00038145,7.8715,0.08125,0.08125,0.32584,C00114;C00670,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114+C00670,mmu05231+C00114:Choline;C00670:sn-Glycero-3-phosphocholine
beta-Alanine metabolism,12,2,0.0040501,5.509,0.85862,0.28756,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Glycerophospholipid metabolism,12,2,0.0040501,5.509,0.85862,0.28756,0.098148,C00114;C00670,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114+C00670,mmu00564+C00114:Choline;C00670:sn-Glycero-3-phosphocholine
Bile secretion,52,3,0.0075914,4.8807,1,0.3617,0.027523,C00114;C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00315+C00750,mmu04976+C00114:Choline;C00315:Spermidine;C00750:Spermine
Ether lipid metabolism,1,1,0.0084906,4.7688,1,0.3617,0.024096,C00670,mmu00565,http://www.kegg.jp/pathway/mmu00565+C00670,mmu00565+C00670:sn-Glycero-3-phosphocholine
Glutathione metabolism,22,2,0.013561,4.3006,1,0.48142,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
Arginine and proline metabolism,35,2,0.032972,3.4121,1,0.89404,0.063725,C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315+C00750,mmu00330+C00315:Spermidine;C00750:Spermine
Cholinergic synapse,4,1,0.033579,3.3939,1,0.89404,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Metabolism of xenobiotics by cytochrome P450,43,2,0.048294,3.0305,1,1,0.015936,C19588;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588+C19594,"mmu00980+C19588:Aflatoxin B1 diol;C19594:Aflatoxin-M1-8,9-epoxide"
ABC transporters,59,2,0.085223,2.4625,1,1,0.014493,C00114;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114+C00315,mmu02010+C00114:Choline;C00315:Spermidine
Pantothenate and CoA biosynthesis,12,1,0.097746,2.3254,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
"Glycine, serine and threonine metabolism",18,1,0.14336,1.9424,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Terpenoid backbone biosynthesis,19,1,0.15075,1.8921,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Nicotinate and nicotinamide metabolism,27,1,0.20793,1.5705,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Purine metabolism,51,1,0.3595,1.023,1,1,0.01083,C00360,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360,mmu00230+C00360:dAMP
beta-Alanine metabolism,12,2,0.0011538,6.7647,0.24576,0.24576,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.0039622,5.531,0.83998,0.42197,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
Arginine and proline metabolism,35,2,0.0099545,4.6097,1,0.70677,0.063725,C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315+C00750,mmu00330+C00315:Spermidine;C00750:Spermine
Bile secretion,52,2,0.021469,3.8412,1,1,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
Caffeine metabolism,7,1,0.032646,3.422,1,1,0.029412,C07481,mmu00232,http://www.kegg.jp/pathway/mmu00232+C07481,mmu00232+C07481:Caffeine
Pantothenate and CoA biosynthesis,12,1,0.055439,2.8925,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Nicotinate and nicotinamide metabolism,27,1,0.12125,2.1099,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Purine metabolism,51,1,0.21888,1.5192,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
ABC transporters,59,1,0.24942,1.3886,1,1,0.0072464,C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00315,mmu02010+C00315:Spermidine
Choline metabolism in cancer,4,2,0.0005813,7.4502,0.12382,0.12382,0.32584,C00114;C00670,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114+C00670,mmu05231+C00114:Choline;C00670:sn-Glycero-3-phosphocholine
beta-Alanine metabolism,12,2,0.0061099,5.0978,1,0.43381,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Glycerophospholipid metabolism,12,2,0.0061099,5.0978,1,0.43381,0.098148,C00114;C00670,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114+C00670,mmu00564+C00114:Choline;C00670:sn-Glycero-3-phosphocholine
Ether lipid metabolism,1,1,0.010377,4.5681,1,0.55259,0.024096,C00670,mmu00565,http://www.kegg.jp/pathway/mmu00565+C00670,mmu00565+C00670:sn-Glycero-3-phosphocholine
Bile secretion,52,3,0.013904,4.2756,1,0.59231,0.027523,C00114;C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00315+C00750,mmu04976+C00114:Choline;C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.020203,3.9019,1,0.7172,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
Pertussis,4,1,0.040925,3.196,1,1,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Cholinergic synapse,4,1,0.040925,3.196,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Arginine and proline metabolism,35,2,0.048332,3.0297,1,1,0.063725,C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315+C00750,mmu00330+C00315:Spermidine;C00750:Spermine
Metabolism of xenobiotics by cytochrome P450,43,2,0.070094,2.6579,1,1,0.015936,C19588;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588+C19594,"mmu00980+C19588:Aflatoxin B1 diol;C19594:Aflatoxin-M1-8,9-epoxide"
Pantothenate and CoA biosynthesis,12,1,0.11824,2.135,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
ABC transporters,59,2,0.12129,2.1095,1,1,0.014493,C00114;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114+C00315,mmu02010+C00114:Choline;C00315:Spermidine
"Glycine, serine and threonine metabolism",18,1,0.17246,1.7576,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Ferroptosis,19,1,0.1812,1.7082,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Terpenoid backbone biosynthesis,19,1,0.1812,1.7082,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phosphonate and phosphinate metabolism,22,1,0.2069,1.5755,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Drug metabolism - cytochrome P450,32,1,0.28739,1.2469,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Arginine and proline metabolism,35,2,0.0031142,5.7718,0.66332,0.30085,0.061275,C00062;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00062+C00750,mmu00330+C00062:L-Arginine;C00750:Spermine
D-Arginine and D-ornithine metabolism,2,1,0.005655,5.1752,1,0.30085,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Chagas disease,2,1,0.005655,5.1752,1,0.30085,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Amyotrophic lateral sclerosis,3,1,0.0084745,4.7707,1,0.30085,0.055556,C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00062,mmu05014+C00062:L-Arginine
Amoebiasis,3,1,0.0084745,4.7707,1,0.30085,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
mTOR signaling pathway,3,1,0.0084745,4.7707,1,0.30085,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
Pathways of neurodegeneration - multiple diseases,8,1,0.022492,3.7946,1,0.6844,0.020833,C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00062,mmu05022+C00062:L-Arginine
Arginine biosynthesis,11,1,0.030839,3.479,1,0.71591,0.050314,C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00062,mmu00220+C00062:L-Arginine
Pantothenate and CoA biosynthesis,12,1,0.033611,3.3929,1,0.71591,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
beta-Alanine metabolism,12,1,0.033611,3.3929,1,0.71591,0.025862,C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00750,mmu00410+C00750:Spermine
Aminoacyl-tRNA biosynthesis,16,1,0.044644,3.109,1,0.84117,0.017857,C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00062,mmu00970+C00062:L-Arginine
Central carbon metabolism in cancer,17,1,0.04739,3.0493,1,0.84117,0.018868,C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00062,mmu05230+C00062:L-Arginine
Protein digestion and absorption,21,1,0.058318,2.8418,1,0.86673,0.021277,C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00062,mmu04974+C00062:L-Arginine
Glutathione metabolism,22,1,0.061037,2.7963,1,0.86673,0.013986,C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00750,mmu00480+C00750:Spermine
Phosphonate and phosphinate metabolism,22,1,0.061037,2.7963,1,0.86673,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Bile secretion,52,1,0.14019,1.9647,1,1,0.0091743,C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00750,mmu04976+C00750:Spermine
ABC transporters,59,1,0.158,1.8452,1,1,0.0072464,C00062,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00062,mmu02010+C00062:L-Arginine
Pathways of neurodegeneration - multiple diseases,8,2,0.00049323,7.6145,0.10358,0.026265,0.041667,C00025;C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025+C00062,mmu05022+C00025:L-Glutamate;C00062:L-Arginine
Arginine biosynthesis,11,2,0.00096334,6.9451,0.20134,0.040961,0.13208,C00025;C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025+C00062,mmu00220+C00025:L-Glutamate;C00062:L-Arginine
beta-Alanine metabolism,12,2,0.0011538,6.7647,0.23999,0.040961,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
ABC transporters,59,3,0.0015146,6.4926,0.31351,0.046086,0.021739,C00025;C00062;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00062+C00315,mmu02010+C00025:L-Glutamate;C00062:L-Arginine;C00315:Spermidine
Aminoacyl-tRNA biosynthesis,16,2,0.0020819,6.1745,0.42888,0.055432,0.035714,C00025;C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025+C00062,mmu00970+C00025:L-Glutamate;C00062:L-Arginine
Central carbon metabolism in cancer,17,2,0.002355,6.0512,0.48279,0.055736,0.056604,C00025;C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025+C00062,mmu05230+C00025:L-Glutamate;C00062:L-Arginine
Protein digestion and absorption,21,2,0.0036088,5.6244,0.7362,0.076868,0.042553,C00025;C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025+C00062,mmu04974+C00025:L-Glutamate;C00062:L-Arginine
Spinocerebellar ataxia,1,1,0.004717,5.3566,0.95755,0.083726,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.004717,5.3566,0.95755,0.083726,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
D-Arginine and D-ornithine metabolism,2,1,0.0094161,4.6653,1,0.11121,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Long-term potentiation,2,1,0.0094161,4.6653,1,0.11121,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Chagas disease,2,1,0.0094161,4.6653,1,0.11121,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Proximal tubule bicarbonate reclamation,3,1,0.014098,4.2618,1,0.11121,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amoebiasis,3,1,0.014098,4.2618,1,0.11121,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
Amphetamine addiction,3,1,0.014098,4.2618,1,0.11121,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.014098,4.2618,1,0.11121,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.014098,4.2618,1,0.11121,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.014098,4.2618,1,0.11121,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.014098,4.2618,1,0.11121,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.014098,4.2618,1,0.11121,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.014098,4.2618,1,0.11121,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.014098,4.2618,1,0.11121,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.014098,4.2618,1,0.11121,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
mTOR signaling pathway,3,1,0.014098,4.2618,1,0.11121,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
Phospholipase D signaling pathway,4,1,0.018761,3.976,1,0.1332,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.018761,3.976,1,0.1332,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.018761,3.976,1,0.1332,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Bile secretion,52,2,0.021469,3.8412,1,0.14751,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
Synaptic vesicle cycle,5,1,0.023407,3.7547,1,0.15108,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.023407,3.7547,1,0.15108,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Retrograde endocannabinoid signaling,8,1,0.03724,3.2904,1,0.2333,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Butanoate metabolism,11,1,0.050915,2.9776,1,0.30125,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.050915,2.9776,1,0.30125,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Pantothenate and CoA biosynthesis,12,1,0.055439,2.8925,1,0.31915,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Taste transduction,14,1,0.064435,2.7421,1,0.35191,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.064435,2.7421,1,0.35191,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Glyoxylate and dicarboxylate metabolism,18,1,0.082221,2.4983,1,0.43782,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Ferroptosis,19,1,0.086625,2.4462,1,0.45003,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
Phosphonate and phosphinate metabolism,22,1,0.099735,2.3052,1,0.5058,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Histidine metabolism,23,1,0.10407,2.2627,1,0.51552,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.11698,2.1457,1,0.56629,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.15068,1.8926,1,0.71322,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Porphyrin and chlorophyll metabolism,54,1,0.23044,1.4677,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
Arginine and proline metabolism,35,4,4.8876E-06,12.229,0.0010411,0.0010411,0.15441,C00025;C00062;C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00062+C00315+C00750,mmu00330+C00025:L-Glutamate;C00062:L-Arginine;C00315:Spermidine;C00750:Spermine
Amyotrophic lateral sclerosis,3,2,5.334900000000001E-05,9.8387,0.01131,0.0053759,0.11111,C00025;C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025+C00062,mmu05014+C00025:L-Glutamate;C00062:L-Arginine
Glutathione metabolism,22,3,7.571700000000001E-05,9.4885,0.015976,0.0053759,0.083916,C00025;C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00315+C00750,mmu00480+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
Amyotrophic lateral sclerosis,3,2,0.00041402,7.7896,0.088187,0.061561,0.11111,C00025;C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025+C00062,mmu05014+C00025:L-Glutamate;C00062:L-Arginine
Arginine and proline metabolism,35,4,0.00057803,7.4559,0.12254,0.061561,0.15441,C00025;C00062;C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00062+C00315+C00750,mmu00330+C00025:L-Glutamate;C00062:L-Arginine;C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,3,0.0019429,6.2436,0.40995,0.13795,0.083916,C00025;C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00315+C00750,mmu00480+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
Pathways of neurodegeneration - multiple diseases,8,2,0.0037322,5.5908,0.78376,0.181,0.041667,C00025;C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025+C00062,mmu05022+C00025:L-Glutamate;C00062:L-Arginine
ABC transporters,59,4,0.0042489,5.4611,0.88801,0.181,0.028986,C00025;C00062;C00114;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00062+C00114+C00315,mmu02010+C00025:L-Glutamate;C00062:L-Arginine;C00114:Choline;C00315:Spermidine
Arginine biosynthesis,11,2,0.0071799,4.9365,1,0.25489,0.13208,C00025;C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025+C00062,mmu00220+C00025:L-Glutamate;C00062:L-Arginine
beta-Alanine metabolism,12,2,0.0085562,4.7611,1,0.26035,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Spinocerebellar ataxia,1,1,0.012264,4.4011,1,0.26718,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.012264,4.4011,1,0.26718,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Aminoacyl-tRNA biosynthesis,16,2,0.015131,4.191,1,0.26718,0.035714,C00025;C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025+C00062,mmu00970+C00025:L-Glutamate;C00062:L-Arginine
Central carbon metabolism in cancer,17,2,0.01703,4.0728,1,0.26718,0.056604,C00025;C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025+C00062,mmu05230+C00025:L-Glutamate;C00062:L-Arginine
Ferroptosis,19,2,0.021117,3.8577,1,0.26718,0.093023,C00025;C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025+C11378,mmu04216+C00025:L-Glutamate;C11378:Ubiquinone-10
Bile secretion,52,3,0.022478,3.7952,1,0.26718,0.027523,C00114;C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00315+C00750,mmu04976+C00114:Choline;C00315:Spermidine;C00750:Spermine
D-Arginine and D-ornithine metabolism,2,1,0.024389,3.7136,1,0.26718,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Long-term potentiation,2,1,0.024389,3.7136,1,0.26718,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Chagas disease,2,1,0.024389,3.7136,1,0.26718,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Protein digestion and absorption,21,2,0.025577,3.6661,1,0.26718,0.042553,C00025;C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025+C00062,mmu04974+C00025:L-Glutamate;C00062:L-Arginine
Proximal tubule bicarbonate reclamation,3,1,0.036377,3.3138,1,0.26718,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amoebiasis,3,1,0.036377,3.3138,1,0.26718,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
Amphetamine addiction,3,1,0.036377,3.3138,1,0.26718,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.036377,3.3138,1,0.26718,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.036377,3.3138,1,0.26718,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.036377,3.3138,1,0.26718,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.036377,3.3138,1,0.26718,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.036377,3.3138,1,0.26718,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.036377,3.3138,1,0.26718,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.036377,3.3138,1,0.26718,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.036377,3.3138,1,0.26718,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
mTOR signaling pathway,3,1,0.036377,3.3138,1,0.26718,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
Phospholipase D signaling pathway,4,1,0.048229,3.0318,1,0.30214,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.048229,3.0318,1,0.30214,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.048229,3.0318,1,0.30214,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Cholinergic synapse,4,1,0.048229,3.0318,1,0.30214,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.048229,3.0318,1,0.30214,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Synaptic vesicle cycle,5,1,0.059945,2.8143,1,0.35468,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.059945,2.8143,1,0.35468,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Retrograde endocannabinoid signaling,8,1,0.094302,2.3613,1,0.52951,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Metabolism of xenobiotics by cytochrome P450,43,2,0.094466,2.3595,1,0.52951,0.015936,C19588;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588+C19594,"mmu00980+C19588:Aflatoxin B1 diol;C19594:Aflatoxin-M1-8,9-epoxide"
Purine metabolism,51,2,0.12624,2.0696,1,0.66236,0.013409,C00360;C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360+C01345,mmu00230+C00360:dAMP;C01345:dITP
Butanoate metabolism,11,1,0.1275,2.0597,1,0.66236,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.1275,2.0597,1,0.66236,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Pantothenate and CoA biosynthesis,12,1,0.13831,1.9783,1,0.68511,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.13831,1.9783,1,0.68511,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
Taste transduction,14,1,0.15956,1.8353,1,0.75527,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.15956,1.8353,1,0.75527,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
"Glycine, serine and threonine metabolism",18,1,0.20063,1.6063,1,0.90924,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Glyoxylate and dicarboxylate metabolism,18,1,0.20063,1.6063,1,0.90924,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Terpenoid backbone biosynthesis,19,1,0.2106,1.5578,1,0.93455,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phenylalanine metabolism,22,1,0.23984,1.4278,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Histidine metabolism,23,1,0.24936,1.3889,1,1,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.27726,1.2828,1,1,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
Nicotinate and nicotinamide metabolism,27,1,0.28635,1.2505,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.34706,1.0583,1,1,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Porphyrin and chlorophyll metabolism,54,1,0.49526,0.70267,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
beta-Alanine metabolism,12,2,0.0023926,6.0354,0.50962,0.36137,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Bile secretion,52,3,0.0033932,5.686,0.71935,0.36137,0.027523,C00114;C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00315+C00750,mmu04976+C00114:Choline;C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.0081128,4.8143,1,0.57601,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
Arginine and proline metabolism,35,2,0.02005,3.9095,1,0.92979,0.063725,C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315+C00750,mmu00330+C00315:Spermidine;C00750:Spermine
Cholinergic synapse,4,1,0.026191,3.6423,1,0.92979,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.026191,3.6423,1,0.92979,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Caffeine metabolism,7,1,0.045447,3.0912,1,1,0.029412,C07481,mmu00232,http://www.kegg.jp/pathway/mmu00232+C07481,mmu00232+C07481:Caffeine
ABC transporters,59,2,0.053397,2.93,1,1,0.014493,C00114;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114+C00315,mmu02010+C00114:Choline;C00315:Spermidine
Pantothenate and CoA biosynthesis,12,1,0.076814,2.5664,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.076814,2.5664,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.11329,2.1778,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Phosphonate and phosphinate metabolism,22,1,0.13691,1.9884,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Nicotinate and nicotinamide metabolism,27,1,0.16567,1.7977,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Purine metabolism,51,1,0.29261,1.2289,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Caffeine metabolism,7,1,0.032646,3.422,1,1,0.029412,C07481,mmu00232,http://www.kegg.jp/pathway/mmu00232+C07481,mmu00232+C07481:Caffeine
Phosphonate and phosphinate metabolism,22,1,0.099735,2.3052,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Nicotinate and nicotinamide metabolism,27,1,0.12125,2.1099,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Metabolism of xenobiotics by cytochrome P450,43,1,0.18735,1.6748,1,1,0.011952,C19588,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588,mmu00980+C19588:Aflatoxin B1 diol
Purine metabolism,51,1,0.21888,1.5192,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Amyotrophic lateral sclerosis,3,2,0.00014909,8.8109,0.031608,0.015879,0.11111,C00025;C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025+C00062,mmu05014+C00025:L-Glutamate;C00062:L-Arginine
Glutathione metabolism,22,3,0.00040711,7.8064,0.085899,0.028905,0.083916,C00025;C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00315+C00750,mmu00480+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
Pathways of neurodegeneration - multiple diseases,8,2,0.0013654,6.5963,0.28674,0.072709,0.041667,C00025;C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025+C00062,mmu05022+C00025:L-Glutamate;C00062:L-Arginine
Arginine biosynthesis,11,2,0.0026517,5.9325,0.55421,0.11254,0.13208,C00025;C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025+C00062,mmu00220+C00025:L-Glutamate;C00062:L-Arginine
beta-Alanine metabolism,12,2,0.00317,5.754,0.65936,0.11254,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Aminoacyl-tRNA biosynthesis,16,2,0.0056768,5.1714,1,0.13396,0.035714,C00025;C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025+C00062,mmu00970+C00025:L-Glutamate;C00062:L-Arginine
Central carbon metabolism in cancer,17,2,0.0064093,5.05,1,0.13396,0.056604,C00025;C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025+C00062,mmu05230+C00025:L-Glutamate;C00062:L-Arginine
ABC transporters,59,3,0.0075159,4.8907,1,0.13396,0.021739,C00025;C00062;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00062+C00315,mmu02010+C00025:L-Glutamate;C00062:L-Arginine;C00315:Spermidine
Ether lipid metabolism,1,1,0.0075472,4.8866,1,0.13396,0.024096,C00670,mmu00565,http://www.kegg.jp/pathway/mmu00565+C00670,mmu00565+C00670:sn-Glycero-3-phosphocholine
Spinocerebellar ataxia,1,1,0.0075472,4.8866,1,0.13396,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.0075472,4.8866,1,0.13396,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Protein digestion and absorption,21,2,0.0097473,4.6308,1,0.15971,0.042553,C00025;C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025+C00062,mmu04974+C00025:L-Glutamate;C00062:L-Arginine
D-Arginine and D-ornithine metabolism,2,1,0.015044,4.1967,1,0.1711,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Long-term potentiation,2,1,0.015044,4.1967,1,0.1711,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Chagas disease,2,1,0.015044,4.1967,1,0.1711,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Proximal tubule bicarbonate reclamation,3,1,0.022492,3.7946,1,0.1711,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amoebiasis,3,1,0.022492,3.7946,1,0.1711,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
Amphetamine addiction,3,1,0.022492,3.7946,1,0.1711,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.022492,3.7946,1,0.1711,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.022492,3.7946,1,0.1711,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.022492,3.7946,1,0.1711,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.022492,3.7946,1,0.1711,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.022492,3.7946,1,0.1711,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.022492,3.7946,1,0.1711,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.022492,3.7946,1,0.1711,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.022492,3.7946,1,0.1711,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
mTOR signaling pathway,3,1,0.022492,3.7946,1,0.1711,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
Phospholipase D signaling pathway,4,1,0.02989,3.5102,1,0.19896,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.02989,3.5102,1,0.19896,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.02989,3.5102,1,0.19896,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Choline metabolism in cancer,4,1,0.02989,3.5102,1,0.19896,0.11236,C00670,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00670,mmu05231+C00670:sn-Glycero-3-phosphocholine
Synaptic vesicle cycle,5,1,0.03724,3.2904,1,0.2333,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.03724,3.2904,1,0.2333,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Caffeine metabolism,7,1,0.051792,2.9605,1,0.31519,0.029412,C07481,mmu00232,http://www.kegg.jp/pathway/mmu00232+C07481,mmu00232+C07481:Caffeine
Bile secretion,52,2,0.054681,2.9062,1,0.32353,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
Retrograde endocannabinoid signaling,8,1,0.058996,2.8303,1,0.33963,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Butanoate metabolism,11,1,0.080321,2.5217,1,0.43868,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.080321,2.5217,1,0.43868,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Pantothenate and CoA biosynthesis,12,1,0.087335,2.438,1,0.45372,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.087335,2.438,1,0.45372,0.025926,C00670,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00670,mmu00564+C00670:sn-Glycero-3-phosphocholine
Taste transduction,14,1,0.10122,2.2904,1,0.5014,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.10122,2.2904,1,0.5014,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Glyoxylate and dicarboxylate metabolism,18,1,0.12844,2.0523,1,0.62178,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Ferroptosis,19,1,0.13513,2.0015,1,0.63964,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
Phosphonate and phosphinate metabolism,22,1,0.15494,1.8647,1,0.71744,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Histidine metabolism,23,1,0.16145,1.8235,1,0.73169,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.18073,1.7108,1,0.80199,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.23025,1.4686,1,1,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Metabolism of xenobiotics by cytochrome P450,43,1,0.28281,1.263,1,1,0.011952,C19588,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588,mmu00980+C19588:Aflatoxin B1 diol
Porphyrin and chlorophyll metabolism,54,1,0.34277,1.0707,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
Arginine and proline metabolism,35,4,6.372E-05,9.661,0.013572,0.013572,0.15441,C00025;C00062;C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00062+C00315+C00750,mmu00330+C00025:L-Glutamate;C00062:L-Arginine;C00315:Spermidine;C00750:Spermine
Amyotrophic lateral sclerosis,3,2,0.00014909,8.8109,0.031757,0.031757,0.11111,C00025;C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025+C00062,mmu05014+C00025:L-Glutamate;C00062:L-Arginine
Pathways of neurodegeneration - multiple diseases,8,2,0.0013654,6.5963,0.28947,0.11723,0.041667,C00025;C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025+C00062,mmu05022+C00025:L-Glutamate;C00062:L-Arginine
Arginine and proline metabolism,35,3,0.0016511,6.4063,0.34838,0.11723,0.11029,C00025;C00062;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00062+C00750,mmu00330+C00025:L-Glutamate;C00062:L-Arginine;C00750:Spermine
Arginine biosynthesis,11,2,0.0026517,5.9325,0.55686,0.1412,0.13208,C00025;C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025+C00062,mmu00220+C00025:L-Glutamate;C00062:L-Arginine
Aminoacyl-tRNA biosynthesis,16,2,0.0056768,5.1714,1,0.17862,0.035714,C00025;C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025+C00062,mmu00970+C00025:L-Glutamate;C00062:L-Arginine
Central carbon metabolism in cancer,17,2,0.0064093,5.05,1,0.17862,0.056604,C00025;C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025+C00062,mmu05230+C00025:L-Glutamate;C00062:L-Arginine
Ether lipid metabolism,1,1,0.0075472,4.8866,1,0.17862,0.024096,C00670,mmu00565,http://www.kegg.jp/pathway/mmu00565+C00670,mmu00565+C00670:sn-Glycero-3-phosphocholine
Spinocerebellar ataxia,1,1,0.0075472,4.8866,1,0.17862,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.0075472,4.8866,1,0.17862,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Protein digestion and absorption,21,2,0.0097473,4.6308,1,0.18426,0.042553,C00025;C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025+C00062,mmu04974+C00025:L-Glutamate;C00062:L-Arginine
Glutathione metabolism,22,2,0.010681,4.5393,1,0.18426,0.055944,C00025;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00750,mmu00480+C00025:L-Glutamate;C00750:Spermine
D-Arginine and D-ornithine metabolism,2,1,0.015044,4.1967,1,0.18426,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Long-term potentiation,2,1,0.015044,4.1967,1,0.18426,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Chagas disease,2,1,0.015044,4.1967,1,0.18426,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Proximal tubule bicarbonate reclamation,3,1,0.022492,3.7946,1,0.18426,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amoebiasis,3,1,0.022492,3.7946,1,0.18426,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
Amphetamine addiction,3,1,0.022492,3.7946,1,0.18426,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.022492,3.7946,1,0.18426,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.022492,3.7946,1,0.18426,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.022492,3.7946,1,0.18426,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.022492,3.7946,1,0.18426,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.022492,3.7946,1,0.18426,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.022492,3.7946,1,0.18426,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.022492,3.7946,1,0.18426,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.022492,3.7946,1,0.18426,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
mTOR signaling pathway,3,1,0.022492,3.7946,1,0.18426,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
Phospholipase D signaling pathway,4,1,0.02989,3.5102,1,0.21222,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.02989,3.5102,1,0.21222,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.02989,3.5102,1,0.21222,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Choline metabolism in cancer,4,1,0.02989,3.5102,1,0.21222,0.11236,C00670,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00670,mmu05231+C00670:sn-Glycero-3-phosphocholine
Synaptic vesicle cycle,5,1,0.03724,3.2904,1,0.24788,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.03724,3.2904,1,0.24788,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Metabolism of xenobiotics by cytochrome P450,43,2,0.038541,3.256,1,0.24877,0.015936,C19588;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588+C19594,"mmu00980+C19588:Aflatoxin B1 diol;C19594:Aflatoxin-M1-8,9-epoxide"
Retrograde endocannabinoid signaling,8,1,0.058996,2.8303,1,0.36959,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
ABC transporters,59,2,0.068691,2.6781,1,0.41803,0.014493,C00025;C00062,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00062,mmu02010+C00025:L-Glutamate;C00062:L-Arginine
Butanoate metabolism,11,1,0.080321,2.5217,1,0.46239,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.080321,2.5217,1,0.46239,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Pantothenate and CoA biosynthesis,12,1,0.087335,2.438,1,0.46506,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
beta-Alanine metabolism,12,1,0.087335,2.438,1,0.46506,0.025862,C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00750,mmu00410+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.087335,2.438,1,0.46506,0.025926,C00670,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00670,mmu00564+C00670:sn-Glycero-3-phosphocholine
Taste transduction,14,1,0.10122,2.2904,1,0.51334,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.10122,2.2904,1,0.51334,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Glyoxylate and dicarboxylate metabolism,18,1,0.12844,2.0523,1,0.63624,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Ferroptosis,19,1,0.13513,2.0015,1,0.65417,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
Phosphonate and phosphinate metabolism,22,1,0.15494,1.8647,1,0.73338,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Histidine metabolism,23,1,0.16145,1.8235,1,0.7476,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.18073,1.7108,1,0.81905,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
Drug metabolism - cytochrome P450,32,1,0.21812,1.5227,1,0.96791,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.23025,1.4686,1,1,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Bile secretion,52,1,0.33221,1.102,1,1,0.0091743,C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00750,mmu04976+C00750:Spermine
Porphyrin and chlorophyll metabolism,54,1,0.34277,1.0707,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
Pantothenate and CoA biosynthesis,12,1,0.011321,4.4811,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
beta-Alanine metabolism,12,1,0.011321,4.4811,1,1,0.025862,C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00750,mmu00410+C00750:Spermine
Glutathione metabolism,22,1,0.020755,3.875,1,1,0.013986,C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00750,mmu00480+C00750:Spermine
Arginine and proline metabolism,35,1,0.033019,3.4107,1,1,0.019608,C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00750,mmu00330+C00750:Spermine
Bile secretion,52,1,0.049057,3.0148,1,1,0.0091743,C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00750,mmu04976+C00750:Spermine
beta-Alanine metabolism,12,1,0.022524,3.7932,1,1,0.025862,C00315,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315,mmu00410+C00315:Spermidine
Phosphonate and phosphinate metabolism,22,1,0.041098,3.1918,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Glutathione metabolism,22,1,0.041098,3.1918,1,1,0.027972,C00315,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315,mmu00480+C00315:Spermidine
Arginine and proline metabolism,35,1,0.064978,2.7337,1,1,0.044118,C00315,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315,mmu00330+C00315:Spermidine
Bile secretion,52,1,0.095751,2.346,1,1,0.0091743,C00315,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315,mmu04976+C00315:Spermidine
ABC transporters,59,1,0.10827,2.2231,1,1,0.0072464,C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00315,mmu02010+C00315:Spermidine
Glutathione metabolism,22,3,0.00014939,8.8089,0.031522,0.010607,0.083916,C00025;C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00315+C00750,mmu00480+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
Pathways of neurodegeneration - multiple diseases,8,2,0.00073705,7.2129,0.15478,0.039248,0.041667,C00025;C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025+C00062,mmu05022+C00025:L-Glutamate;C00062:L-Arginine
Arginine biosynthesis,11,2,0.0014368,6.5453,0.3003,0.061054,0.13208,C00025;C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025+C00062,mmu00220+C00025:L-Glutamate;C00062:L-Arginine
beta-Alanine metabolism,12,2,0.0017198,6.3655,0.35772,0.061054,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
ABC transporters,59,3,0.0029092,5.8399,0.60221,0.082415,0.021739,C00025;C00062;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00062+C00315,mmu02010+C00025:L-Glutamate;C00062:L-Arginine;C00315:Spermidine
Aminoacyl-tRNA biosynthesis,16,2,0.0030954,5.7778,0.63765,0.082415,0.035714,C00025;C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025+C00062,mmu00970+C00025:L-Glutamate;C00062:L-Arginine
Central carbon metabolism in cancer,17,2,0.0034992,5.6552,0.71734,0.082815,0.056604,C00025;C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025+C00062,mmu05230+C00025:L-Glutamate;C00062:L-Arginine
Protein digestion and absorption,21,2,0.0053486,5.2309,1,0.10047,0.042553,C00025;C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025+C00062,mmu04974+C00025:L-Glutamate;C00062:L-Arginine
Spinocerebellar ataxia,1,1,0.0056604,5.1743,1,0.10047,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.0056604,5.1743,1,0.10047,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
D-Arginine and D-ornithine metabolism,2,1,0.011294,4.4835,1,0.13333,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Long-term potentiation,2,1,0.011294,4.4835,1,0.13333,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Chagas disease,2,1,0.011294,4.4835,1,0.13333,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Proximal tubule bicarbonate reclamation,3,1,0.016901,4.0804,1,0.13333,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amoebiasis,3,1,0.016901,4.0804,1,0.13333,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
Amphetamine addiction,3,1,0.016901,4.0804,1,0.13333,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.016901,4.0804,1,0.13333,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.016901,4.0804,1,0.13333,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.016901,4.0804,1,0.13333,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.016901,4.0804,1,0.13333,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.016901,4.0804,1,0.13333,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.016901,4.0804,1,0.13333,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.016901,4.0804,1,0.13333,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.016901,4.0804,1,0.13333,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
mTOR signaling pathway,3,1,0.016901,4.0804,1,0.13333,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
Phospholipase D signaling pathway,4,1,0.022482,3.7951,1,0.15962,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.022482,3.7951,1,0.15962,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.022482,3.7951,1,0.15962,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Synaptic vesicle cycle,5,1,0.028036,3.5743,1,0.18661,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.028036,3.5743,1,0.18661,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Bile secretion,52,2,0.031199,3.4674,1,0.20137,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
Retrograde endocannabinoid signaling,8,1,0.04454,3.1114,1,0.27903,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Butanoate metabolism,11,1,0.060811,2.8,1,0.3598,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.060811,2.8,1,0.3598,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Pantothenate and CoA biosynthesis,12,1,0.066183,2.7153,1,0.381,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Taste transduction,14,1,0.07685,2.5659,1,0.41972,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.07685,2.5659,1,0.41972,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Glyoxylate and dicarboxylate metabolism,18,1,0.097879,2.324,1,0.52121,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Ferroptosis,19,1,0.10307,2.2723,1,0.53548,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
Phosphonate and phosphinate metabolism,22,1,0.11851,2.1328,1,0.60101,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Histidine metabolism,23,1,0.1236,2.0907,1,0.61227,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.13874,1.9751,1,0.67164,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.17805,1.7257,1,0.84278,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Metabolism of xenobiotics by cytochrome P450,43,1,0.22048,1.512,1,1,0.011952,C19588,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588,mmu00980+C19588:Aflatoxin B1 diol
Porphyrin and chlorophyll metabolism,54,1,0.26983,1.3099,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
Arginine and proline metabolism,35,4,1.4319000000000001E-05,11.154,0.0030499,0.0030499,0.15441,C00025;C00062;C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00062+C00315+C00750,mmu00330+C00025:L-Glutamate;C00062:L-Arginine;C00315:Spermidine;C00750:Spermine
Amyotrophic lateral sclerosis,3,2,7.9973E-05,9.4338,0.016954,0.0085171,0.11111,C00025;C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025+C00062,mmu05014+C00025:L-Glutamate;C00062:L-Arginine
beta-Alanine metabolism,12,2,0.00035055,7.956,0.074316,0.037333,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.0012191,6.7096,0.25724,0.086559,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
D-Arginine and D-ornithine metabolism,2,1,0.005655,5.1752,1,0.1878,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Chagas disease,2,1,0.005655,5.1752,1,0.1878,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Bile secretion,52,2,0.0068642,4.9814,1,0.1878,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
Amyotrophic lateral sclerosis,3,1,0.0084745,4.7707,1,0.1878,0.055556,C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00062,mmu05014+C00062:L-Arginine
Amoebiasis,3,1,0.0084745,4.7707,1,0.1878,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
mTOR signaling pathway,3,1,0.0084745,4.7707,1,0.1878,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
ABC transporters,59,2,0.0088169,4.7311,1,0.1878,0.014493,C00062;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00062+C00315,mmu02010+C00062:L-Arginine;C00315:Spermidine
Pathways of neurodegeneration - multiple diseases,8,1,0.022492,3.7946,1,0.43553,0.020833,C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00062,mmu05022+C00062:L-Arginine
Arginine biosynthesis,11,1,0.030839,3.479,1,0.54739,0.050314,C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00062,mmu00220+C00062:L-Arginine
Pantothenate and CoA biosynthesis,12,1,0.033611,3.3929,1,0.5507,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Aminoacyl-tRNA biosynthesis,16,1,0.044644,3.109,1,0.67293,0.017857,C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00062,mmu00970+C00062:L-Arginine
Central carbon metabolism in cancer,17,1,0.04739,3.0493,1,0.67293,0.018868,C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00062,mmu05230+C00062:L-Arginine
Protein digestion and absorption,21,1,0.058318,2.8418,1,0.77636,0.021277,C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00062,mmu04974+C00062:L-Arginine
Arginine and proline metabolism,35,3,3.3065E-05,10.317,0.0070429,0.0070429,0.10539,C00062;C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00062+C00315+C00750,mmu00330+C00062:L-Arginine;C00315:Spermidine;C00750:Spermine
Arginine and proline metabolism,35,3,0.00061731,7.3901,0.13149,0.13149,0.10539,C00062;C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00062+C00315+C00750,mmu00330+C00062:L-Arginine;C00315:Spermidine;C00750:Spermine
beta-Alanine metabolism,12,2,0.0017198,6.3655,0.3646,0.18316,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Ether lipid metabolism,1,1,0.0056604,5.1743,1,0.3125,0.024096,C00670,mmu00565,http://www.kegg.jp/pathway/mmu00565+C00670,mmu00565+C00670:sn-Glycero-3-phosphocholine
Glutathione metabolism,22,2,0.0058685,5.1382,1,0.3125,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
D-Arginine and D-ornithine metabolism,2,1,0.011294,4.4835,1,0.39999,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Chagas disease,2,1,0.011294,4.4835,1,0.39999,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Amyotrophic lateral sclerosis,3,1,0.016901,4.0804,1,0.39999,0.055556,C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00062,mmu05014+C00062:L-Arginine
Amoebiasis,3,1,0.016901,4.0804,1,0.39999,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
mTOR signaling pathway,3,1,0.016901,4.0804,1,0.39999,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
Choline metabolism in cancer,4,1,0.022482,3.7951,1,0.47886,0.11236,C00670,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00670,mmu05231+C00670:sn-Glycero-3-phosphocholine
Bile secretion,52,2,0.031199,3.4674,1,0.60412,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
Caffeine metabolism,7,1,0.039065,3.2425,1,0.64782,0.029412,C07481,mmu00232,http://www.kegg.jp/pathway/mmu00232+C07481,mmu00232+C07481:Caffeine
ABC transporters,59,2,0.039538,3.2305,1,0.64782,0.014493,C00062;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00062+C00315,mmu02010+C00062:L-Arginine;C00315:Spermidine
Pathways of neurodegeneration - multiple diseases,8,1,0.04454,3.1114,1,0.67765,0.020833,C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00062,mmu05022+C00062:L-Arginine
Arginine biosynthesis,11,1,0.060811,2.8,1,0.82923,0.050314,C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00062,mmu00220+C00062:L-Arginine
Pantothenate and CoA biosynthesis,12,1,0.066183,2.7153,1,0.82923,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.066183,2.7153,1,0.82923,0.025926,C00670,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00670,mmu00564+C00670:sn-Glycero-3-phosphocholine
Aminoacyl-tRNA biosynthesis,16,1,0.087415,2.4371,1,1,0.017857,C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00062,mmu00970+C00062:L-Arginine
Central carbon metabolism in cancer,17,1,0.09266,2.3788,1,1,0.018868,C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00062,mmu05230+C00062:L-Arginine
Protein digestion and absorption,21,1,0.11339,2.1769,1,1,0.021277,C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00062,mmu04974+C00062:L-Arginine
Metabolism of xenobiotics by cytochrome P450,43,1,0.22048,1.512,1,1,0.011952,C19588,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588,mmu00980+C19588:Aflatoxin B1 diol
Pathways of neurodegeneration - multiple diseases,8,2,0.00029706,8.1216,0.062383,0.015819,0.041667,C00025;C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025+C00062,mmu05022+C00025:L-Glutamate;C00062:L-Arginine
Arginine biosynthesis,11,2,0.0005813,7.4502,0.12149,0.021199,0.13208,C00025;C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025+C00062,mmu00220+C00025:L-Glutamate;C00062:L-Arginine
ABC transporters,59,3,0.00063084,7.3685,0.13121,0.021199,0.021739,C00025;C00062;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00062+C00315,mmu02010+C00025:L-Glutamate;C00062:L-Arginine;C00315:Spermidine
beta-Alanine metabolism,12,2,0.00069668,7.2692,0.14421,0.021199,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Aminoacyl-tRNA biosynthesis,16,2,0.0012603,6.6764,0.25962,0.033555,0.035714,C00025;C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025+C00062,mmu00970+C00025:L-Glutamate;C00062:L-Arginine
Central carbon metabolism in cancer,17,2,0.0014265,6.5525,0.29243,0.03376,0.056604,C00025;C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025+C00062,mmu05230+C00025:L-Glutamate;C00062:L-Arginine
Protein digestion and absorption,21,2,0.0021915,6.1232,0.44707,0.046679,0.042553,C00025;C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025+C00062,mmu04974+C00025:L-Glutamate;C00062:L-Arginine
Spinocerebellar ataxia,1,1,0.0037736,5.5797,0.76604,0.066981,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.0037736,5.5797,0.76604,0.066981,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
D-Arginine and D-ornithine metabolism,2,1,0.0075365,4.888,1,0.089055,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Long-term potentiation,2,1,0.0075365,4.888,1,0.089055,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Chagas disease,2,1,0.0075365,4.888,1,0.089055,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Proximal tubule bicarbonate reclamation,3,1,0.011289,4.484,1,0.089055,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amoebiasis,3,1,0.011289,4.484,1,0.089055,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
Amphetamine addiction,3,1,0.011289,4.484,1,0.089055,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.011289,4.484,1,0.089055,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.011289,4.484,1,0.089055,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.011289,4.484,1,0.089055,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.011289,4.484,1,0.089055,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.011289,4.484,1,0.089055,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.011289,4.484,1,0.089055,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.011289,4.484,1,0.089055,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.011289,4.484,1,0.089055,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
mTOR signaling pathway,3,1,0.011289,4.484,1,0.089055,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
Bile secretion,52,2,0.013297,4.3202,1,0.10115,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
Phospholipase D signaling pathway,4,1,0.01503,4.1977,1,0.10327,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.01503,4.1977,1,0.10327,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.01503,4.1977,1,0.10327,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Synaptic vesicle cycle,5,1,0.018761,3.976,1,0.1211,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.018761,3.976,1,0.1211,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Retrograde endocannabinoid signaling,8,1,0.02989,3.5102,1,0.18726,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Butanoate metabolism,11,1,0.040925,3.196,1,0.24214,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.040925,3.196,1,0.24214,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Pantothenate and CoA biosynthesis,12,1,0.044582,3.1104,1,0.25665,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Taste transduction,14,1,0.051865,2.9591,1,0.28326,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.051865,2.9591,1,0.28326,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Glyoxylate and dicarboxylate metabolism,18,1,0.066305,2.7135,1,0.35308,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Ferroptosis,19,1,0.06989,2.6608,1,0.36309,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
Histidine metabolism,23,1,0.084123,2.4755,1,0.42663,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.094691,2.3571,1,0.46905,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.12242,2.1003,1,0.59265,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Porphyrin and chlorophyll metabolism,54,1,0.18897,1.6662,1,0.89446,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
Arginine and proline metabolism,35,4,1.0009999999999998E-06,13.814,0.00021322,0.00021322,0.15441,C00025;C00062;C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00062+C00315+C00750,mmu00330+C00025:L-Glutamate;C00062:L-Arginine;C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,3,3.0701E-05,10.391,0.0065086,0.0022741,0.083916,C00025;C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00315+C00750,mmu00480+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
Amyotrophic lateral sclerosis,3,2,3.203E-05,10.349,0.0067583,0.0022741,0.11111,C00025;C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025+C00062,mmu05014+C00025:L-Glutamate;C00062:L-Arginine
Glutathione metabolism,22,3,0.00014939,8.8089,0.031821,0.031821,0.083916,C00025;C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00315+C00750,mmu00480+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
Arginine and proline metabolism,35,3,0.00061731,7.3901,0.13087,0.065744,0.11275,C00025;C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00315+C00750,mmu00330+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
beta-Alanine metabolism,12,2,0.0017198,6.3655,0.36288,0.12211,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Spinocerebellar ataxia,1,1,0.0056604,5.1743,1,0.21176,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.0056604,5.1743,1,0.21176,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Long-term potentiation,2,1,0.011294,4.4835,1,0.21176,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Amyotrophic lateral sclerosis,3,1,0.016901,4.0804,1,0.21176,0.055556,C00025,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025,mmu05014+C00025:L-Glutamate
Proximal tubule bicarbonate reclamation,3,1,0.016901,4.0804,1,0.21176,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amphetamine addiction,3,1,0.016901,4.0804,1,0.21176,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.016901,4.0804,1,0.21176,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.016901,4.0804,1,0.21176,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.016901,4.0804,1,0.21176,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.016901,4.0804,1,0.21176,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.016901,4.0804,1,0.21176,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.016901,4.0804,1,0.21176,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.016901,4.0804,1,0.21176,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.016901,4.0804,1,0.21176,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
Phospholipase D signaling pathway,4,1,0.022482,3.7951,1,0.23943,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.022482,3.7951,1,0.23943,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.022482,3.7951,1,0.23943,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Synaptic vesicle cycle,5,1,0.028036,3.5743,1,0.27144,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.028036,3.5743,1,0.27144,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Bile secretion,52,2,0.031199,3.4674,1,0.28893,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
Caffeine metabolism,7,1,0.039065,3.2425,1,0.33686,0.029412,C07481,mmu00232,http://www.kegg.jp/pathway/mmu00232+C07481,mmu00232+C07481:Caffeine
ABC transporters,59,2,0.039538,3.2305,1,0.33686,0.014493,C00025;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00315,mmu02010+C00025:L-Glutamate;C00315:Spermidine
Pathways of neurodegeneration - multiple diseases,8,1,0.04454,3.1114,1,0.35137,0.020833,C00025,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025,mmu05022+C00025:L-Glutamate
Retrograde endocannabinoid signaling,8,1,0.04454,3.1114,1,0.35137,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Butanoate metabolism,11,1,0.060811,2.8,1,0.43176,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
Arginine biosynthesis,11,1,0.060811,2.8,1,0.43176,0.081761,C00025,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025,mmu00220+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.060811,2.8,1,0.43176,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Pantothenate and CoA biosynthesis,12,1,0.066183,2.7153,1,0.45474,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Taste transduction,14,1,0.07685,2.5659,1,0.49603,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.07685,2.5659,1,0.49603,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Aminoacyl-tRNA biosynthesis,16,1,0.087415,2.4371,1,0.54763,0.017857,C00025,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025,mmu00970+C00025:L-Glutamate
Central carbon metabolism in cancer,17,1,0.09266,2.3788,1,0.5639,0.037736,C00025,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025,mmu05230+C00025:L-Glutamate
Glyoxylate and dicarboxylate metabolism,18,1,0.097879,2.324,1,0.57912,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Ferroptosis,19,1,0.10307,2.2723,1,0.59337,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
Protein digestion and absorption,21,1,0.11339,2.1769,1,0.63557,0.021277,C00025,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025,mmu04974+C00025:L-Glutamate
Phosphonate and phosphinate metabolism,22,1,0.11851,2.1328,1,0.64724,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Histidine metabolism,23,1,0.1236,2.0907,1,0.65819,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.13874,1.9751,1,0.72078,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
Nicotinate and nicotinamide metabolism,27,1,0.14374,1.9397,1,0.72897,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.17805,1.7257,1,0.88198,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Porphyrin and chlorophyll metabolism,54,1,0.26983,1.3099,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
Ether lipid metabolism,1,1,0.0037736,5.5797,0.80377,0.40075,0.024096,C00670,mmu00565,http://www.kegg.jp/pathway/mmu00565+C00670,mmu00565+C00670:sn-Glycero-3-phosphocholine
D-Arginine and D-ornithine metabolism,2,1,0.0075365,4.888,1,0.40075,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Chagas disease,2,1,0.0075365,4.888,1,0.40075,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Amyotrophic lateral sclerosis,3,1,0.011289,4.484,1,0.40075,0.055556,C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00062,mmu05014+C00062:L-Arginine
Amoebiasis,3,1,0.011289,4.484,1,0.40075,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
mTOR signaling pathway,3,1,0.011289,4.484,1,0.40075,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
Choline metabolism in cancer,4,1,0.01503,4.1977,1,0.45735,0.11236,C00670,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00670,mmu05231+C00670:sn-Glycero-3-phosphocholine
Caffeine metabolism,7,1,0.026191,3.6423,1,0.69734,0.029412,C07481,mmu00232,http://www.kegg.jp/pathway/mmu00232+C07481,mmu00232+C07481:Caffeine
Pathways of neurodegeneration - multiple diseases,8,1,0.02989,3.5102,1,0.70741,0.020833,C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00062,mmu05022+C00062:L-Arginine
Arginine biosynthesis,11,1,0.040925,3.196,1,0.86327,0.050314,C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00062,mmu00220+C00062:L-Arginine
Glycerophospholipid metabolism,12,1,0.044582,3.1104,1,0.86327,0.025926,C00670,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00670,mmu00564+C00670:sn-Glycero-3-phosphocholine
Aminoacyl-tRNA biosynthesis,16,1,0.059106,2.8284,1,1,0.017857,C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00062,mmu00970+C00062:L-Arginine
Central carbon metabolism in cancer,17,1,0.062711,2.7692,1,1,0.018868,C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00062,mmu05230+C00062:L-Arginine
Protein digestion and absorption,21,1,0.077027,2.5636,1,1,0.021277,C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00062,mmu04974+C00062:L-Arginine
Drug metabolism - cytochrome P450,32,1,0.11555,2.158,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Arginine and proline metabolism,35,1,0.12585,2.0727,1,1,0.041667,C00062,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00062,mmu00330+C00062:L-Arginine
ABC transporters,59,1,0.205,1.5847,1,1,0.0072464,C00062,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00062,mmu02010+C00062:L-Arginine
Choline metabolism in cancer,4,2,0.00029706,8.1216,0.063274,0.063274,0.32584,C00114;C00670,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114+C00670,mmu05231+C00114:Choline;C00670:sn-Glycero-3-phosphocholine
Arginine and proline metabolism,35,3,0.0016511,6.4063,0.35003,0.1688,0.10539,C00062;C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00062+C00315+C00750,mmu00330+C00062:L-Arginine;C00315:Spermidine;C00750:Spermine
beta-Alanine metabolism,12,2,0.00317,5.754,0.66887,0.1688,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Glycerophospholipid metabolism,12,2,0.00317,5.754,0.66887,0.1688,0.098148,C00114;C00670,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114+C00670,mmu00564+C00114:Choline;C00670:sn-Glycero-3-phosphocholine
Bile secretion,52,3,0.0052416,5.2511,1,0.22329,0.027523,C00114;C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00315+C00750,mmu04976+C00114:Choline;C00315:Spermidine;C00750:Spermine
ABC transporters,59,3,0.0075159,4.8907,1,0.22965,0.021739,C00062;C00114;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00062+C00114+C00315,mmu02010+C00062:L-Arginine;C00114:Choline;C00315:Spermidine
Ether lipid metabolism,1,1,0.0075472,4.8866,1,0.22965,0.024096,C00670,mmu00565,http://www.kegg.jp/pathway/mmu00565+C00670,mmu00565+C00670:sn-Glycero-3-phosphocholine
Glutathione metabolism,22,2,0.010681,4.5393,1,0.28439,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
D-Arginine and D-ornithine metabolism,2,1,0.015044,4.1967,1,0.32045,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Chagas disease,2,1,0.015044,4.1967,1,0.32045,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Amyotrophic lateral sclerosis,3,1,0.022492,3.7946,1,0.36852,0.055556,C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00062,mmu05014+C00062:L-Arginine
Amoebiasis,3,1,0.022492,3.7946,1,0.36852,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
mTOR signaling pathway,3,1,0.022492,3.7946,1,0.36852,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
Cholinergic synapse,4,1,0.02989,3.5102,1,0.45476,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Pathways of neurodegeneration - multiple diseases,8,1,0.058996,2.8303,1,0.83775,0.020833,C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00062,mmu05022+C00062:L-Arginine
Arginine biosynthesis,11,1,0.080321,2.5217,1,1,0.050314,C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00062,mmu00220+C00062:L-Arginine
Pantothenate and CoA biosynthesis,12,1,0.087335,2.438,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Aminoacyl-tRNA biosynthesis,16,1,0.11492,2.1635,1,1,0.017857,C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00062,mmu00970+C00062:L-Arginine
Central carbon metabolism in cancer,17,1,0.12171,2.1061,1,1,0.018868,C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00062,mmu05230+C00062:L-Arginine
"Glycine, serine and threonine metabolism",18,1,0.12844,2.0523,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Protein digestion and absorption,21,1,0.14838,1.908,1,1,0.021277,C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00062,mmu04974+C00062:L-Arginine
Phosphonate and phosphinate metabolism,22,1,0.15494,1.8647,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Nicotinate and nicotinamide metabolism,27,1,0.18707,1.6763,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Purine metabolism,51,1,0.32687,1.1182,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Glutathione metabolism,22,3,0.00014939,8.8089,0.031522,0.010607,0.083916,C00025;C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00315+C00750,mmu00480+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
Pathways of neurodegeneration - multiple diseases,8,2,0.00073705,7.2129,0.15478,0.039248,0.041667,C00025;C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025+C00062,mmu05022+C00025:L-Glutamate;C00062:L-Arginine
Arginine biosynthesis,11,2,0.0014368,6.5453,0.3003,0.061054,0.13208,C00025;C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025+C00062,mmu00220+C00025:L-Glutamate;C00062:L-Arginine
beta-Alanine metabolism,12,2,0.0017198,6.3655,0.35772,0.061054,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
ABC transporters,59,3,0.0029092,5.8399,0.60221,0.082415,0.021739,C00025;C00062;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00062+C00315,mmu02010+C00025:L-Glutamate;C00062:L-Arginine;C00315:Spermidine
Aminoacyl-tRNA biosynthesis,16,2,0.0030954,5.7778,0.63765,0.082415,0.035714,C00025;C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025+C00062,mmu00970+C00025:L-Glutamate;C00062:L-Arginine
Central carbon metabolism in cancer,17,2,0.0034992,5.6552,0.71734,0.082815,0.056604,C00025;C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025+C00062,mmu05230+C00025:L-Glutamate;C00062:L-Arginine
Protein digestion and absorption,21,2,0.0053486,5.2309,1,0.092743,0.042553,C00025;C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025+C00062,mmu04974+C00025:L-Glutamate;C00062:L-Arginine
Ether lipid metabolism,1,1,0.0056604,5.1743,1,0.092743,0.024096,C00670,mmu00565,http://www.kegg.jp/pathway/mmu00565+C00670,mmu00565+C00670:sn-Glycero-3-phosphocholine
Spinocerebellar ataxia,1,1,0.0056604,5.1743,1,0.092743,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.0056604,5.1743,1,0.092743,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
D-Arginine and D-ornithine metabolism,2,1,0.011294,4.4835,1,0.12857,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Long-term potentiation,2,1,0.011294,4.4835,1,0.12857,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Chagas disease,2,1,0.011294,4.4835,1,0.12857,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Proximal tubule bicarbonate reclamation,3,1,0.016901,4.0804,1,0.12857,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amoebiasis,3,1,0.016901,4.0804,1,0.12857,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
Amphetamine addiction,3,1,0.016901,4.0804,1,0.12857,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.016901,4.0804,1,0.12857,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.016901,4.0804,1,0.12857,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.016901,4.0804,1,0.12857,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.016901,4.0804,1,0.12857,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.016901,4.0804,1,0.12857,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.016901,4.0804,1,0.12857,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.016901,4.0804,1,0.12857,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.016901,4.0804,1,0.12857,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
mTOR signaling pathway,3,1,0.016901,4.0804,1,0.12857,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
Phospholipase D signaling pathway,4,1,0.022482,3.7951,1,0.14964,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.022482,3.7951,1,0.14964,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.022482,3.7951,1,0.14964,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Choline metabolism in cancer,4,1,0.022482,3.7951,1,0.14964,0.11236,C00670,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00670,mmu05231+C00670:sn-Glycero-3-phosphocholine
Synaptic vesicle cycle,5,1,0.028036,3.5743,1,0.17564,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.028036,3.5743,1,0.17564,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Bile secretion,52,2,0.031199,3.4674,1,0.18987,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
Caffeine metabolism,7,1,0.039065,3.2425,1,0.23113,0.029412,C07481,mmu00232,http://www.kegg.jp/pathway/mmu00232+C07481,mmu00232+C07481:Caffeine
Retrograde endocannabinoid signaling,8,1,0.04454,3.1114,1,0.25641,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Butanoate metabolism,11,1,0.060811,2.8,1,0.33212,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.060811,2.8,1,0.33212,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Pantothenate and CoA biosynthesis,12,1,0.066183,2.7153,1,0.34383,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.066183,2.7153,1,0.34383,0.025926,C00670,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00670,mmu00564+C00670:sn-Glycero-3-phosphocholine
Taste transduction,14,1,0.07685,2.5659,1,0.38067,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.07685,2.5659,1,0.38067,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Glyoxylate and dicarboxylate metabolism,18,1,0.097879,2.324,1,0.47383,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Ferroptosis,19,1,0.10307,2.2723,1,0.48788,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
Histidine metabolism,23,1,0.1236,2.0907,1,0.57234,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.13874,1.9751,1,0.62877,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.17805,1.7257,1,0.7901,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Porphyrin and chlorophyll metabolism,54,1,0.26983,1.3099,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
Arginine and proline metabolism,35,4,1.4319000000000001E-05,11.154,0.0030499,0.0030499,0.15441,C00025;C00062;C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00062+C00315+C00750,mmu00330+C00025:L-Glutamate;C00062:L-Arginine;C00315:Spermidine;C00750:Spermine
Amyotrophic lateral sclerosis,3,2,7.9973E-05,9.4338,0.016954,0.0085171,0.11111,C00025;C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025+C00062,mmu05014+C00025:L-Glutamate;C00062:L-Arginine
Arginine and proline metabolism,35,3,0.0016511,6.4063,0.35168,0.33761,0.10539,C00062;C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00062+C00315+C00750,mmu00330+C00062:L-Arginine;C00315:Spermidine;C00750:Spermine
beta-Alanine metabolism,12,2,0.00317,5.754,0.67204,0.33761,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.010681,4.5393,1,0.59885,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
D-Arginine and D-ornithine metabolism,2,1,0.015044,4.1967,1,0.59885,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Chagas disease,2,1,0.015044,4.1967,1,0.59885,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Amyotrophic lateral sclerosis,3,1,0.022492,3.7946,1,0.59885,0.055556,C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00062,mmu05014+C00062:L-Arginine
Amoebiasis,3,1,0.022492,3.7946,1,0.59885,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
mTOR signaling pathway,3,1,0.022492,3.7946,1,0.59885,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
Caffeine metabolism,7,1,0.051792,2.9605,1,1,0.029412,C07481,mmu00232,http://www.kegg.jp/pathway/mmu00232+C07481,mmu00232+C07481:Caffeine
Bile secretion,52,2,0.054681,2.9062,1,1,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
Pathways of neurodegeneration - multiple diseases,8,1,0.058996,2.8303,1,1,0.020833,C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00062,mmu05022+C00062:L-Arginine
ABC transporters,59,2,0.068691,2.6781,1,1,0.014493,C00062;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00062+C00315,mmu02010+C00062:L-Arginine;C00315:Spermidine
Arginine biosynthesis,11,1,0.080321,2.5217,1,1,0.050314,C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00062,mmu00220+C00062:L-Arginine
Pantothenate and CoA biosynthesis,12,1,0.087335,2.438,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Aminoacyl-tRNA biosynthesis,16,1,0.11492,2.1635,1,1,0.017857,C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00062,mmu00970+C00062:L-Arginine
Central carbon metabolism in cancer,17,1,0.12171,2.1061,1,1,0.018868,C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00062,mmu05230+C00062:L-Arginine
Protein digestion and absorption,21,1,0.14838,1.908,1,1,0.021277,C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00062,mmu04974+C00062:L-Arginine
Phosphonate and phosphinate metabolism,22,1,0.15494,1.8647,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Nicotinate and nicotinamide metabolism,27,1,0.18707,1.6763,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Metabolism of xenobiotics by cytochrome P450,43,1,0.28281,1.263,1,1,0.011952,C19588,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588,mmu00980+C19588:Aflatoxin B1 diol
Purine metabolism,51,1,0.32687,1.1182,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Arginine and proline metabolism,35,3,0.0010558,6.8534,0.22489,0.22489,0.10539,C00062;C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00062+C00315+C00750,mmu00330+C00062:L-Arginine;C00315:Spermidine;C00750:Spermine
beta-Alanine metabolism,12,2,0.0023926,6.0354,0.50723,0.25481,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Ether lipid metabolism,1,1,0.0066038,5.0201,1,0.43201,0.024096,C00670,mmu00565,http://www.kegg.jp/pathway/mmu00565+C00670,mmu00565+C00670:sn-Glycero-3-phosphocholine
Glutathione metabolism,22,2,0.0081128,4.8143,1,0.43201,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
D-Arginine and D-ornithine metabolism,2,1,0.01317,4.3298,1,0.46622,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Chagas disease,2,1,0.01317,4.3298,1,0.46622,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Amyotrophic lateral sclerosis,3,1,0.019699,3.9272,1,0.46622,0.055556,C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00062,mmu05014+C00062:L-Arginine
Amoebiasis,3,1,0.019699,3.9272,1,0.46622,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
mTOR signaling pathway,3,1,0.019699,3.9272,1,0.46622,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
Choline metabolism in cancer,4,1,0.026191,3.6423,1,0.55787,0.11236,C00670,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00670,mmu05231+C00670:sn-Glycero-3-phosphocholine
Bile secretion,52,2,0.042321,3.1625,1,0.81949,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
Pathways of neurodegeneration - multiple diseases,8,1,0.051792,2.9605,1,0.87489,0.020833,C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00062,mmu05022+C00062:L-Arginine
ABC transporters,59,2,0.053397,2.93,1,0.87489,0.014493,C00062;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00062+C00315,mmu02010+C00062:L-Arginine;C00315:Spermidine
Arginine biosynthesis,11,1,0.070613,2.6505,1,1,0.050314,C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00062,mmu00220+C00062:L-Arginine
Pantothenate and CoA biosynthesis,12,1,0.076814,2.5664,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.076814,2.5664,1,1,0.025926,C00670,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00670,mmu00564+C00670:sn-Glycero-3-phosphocholine
Aminoacyl-tRNA biosynthesis,16,1,0.10127,2.29,1,1,0.017857,C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00062,mmu00970+C00062:L-Arginine
Central carbon metabolism in cancer,17,1,0.10729,2.2322,1,1,0.018868,C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00062,mmu05230+C00062:L-Arginine
Terpenoid backbone biosynthesis,19,1,0.11924,2.1266,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Protein digestion and absorption,21,1,0.13105,2.0322,1,1,0.021277,C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00062,mmu04974+C00062:L-Arginine
Nicotinate and nicotinamide metabolism,27,1,0.16567,1.7977,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Purine metabolism,51,1,0.29261,1.2289,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Ferroptosis,19,1,0.052864,2.94,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.061037,2.7963,1,1,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Metabolism of xenobiotics by cytochrome P450,43,1,0.11693,2.1461,1,1,0.0039841,C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19594,"mmu00980+C19594:Aflatoxin-M1-8,9-epoxide"
Glutathione metabolism,22,3,0.00084903,7.0714,0.18084,0.18084,0.083916,C00025;C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00315+C00750,mmu00480+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
Arginine and proline metabolism,35,3,0.0033799,5.6899,0.71654,0.31459,0.11275,C00025;C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00315+C00750,mmu00330+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
beta-Alanine metabolism,12,2,0.0050307,5.2922,1,0.31459,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Spinocerebellar ataxia,1,1,0.009434,4.6634,1,0.31459,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.009434,4.6634,1,0.31459,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Bile secretion,52,3,0.010472,4.5591,1,0.31459,0.027523,C00114;C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00315+C00750,mmu04976+C00114:Choline;C00315:Spermidine;C00750:Spermine
ABC transporters,59,3,0.014865,4.2087,1,0.31459,0.021739,C00025;C00114;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00114+C00315,mmu02010+C00025:L-Glutamate;C00114:Choline;C00315:Spermidine
Long-term potentiation,2,1,0.018788,3.9746,1,0.31459,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Amyotrophic lateral sclerosis,3,1,0.028062,3.5733,1,0.31459,0.055556,C00025,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025,mmu05014+C00025:L-Glutamate
Proximal tubule bicarbonate reclamation,3,1,0.028062,3.5733,1,0.31459,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amphetamine addiction,3,1,0.028062,3.5733,1,0.31459,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.028062,3.5733,1,0.31459,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.028062,3.5733,1,0.31459,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.028062,3.5733,1,0.31459,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.028062,3.5733,1,0.31459,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.028062,3.5733,1,0.31459,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.028062,3.5733,1,0.31459,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.028062,3.5733,1,0.31459,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.028062,3.5733,1,0.31459,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
Phospholipase D signaling pathway,4,1,0.037257,3.2899,1,0.33066,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.037257,3.2899,1,0.33066,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.037257,3.2899,1,0.33066,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Cholinergic synapse,4,1,0.037257,3.2899,1,0.33066,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.037257,3.2899,1,0.33066,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Synaptic vesicle cycle,5,1,0.046374,3.071,1,0.37991,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.046374,3.071,1,0.37991,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Metabolism of xenobiotics by cytochrome P450,43,2,0.058837,2.833,1,0.46416,0.015936,C19588;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588+C19594,"mmu00980+C19588:Aflatoxin B1 diol;C19594:Aflatoxin-M1-8,9-epoxide"
Caffeine metabolism,7,1,0.064375,2.743,1,0.48971,0.029412,C07481,mmu00232,http://www.kegg.jp/pathway/mmu00232+C07481,mmu00232+C07481:Caffeine
Pathways of neurodegeneration - multiple diseases,8,1,0.07326,2.6137,1,0.52015,0.020833,C00025,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025,mmu05022+C00025:L-Glutamate
Retrograde endocannabinoid signaling,8,1,0.07326,2.6137,1,0.52015,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Butanoate metabolism,11,1,0.099463,2.308,1,0.64199,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
Arginine biosynthesis,11,1,0.099463,2.308,1,0.64199,0.081761,C00025,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025,mmu00220+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.099463,2.308,1,0.64199,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Pantothenate and CoA biosynthesis,12,1,0.10805,2.2252,1,0.65755,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.10805,2.2252,1,0.65755,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
Taste transduction,14,1,0.125,2.0795,1,0.71957,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.125,2.0795,1,0.71957,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Aminoacyl-tRNA biosynthesis,16,1,0.14165,1.9544,1,0.79401,0.017857,C00025,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025,mmu00970+C00025:L-Glutamate
Central carbon metabolism in cancer,17,1,0.14988,1.8979,1,0.81856,0.037736,C00025,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025,mmu05230+C00025:L-Glutamate
"Glycine, serine and threonine metabolism",18,1,0.15803,1.845,1,0.82097,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Glyoxylate and dicarboxylate metabolism,18,1,0.15803,1.845,1,0.82097,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Ferroptosis,19,1,0.16611,1.7951,1,0.8424,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
Protein digestion and absorption,21,1,0.18206,1.7034,1,0.90183,0.021277,C00025,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025,mmu04974+C00025:L-Glutamate
Phenylalanine metabolism,22,1,0.18993,1.6611,1,0.91944,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Histidine metabolism,23,1,0.19774,1.6208,1,0.93595,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.22074,1.5108,1,1,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
Nicotinate and nicotinamide metabolism,27,1,0.22828,1.4772,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.27922,1.2757,1,1,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Purine metabolism,51,1,0.39058,0.94012,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Porphyrin and chlorophyll metabolism,54,1,0.40854,0.89517,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
Cholinergic synapse,4,1,0.02989,3.5102,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.02989,3.5102,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Metabolism of xenobiotics by cytochrome P450,43,2,0.038541,3.256,1,1,0.015936,C19588;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588+C19594,"mmu00980+C19588:Aflatoxin B1 diol;C19594:Aflatoxin-M1-8,9-epoxide"
Caffeine metabolism,7,1,0.051792,2.9605,1,1,0.029412,C07481,mmu00232,http://www.kegg.jp/pathway/mmu00232+C07481,mmu00232+C07481:Caffeine
Glycerophospholipid metabolism,12,1,0.087335,2.438,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.12844,2.0523,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Phenylalanine metabolism,22,1,0.15494,1.8647,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Nicotinate and nicotinamide metabolism,27,1,0.18707,1.6763,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Drug metabolism - cytochrome P450,32,1,0.21812,1.5227,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Purine metabolism,51,1,0.32687,1.1182,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Bile secretion,52,1,0.33221,1.102,1,1,0.0091743,C00114,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114,mmu04976+C00114:Choline
ABC transporters,59,1,0.36854,0.99821,1,1,0.0072464,C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114,mmu02010+C00114:Choline
Cholinergic synapse,4,1,0.033579,3.3939,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.033579,3.3939,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Caffeine metabolism,7,1,0.058102,2.8456,1,1,0.029412,C07481,mmu00232,http://www.kegg.jp/pathway/mmu00232+C07481,mmu00232+C07481:Caffeine
Glycerophospholipid metabolism,12,1,0.097746,2.3254,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.14336,1.9424,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Ferroptosis,19,1,0.15075,1.8921,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Phenylalanine metabolism,22,1,0.17261,1.7567,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.17261,1.7567,1,1,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Nicotinate and nicotinamide metabolism,27,1,0.20793,1.5705,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Drug metabolism - cytochrome P450,32,1,0.24191,1.4192,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Metabolism of xenobiotics by cytochrome P450,43,1,0.31213,1.1643,1,1,0.0039841,C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19594,"mmu00980+C19594:Aflatoxin-M1-8,9-epoxide"
Purine metabolism,51,1,0.3595,1.023,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Bile secretion,52,1,0.36521,1.0073,1,1,0.0091743,C00114,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114,mmu04976+C00114:Choline
ABC transporters,59,1,0.40395,0.90645,1,1,0.0072464,C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114,mmu02010+C00114:Choline
Ferroptosis,19,1,0.052864,2.94,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Phosphonate and phosphinate metabolism,22,1,0.061037,2.7963,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Metabolism of xenobiotics by cytochrome P450,43,1,0.11693,2.1461,1,1,0.0039841,C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19594,"mmu00980+C19594:Aflatoxin-M1-8,9-epoxide"
Spinocerebellar ataxia,1,1,0.0056604,5.1743,1,0.225,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.0056604,5.1743,1,0.225,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Glutathione metabolism,22,2,0.0058685,5.1382,1,0.225,0.06993,C00025;C00315,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00315,mmu00480+C00025:L-Glutamate;C00315:Spermidine
Long-term potentiation,2,1,0.011294,4.4835,1,0.225,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Arginine and proline metabolism,35,2,0.014623,4.2251,1,0.225,0.093137,C00025;C00315,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00315,mmu00330+C00025:L-Glutamate;C00315:Spermidine
Amyotrophic lateral sclerosis,3,1,0.016901,4.0804,1,0.225,0.055556,C00025,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025,mmu05014+C00025:L-Glutamate
Proximal tubule bicarbonate reclamation,3,1,0.016901,4.0804,1,0.225,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amphetamine addiction,3,1,0.016901,4.0804,1,0.225,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.016901,4.0804,1,0.225,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.016901,4.0804,1,0.225,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.016901,4.0804,1,0.225,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.016901,4.0804,1,0.225,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.016901,4.0804,1,0.225,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.016901,4.0804,1,0.225,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.016901,4.0804,1,0.225,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.016901,4.0804,1,0.225,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
Metabolism of xenobiotics by cytochrome P450,43,2,0.021743,3.8285,1,0.23943,0.015936,C19588;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588+C19594,"mmu00980+C19588:Aflatoxin B1 diol;C19594:Aflatoxin-M1-8,9-epoxide"
Phospholipase D signaling pathway,4,1,0.022482,3.7951,1,0.23943,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.022482,3.7951,1,0.23943,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.022482,3.7951,1,0.23943,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Synaptic vesicle cycle,5,1,0.028036,3.5743,1,0.27144,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.028036,3.5743,1,0.27144,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
ABC transporters,59,2,0.039538,3.2305,1,0.36489,0.014493,C00025;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00315,mmu02010+C00025:L-Glutamate;C00315:Spermidine
Pathways of neurodegeneration - multiple diseases,8,1,0.04454,3.1114,1,0.36489,0.020833,C00025,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025,mmu05022+C00025:L-Glutamate
Glycolysis / Gluconeogenesis,8,1,0.04454,3.1114,1,0.36489,0.037344,C00236,mmu00010,http://www.kegg.jp/pathway/mmu00010+C00236,mmu00010+C00236:3-Phospho-D-glyceroyl phosphate
Retrograde endocannabinoid signaling,8,1,0.04454,3.1114,1,0.36489,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Butanoate metabolism,11,1,0.060811,2.8,1,0.44665,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
Arginine biosynthesis,11,1,0.060811,2.8,1,0.44665,0.081761,C00025,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025,mmu00220+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.060811,2.8,1,0.44665,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
beta-Alanine metabolism,12,1,0.066183,2.7153,1,0.4699,0.025862,C00315,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315,mmu00410+C00315:Spermidine
Taste transduction,14,1,0.07685,2.5659,1,0.51153,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.07685,2.5659,1,0.51153,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Aminoacyl-tRNA biosynthesis,16,1,0.087415,2.4371,1,0.56422,0.017857,C00025,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025,mmu00970+C00025:L-Glutamate
Central carbon metabolism in cancer,17,1,0.09266,2.3788,1,0.58049,0.037736,C00025,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025,mmu05230+C00025:L-Glutamate
Glyoxylate and dicarboxylate metabolism,18,1,0.097879,2.324,1,0.59567,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Ferroptosis,19,1,0.10307,2.2723,1,0.60985,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
Protein digestion and absorption,21,1,0.11339,2.1769,1,0.65275,0.021277,C00025,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025,mmu04974+C00025:L-Glutamate
Phosphonate and phosphinate metabolism,22,1,0.11851,2.1328,1,0.66427,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Histidine metabolism,23,1,0.1236,2.0907,1,0.67507,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.13874,1.9751,1,0.7388,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.17805,1.7257,1,0.925,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Bile secretion,52,1,0.26106,1.343,1,1,0.0091743,C00315,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315,mmu04976+C00315:Spermidine
Porphyrin and chlorophyll metabolism,54,1,0.26983,1.3099,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
Cholinergic synapse,4,1,0.018761,3.976,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.018761,3.976,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Glycerophospholipid metabolism,12,1,0.055439,2.8925,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.082221,2.4983,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Ferroptosis,19,1,0.086625,2.4462,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.099735,2.3052,1,1,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Drug metabolism - cytochrome P450,32,1,0.14235,1.9494,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Metabolism of xenobiotics by cytochrome P450,43,1,0.18735,1.6748,1,1,0.0039841,C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19594,"mmu00980+C19594:Aflatoxin-M1-8,9-epoxide"
Bile secretion,52,1,0.22275,1.5017,1,1,0.0091743,C00114,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114,mmu04976+C00114:Choline
ABC transporters,59,1,0.24942,1.3886,1,1,0.0072464,C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114,mmu02010+C00114:Choline
beta-Alanine metabolism,12,2,0.00317,5.754,0.67521,0.55823,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Bile secretion,52,3,0.0052416,5.2511,1,0.55823,0.027523,C00114;C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00315+C00750,mmu04976+C00114:Choline;C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.010681,4.5393,1,0.75837,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
Arginine and proline metabolism,35,2,0.026183,3.6426,1,1,0.063725,C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315+C00750,mmu00330+C00315:Spermidine;C00750:Spermine
Cholinergic synapse,4,1,0.02989,3.5102,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.02989,3.5102,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Metabolism of xenobiotics by cytochrome P450,43,2,0.038541,3.256,1,1,0.015936,C19588;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588+C19594,"mmu00980+C19588:Aflatoxin B1 diol;C19594:Aflatoxin-M1-8,9-epoxide"
ABC transporters,59,2,0.068691,2.6781,1,1,0.014493,C00114;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114+C00315,mmu02010+C00114:Choline;C00315:Spermidine
Pantothenate and CoA biosynthesis,12,1,0.087335,2.438,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.087335,2.438,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.12844,2.0523,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Phenylalanine metabolism,22,1,0.15494,1.8647,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Drug metabolism - cytochrome P450,32,1,0.21812,1.5227,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Purine metabolism,51,1,0.32687,1.1182,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Amyotrophic lateral sclerosis,3,2,0.00048272,7.6361,0.10282,0.084165,0.11111,C00025;C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025+C00062,mmu05014+C00025:L-Glutamate;C00062:L-Arginine
Arginine and proline metabolism,35,4,0.00079029,7.1431,0.16754,0.084165,0.15441,C00025;C00062;C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00062+C00315+C00750,mmu00330+C00025:L-Glutamate;C00062:L-Arginine;C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,3,0.0024395,6.016,0.51473,0.1732,0.083916,C00025;C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00315+C00750,mmu00480+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
Pathways of neurodegeneration - multiple diseases,8,2,0.0043377,5.4404,0.91092,0.23098,0.041667,C00025;C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025+C00062,mmu05022+C00025:L-Glutamate;C00062:L-Arginine
Arginine biosynthesis,11,2,0.008329,4.788,1,0.28746,0.13208,C00025;C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025+C00062,mmu00220+C00025:L-Glutamate;C00062:L-Arginine
beta-Alanine metabolism,12,2,0.0099195,4.6133,1,0.28746,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Ether lipid metabolism,1,1,0.013208,4.327,1,0.28746,0.024096,C00670,mmu00565,http://www.kegg.jp/pathway/mmu00565+C00670,mmu00565+C00670:sn-Glycero-3-phosphocholine
Spinocerebellar ataxia,1,1,0.013208,4.327,1,0.28746,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.013208,4.327,1,0.28746,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Aminoacyl-tRNA biosynthesis,16,2,0.017498,4.0457,1,0.28746,0.035714,C00025;C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025+C00062,mmu00970+C00025:L-Glutamate;C00062:L-Arginine
Central carbon metabolism in cancer,17,2,0.019681,3.9281,1,0.28746,0.056604,C00025;C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025+C00062,mmu05230+C00025:L-Glutamate;C00062:L-Arginine
Ferroptosis,19,2,0.024375,3.7142,1,0.28746,0.093023,C00025;C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025+C11378,mmu04216+C00025:L-Glutamate;C11378:Ubiquinone-10
D-Arginine and D-ornithine metabolism,2,1,0.026253,3.64,1,0.28746,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Long-term potentiation,2,1,0.026253,3.64,1,0.28746,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Chagas disease,2,1,0.026253,3.64,1,0.28746,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Protein digestion and absorption,21,2,0.029486,3.5239,1,0.28746,0.042553,C00025;C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025+C00062,mmu04974+C00025:L-Glutamate;C00062:L-Arginine
ABC transporters,59,3,0.038456,3.2582,1,0.28746,0.021739,C00025;C00062;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00062+C00315,mmu02010+C00025:L-Glutamate;C00062:L-Arginine;C00315:Spermidine
Proximal tubule bicarbonate reclamation,3,1,0.039138,3.2407,1,0.28746,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amoebiasis,3,1,0.039138,3.2407,1,0.28746,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
Amphetamine addiction,3,1,0.039138,3.2407,1,0.28746,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.039138,3.2407,1,0.28746,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.039138,3.2407,1,0.28746,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.039138,3.2407,1,0.28746,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.039138,3.2407,1,0.28746,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.039138,3.2407,1,0.28746,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.039138,3.2407,1,0.28746,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.039138,3.2407,1,0.28746,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.039138,3.2407,1,0.28746,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
mTOR signaling pathway,3,1,0.039138,3.2407,1,0.28746,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
Phospholipase D signaling pathway,4,1,0.051865,2.9591,1,0.32492,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.051865,2.9591,1,0.32492,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.051865,2.9591,1,0.32492,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Pertussis,4,1,0.051865,2.9591,1,0.32492,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Choline metabolism in cancer,4,1,0.051865,2.9591,1,0.32492,0.11236,C00670,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00670,mmu05231+C00670:sn-Glycero-3-phosphocholine
Synaptic vesicle cycle,5,1,0.064435,2.7421,1,0.38124,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.064435,2.7421,1,0.38124,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Caffeine metabolism,7,1,0.089112,2.4179,1,0.51299,0.029412,C07481,mmu00232,http://www.kegg.jp/pathway/mmu00232+C07481,mmu00232+C07481:Caffeine
Retrograde endocannabinoid signaling,8,1,0.10122,2.2904,1,0.56738,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Metabolism of xenobiotics by cytochrome P450,43,2,0.10745,2.2307,1,0.58684,0.0079681,C19591;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19591+C19594,"mmu00980+C19591:1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal;C19594:Aflatoxin-M1-8,9-epoxide"
Butanoate metabolism,11,1,0.13666,1.9902,1,0.70998,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.13666,1.9902,1,0.70998,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Bile secretion,52,2,0.14751,1.9138,1,0.71735,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
Pantothenate and CoA biosynthesis,12,1,0.14819,1.9093,1,0.71735,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.14819,1.9093,1,0.71735,0.025926,C00670,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00670,mmu00564+C00670:sn-Glycero-3-phosphocholine
Taste transduction,14,1,0.1708,1.7672,1,0.79089,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.1708,1.7672,1,0.79089,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Glyoxylate and dicarboxylate metabolism,18,1,0.21437,1.54,1,0.97152,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Phenylalanine metabolism,22,1,0.25581,1.3633,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.25581,1.3633,1,1,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Histidine metabolism,23,1,0.26585,1.3248,1,1,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.29521,1.2201,1,1,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
Nicotinate and nicotinamide metabolism,27,1,0.30475,1.1883,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.36827,0.99895,1,1,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Purine metabolism,51,1,0.50078,0.69159,1,1,0.01083,C00360,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360,mmu00230+C00360:dAMP
Porphyrin and chlorophyll metabolism,54,1,0.52129,0.65144,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
D-Arginine and D-ornithine metabolism,2,1,0.011294,4.4835,1,0.71999,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Chagas disease,2,1,0.011294,4.4835,1,0.71999,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Amyotrophic lateral sclerosis,3,1,0.016901,4.0804,1,0.71999,0.055556,C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00062,mmu05014+C00062:L-Arginine
Amoebiasis,3,1,0.016901,4.0804,1,0.71999,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
mTOR signaling pathway,3,1,0.016901,4.0804,1,0.71999,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
Metabolism of xenobiotics by cytochrome P450,43,2,0.021743,3.8285,1,0.77188,0.015936,C19588;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588+C19594,"mmu00980+C19588:Aflatoxin B1 diol;C19594:Aflatoxin-M1-8,9-epoxide"
Pathways of neurodegeneration - multiple diseases,8,1,0.04454,3.1114,1,1,0.020833,C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00062,mmu05022+C00062:L-Arginine
Arginine biosynthesis,11,1,0.060811,2.8,1,1,0.050314,C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00062,mmu00220+C00062:L-Arginine
Aminoacyl-tRNA biosynthesis,16,1,0.087415,2.4371,1,1,0.017857,C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00062,mmu00970+C00062:L-Arginine
Central carbon metabolism in cancer,17,1,0.09266,2.3788,1,1,0.018868,C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00062,mmu05230+C00062:L-Arginine
Protein digestion and absorption,21,1,0.11339,2.1769,1,1,0.021277,C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00062,mmu04974+C00062:L-Arginine
Phosphonate and phosphinate metabolism,22,1,0.11851,2.1328,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Nicotinate and nicotinamide metabolism,27,1,0.14374,1.9397,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Drug metabolism - cytochrome P450,32,1,0.16837,1.7816,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Arginine and proline metabolism,35,1,0.18286,1.699,1,1,0.041667,C00062,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00062,mmu00330+C00062:L-Arginine
ABC transporters,59,1,0.29139,1.2331,1,1,0.0072464,C00062,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00062,mmu02010+C00062:L-Arginine
beta-Alanine metabolism,12,2,0.0061099,5.0978,1,1,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Bile secretion,52,3,0.013904,4.2756,1,1,0.027523,C00114;C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00315+C00750,mmu04976+C00114:Choline;C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.020203,3.9019,1,1,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
Cholinergic synapse,4,1,0.040925,3.196,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.040925,3.196,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Arginine and proline metabolism,35,2,0.048332,3.0297,1,1,0.063725,C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315+C00750,mmu00330+C00315:Spermidine;C00750:Spermine
Metabolism of xenobiotics by cytochrome P450,43,2,0.070094,2.6579,1,1,0.0079681,C19591;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19591+C19594,"mmu00980+C19591:1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal;C19594:Aflatoxin-M1-8,9-epoxide"
Caffeine metabolism,7,1,0.070613,2.6505,1,1,0.029412,C07481,mmu00232,http://www.kegg.jp/pathway/mmu00232+C07481,mmu00232+C07481:Caffeine
Pantothenate and CoA biosynthesis,12,1,0.11824,2.135,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.11824,2.135,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
ABC transporters,59,2,0.12129,2.1095,1,1,0.014493,C00114;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114+C00315,mmu02010+C00114:Choline;C00315:Spermidine
"Glycine, serine and threonine metabolism",18,1,0.17246,1.7576,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Phenylalanine metabolism,22,1,0.2069,1.5755,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.2069,1.5755,1,1,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Nicotinate and nicotinamide metabolism,27,1,0.24812,1.3938,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Drug metabolism - cytochrome P450,32,1,0.28739,1.2469,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Purine metabolism,51,1,0.42018,0.86707,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Choline metabolism in cancer,4,2,0.00069668,7.2692,0.14839,0.14839,0.32584,C00114;C00670,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114+C00670,mmu05231+C00114:Choline;C00670:sn-Glycero-3-phosphocholine
Glycerophospholipid metabolism,12,2,0.0072858,4.9218,1,0.37679,0.098148,C00114;C00670,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114+C00670,mmu00564+C00114:Choline;C00670:sn-Glycero-3-phosphocholine
Metabolism of xenobiotics by cytochrome P450,43,3,0.010599,4.547,1,0.37679,0.01992,C19588;C19591;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588+C19591+C19594,"mmu00980+C19588:Aflatoxin B1 diol;C19591:1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal;C19594:Aflatoxin-M1-8,9-epoxide"
Ether lipid metabolism,1,1,0.011321,4.4811,1,0.37679,0.024096,C00670,mmu00565,http://www.kegg.jp/pathway/mmu00565+C00670,mmu00565+C00670:sn-Glycero-3-phosphocholine
Spinocerebellar ataxia,1,1,0.011321,4.4811,1,0.37679,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.011321,4.4811,1,0.37679,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Ferroptosis,19,2,0.018061,4.014,1,0.37679,0.093023,C00025;C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025+C11378,mmu04216+C00025:L-Glutamate;C11378:Ubiquinone-10
Long-term potentiation,2,1,0.022524,3.7932,1,0.37679,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Amyotrophic lateral sclerosis,3,1,0.033611,3.3929,1,0.37679,0.055556,C00025,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025,mmu05014+C00025:L-Glutamate
Proximal tubule bicarbonate reclamation,3,1,0.033611,3.3929,1,0.37679,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amphetamine addiction,3,1,0.033611,3.3929,1,0.37679,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.033611,3.3929,1,0.37679,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.033611,3.3929,1,0.37679,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.033611,3.3929,1,0.37679,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.033611,3.3929,1,0.37679,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.033611,3.3929,1,0.37679,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.033611,3.3929,1,0.37679,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.033611,3.3929,1,0.37679,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.033611,3.3929,1,0.37679,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
Phospholipase D signaling pathway,4,1,0.044582,3.1104,1,0.41287,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.044582,3.1104,1,0.41287,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.044582,3.1104,1,0.41287,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Cholinergic synapse,4,1,0.044582,3.1104,1,0.41287,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Synaptic vesicle cycle,5,1,0.055439,2.8925,1,0.47234,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.055439,2.8925,1,0.47234,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Caffeine metabolism,7,1,0.076814,2.5664,1,0.62929,0.029412,C07481,mmu00232,http://www.kegg.jp/pathway/mmu00232+C07481,mmu00232+C07481:Caffeine
Pathways of neurodegeneration - multiple diseases,8,1,0.087335,2.438,1,0.64146,0.020833,C00025,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025,mmu05022+C00025:L-Glutamate
Glycolysis / Gluconeogenesis,8,1,0.087335,2.438,1,0.64146,0.037344,C00236,mmu00010,http://www.kegg.jp/pathway/mmu00010+C00236,mmu00010+C00236:3-Phospho-D-glyceroyl phosphate
Retrograde endocannabinoid signaling,8,1,0.087335,2.438,1,0.64146,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Butanoate metabolism,11,1,0.11824,2.135,1,0.78704,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
Arginine biosynthesis,11,1,0.11824,2.135,1,0.78704,0.081761,C00025,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025,mmu00220+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.11824,2.135,1,0.78704,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
ABC transporters,59,2,0.14052,1.9624,1,0.90181,0.014493,C00025;C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00114,mmu02010+C00025:L-Glutamate;C00114:Choline
Taste transduction,14,1,0.14819,1.9093,1,0.90181,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.14819,1.9093,1,0.90181,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Aminoacyl-tRNA biosynthesis,16,1,0.16763,1.786,1,0.99179,0.017857,C00025,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025,mmu00970+C00025:L-Glutamate
Central carbon metabolism in cancer,17,1,0.17719,1.7305,1,1,0.037736,C00025,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025,mmu05230+C00025:L-Glutamate
"Glycine, serine and threonine metabolism",18,1,0.18666,1.6785,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Glyoxylate and dicarboxylate metabolism,18,1,0.18666,1.6785,1,1,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Protein digestion and absorption,21,1,0.21446,1.5396,1,1,0.021277,C00025,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025,mmu04974+C00025:L-Glutamate
Phosphonate and phosphinate metabolism,22,1,0.22354,1.4982,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.22354,1.4982,1,1,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Glutathione metabolism,22,1,0.22354,1.4982,1,1,0.041958,C00025,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025,mmu00480+C00025:L-Glutamate
Histidine metabolism,23,1,0.23251,1.4588,1,1,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.25888,1.3514,1,1,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.32517,1.1234,1,1,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Arginine and proline metabolism,35,1,0.33306,1.0994,1,1,0.04902,C00025,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025,mmu00330+C00025:L-Glutamate
Purine metabolism,51,1,0.44837,0.80213,1,1,0.01083,C00360,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360,mmu00230+C00360:dAMP
Bile secretion,52,1,0.45493,0.78761,1,1,0.0091743,C00114,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114,mmu04976+C00114:Choline
Porphyrin and chlorophyll metabolism,54,1,0.46784,0.75963,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
beta-Alanine metabolism,12,2,0.0061099,5.0978,1,1,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Bile secretion,52,3,0.013904,4.2756,1,1,0.027523,C00114;C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00315+C00750,mmu04976+C00114:Choline;C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.020203,3.9019,1,1,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
Cholinergic synapse,4,1,0.040925,3.196,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.040925,3.196,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Arginine and proline metabolism,35,2,0.048332,3.0297,1,1,0.063725,C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315+C00750,mmu00330+C00315:Spermidine;C00750:Spermine
Metabolism of xenobiotics by cytochrome P450,43,2,0.070094,2.6579,1,1,0.015936,C19588;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588+C19594,"mmu00980+C19588:Aflatoxin B1 diol;C19594:Aflatoxin-M1-8,9-epoxide"
Pantothenate and CoA biosynthesis,12,1,0.11824,2.135,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.11824,2.135,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
ABC transporters,59,2,0.12129,2.1095,1,1,0.014493,C00114;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114+C00315,mmu02010+C00114:Choline;C00315:Spermidine
"Glycine, serine and threonine metabolism",18,1,0.17246,1.7576,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Terpenoid backbone biosynthesis,19,1,0.1812,1.7082,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phenylalanine metabolism,22,1,0.2069,1.5755,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.2069,1.5755,1,1,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Nicotinate and nicotinamide metabolism,27,1,0.24812,1.3938,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Drug metabolism - cytochrome P450,32,1,0.28739,1.2469,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Purine metabolism,51,1,0.42018,0.86707,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Amyotrophic lateral sclerosis,3,2,0.00041402,7.7896,0.088187,0.061561,0.11111,C00025;C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025+C00062,mmu05014+C00025:L-Glutamate;C00062:L-Arginine
Arginine and proline metabolism,35,4,0.00057803,7.4559,0.12254,0.061561,0.15441,C00025;C00062;C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00062+C00315+C00750,mmu00330+C00025:L-Glutamate;C00062:L-Arginine;C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,3,0.0019429,6.2436,0.40995,0.13795,0.083916,C00025;C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00315+C00750,mmu00480+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
Pathways of neurodegeneration - multiple diseases,8,2,0.0037322,5.5908,0.78376,0.19874,0.041667,C00025;C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025+C00062,mmu05022+C00025:L-Glutamate;C00062:L-Arginine
Arginine biosynthesis,11,2,0.0071799,4.9365,1,0.25828,0.13208,C00025;C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025+C00062,mmu00220+C00025:L-Glutamate;C00062:L-Arginine
beta-Alanine metabolism,12,2,0.0085562,4.7611,1,0.25828,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Ether lipid metabolism,1,1,0.012264,4.4011,1,0.25828,0.024096,C00670,mmu00565,http://www.kegg.jp/pathway/mmu00565+C00670,mmu00565+C00670:sn-Glycero-3-phosphocholine
Spinocerebellar ataxia,1,1,0.012264,4.4011,1,0.25828,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.012264,4.4011,1,0.25828,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Metabolism of xenobiotics by cytochrome P450,43,3,0.013392,4.3131,1,0.25828,0.01992,C19588;C19591;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588+C19591+C19594,"mmu00980+C19588:Aflatoxin B1 diol;C19591:1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal;C19594:Aflatoxin-M1-8,9-epoxide"
Aminoacyl-tRNA biosynthesis,16,2,0.015131,4.191,1,0.25828,0.035714,C00025;C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025+C00062,mmu00970+C00025:L-Glutamate;C00062:L-Arginine
Central carbon metabolism in cancer,17,2,0.01703,4.0728,1,0.25828,0.056604,C00025;C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025+C00062,mmu05230+C00025:L-Glutamate;C00062:L-Arginine
Ferroptosis,19,2,0.021117,3.8577,1,0.25828,0.093023,C00025;C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025+C11378,mmu04216+C00025:L-Glutamate;C11378:Ubiquinone-10
D-Arginine and D-ornithine metabolism,2,1,0.024389,3.7136,1,0.25828,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Long-term potentiation,2,1,0.024389,3.7136,1,0.25828,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Chagas disease,2,1,0.024389,3.7136,1,0.25828,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Protein digestion and absorption,21,2,0.025577,3.6661,1,0.25828,0.042553,C00025;C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025+C00062,mmu04974+C00025:L-Glutamate;C00062:L-Arginine
ABC transporters,59,3,0.031437,3.4598,1,0.25828,0.021739,C00025;C00062;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00062+C00315,mmu02010+C00025:L-Glutamate;C00062:L-Arginine;C00315:Spermidine
Proximal tubule bicarbonate reclamation,3,1,0.036377,3.3138,1,0.25828,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amoebiasis,3,1,0.036377,3.3138,1,0.25828,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
Amphetamine addiction,3,1,0.036377,3.3138,1,0.25828,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.036377,3.3138,1,0.25828,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.036377,3.3138,1,0.25828,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.036377,3.3138,1,0.25828,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.036377,3.3138,1,0.25828,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.036377,3.3138,1,0.25828,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.036377,3.3138,1,0.25828,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.036377,3.3138,1,0.25828,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.036377,3.3138,1,0.25828,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
mTOR signaling pathway,3,1,0.036377,3.3138,1,0.25828,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
Phospholipase D signaling pathway,4,1,0.048229,3.0318,1,0.30214,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.048229,3.0318,1,0.30214,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.048229,3.0318,1,0.30214,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Choline metabolism in cancer,4,1,0.048229,3.0318,1,0.30214,0.11236,C00670,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00670,mmu05231+C00670:sn-Glycero-3-phosphocholine
Synaptic vesicle cycle,5,1,0.059945,2.8143,1,0.35468,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.059945,2.8143,1,0.35468,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Caffeine metabolism,7,1,0.082981,2.4891,1,0.4777,0.029412,C07481,mmu00232,http://www.kegg.jp/pathway/mmu00232+C07481,mmu00232+C07481:Caffeine
Retrograde endocannabinoid signaling,8,1,0.094302,2.3613,1,0.52859,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Butanoate metabolism,11,1,0.1275,2.0597,1,0.67738,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.1275,2.0597,1,0.67738,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Bile secretion,52,2,0.13039,2.0372,1,0.67738,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
Pantothenate and CoA biosynthesis,12,1,0.13831,1.9783,1,0.68511,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.13831,1.9783,1,0.68511,0.025926,C00670,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00670,mmu00564+C00670:sn-Glycero-3-phosphocholine
Taste transduction,14,1,0.15956,1.8353,1,0.75527,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.15956,1.8353,1,0.75527,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Glyoxylate and dicarboxylate metabolism,18,1,0.20063,1.6063,1,0.92901,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Phosphonate and phosphinate metabolism,22,1,0.23984,1.4278,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.23984,1.4278,1,1,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Histidine metabolism,23,1,0.24936,1.3889,1,1,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.27726,1.2828,1,1,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.34706,1.0583,1,1,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Purine metabolism,51,1,0.47522,0.74399,1,1,0.01083,C00360,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360,mmu00230+C00360:dAMP
Porphyrin and chlorophyll metabolism,54,1,0.49526,0.70267,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
beta-Alanine metabolism,12,2,0.0050307,5.2922,1,1,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Bile secretion,52,3,0.010472,4.5591,1,1,0.027523,C00114;C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00315+C00750,mmu04976+C00114:Choline;C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.016739,4.09,1,1,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
Cholinergic synapse,4,1,0.037257,3.2899,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.037257,3.2899,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Arginine and proline metabolism,35,2,0.040371,3.2097,1,1,0.063725,C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315+C00750,mmu00330+C00315:Spermidine;C00750:Spermine
Metabolism of xenobiotics by cytochrome P450,43,2,0.058837,2.833,1,1,0.015936,C19588;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588+C19594,"mmu00980+C19588:Aflatoxin B1 diol;C19594:Aflatoxin-M1-8,9-epoxide"
ABC transporters,59,2,0.10281,2.2749,1,1,0.014493,C00114;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114+C00315,mmu02010+C00114:Choline;C00315:Spermidine
Pantothenate and CoA biosynthesis,12,1,0.10805,2.2252,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.10805,2.2252,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.15803,1.845,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Ferroptosis,19,1,0.16611,1.7951,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Phenylalanine metabolism,22,1,0.18993,1.6611,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Nicotinate and nicotinamide metabolism,27,1,0.22828,1.4772,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Drug metabolism - cytochrome P450,32,1,0.26499,1.3281,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Purine metabolism,51,1,0.39058,0.94012,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
beta-Alanine metabolism,12,2,0.0061099,5.0978,1,1,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Bile secretion,52,3,0.013904,4.2756,1,1,0.027523,C00114;C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00315+C00750,mmu04976+C00114:Choline;C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.020203,3.9019,1,1,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
Cholinergic synapse,4,1,0.040925,3.196,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.040925,3.196,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Arginine and proline metabolism,35,2,0.048332,3.0297,1,1,0.063725,C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315+C00750,mmu00330+C00315:Spermidine;C00750:Spermine
Metabolism of xenobiotics by cytochrome P450,43,2,0.070094,2.6579,1,1,0.015936,C19588;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588+C19594,"mmu00980+C19588:Aflatoxin B1 diol;C19594:Aflatoxin-M1-8,9-epoxide"
Glycolysis / Gluconeogenesis,8,1,0.080321,2.5217,1,1,0.037344,C00236,mmu00010,http://www.kegg.jp/pathway/mmu00010+C00236,mmu00010+C00236:3-Phospho-D-glyceroyl phosphate
Pantothenate and CoA biosynthesis,12,1,0.11824,2.135,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.11824,2.135,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
ABC transporters,59,2,0.12129,2.1095,1,1,0.014493,C00114;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114+C00315,mmu02010+C00114:Choline;C00315:Spermidine
"Glycine, serine and threonine metabolism",18,1,0.17246,1.7576,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Terpenoid backbone biosynthesis,19,1,0.1812,1.7082,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phenylalanine metabolism,22,1,0.2069,1.5755,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Phosphonate and phosphinate metabolism,22,1,0.2069,1.5755,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Nicotinate and nicotinamide metabolism,27,1,0.24812,1.3938,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Purine metabolism,51,1,0.42018,0.86707,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Phenylalanine metabolism,22,1,0.020755,3.875,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Ferroptosis,19,1,0.052864,2.94,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Phosphonate and phosphinate metabolism,22,1,0.061037,2.7963,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Drug metabolism - cytochrome P450,32,1,0.08794,2.4311,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Ferroptosis,19,1,0.035544,3.337,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Phosphonate and phosphinate metabolism,22,1,0.041098,3.1918,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Glycolysis / Gluconeogenesis,8,1,0.02989,3.5102,1,1,0.037344,C00236,mmu00010,http://www.kegg.jp/pathway/mmu00010+C00236,mmu00010+C00236:3-Phospho-D-glyceroyl phosphate
beta-Alanine metabolism,12,1,0.044582,3.1104,1,1,0.025862,C00315,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315,mmu00410+C00315:Spermidine
Terpenoid backbone biosynthesis,19,1,0.06989,2.6608,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phosphonate and phosphinate metabolism,22,1,0.08058,2.5185,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Glutathione metabolism,22,1,0.08058,2.5185,1,1,0.027972,C00315,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315,mmu00480+C00315:Spermidine
Arginine and proline metabolism,35,1,0.12585,2.0727,1,1,0.044118,C00315,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315,mmu00330+C00315:Spermidine
Bile secretion,52,1,0.18249,1.701,1,1,0.0091743,C00315,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315,mmu04976+C00315:Spermidine
ABC transporters,59,1,0.205,1.5847,1,1,0.0072464,C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00315,mmu02010+C00315:Spermidine
Terpenoid backbone biosynthesis,19,1,0.035544,3.337,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phosphonate and phosphinate metabolism,22,1,0.041098,3.1918,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Glycolysis / Gluconeogenesis,8,1,0.03724,3.2904,1,1,0.037344,C00236,mmu00010,http://www.kegg.jp/pathway/mmu00010+C00236,mmu00010+C00236:3-Phospho-D-glyceroyl phosphate
beta-Alanine metabolism,12,1,0.055439,2.8925,1,1,0.025862,C00315,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315,mmu00410+C00315:Spermidine
Phosphonate and phosphinate metabolism,22,1,0.099735,2.3052,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Glutathione metabolism,22,1,0.099735,2.3052,1,1,0.027972,C00315,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315,mmu00480+C00315:Spermidine
Drug metabolism - cytochrome P450,32,1,0.14235,1.9494,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Arginine and proline metabolism,35,1,0.15482,1.8655,1,1,0.044118,C00315,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315,mmu00330+C00315:Spermidine
Metabolism of xenobiotics by cytochrome P450,43,1,0.18735,1.6748,1,1,0.011952,C19588,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588,mmu00980+C19588:Aflatoxin B1 diol
Bile secretion,52,1,0.22275,1.5017,1,1,0.0091743,C00315,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315,mmu04976+C00315:Spermidine
ABC transporters,59,1,0.24942,1.3886,1,1,0.0072464,C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00315,mmu02010+C00315:Spermidine
beta-Alanine metabolism,12,1,0.033611,3.3929,1,1,0.025862,C00315,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315,mmu00410+C00315:Spermidine
Ferroptosis,19,1,0.052864,2.94,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Terpenoid backbone biosynthesis,19,1,0.052864,2.94,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Glutathione metabolism,22,1,0.061037,2.7963,1,1,0.027972,C00315,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315,mmu00480+C00315:Spermidine
Arginine and proline metabolism,35,1,0.095909,2.3444,1,1,0.044118,C00315,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315,mmu00330+C00315:Spermidine
Bile secretion,52,1,0.14019,1.9647,1,1,0.0091743,C00315,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315,mmu04976+C00315:Spermidine
ABC transporters,59,1,0.158,1.8452,1,1,0.0072464,C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00315,mmu02010+C00315:Spermidine
beta-Alanine metabolism,12,1,0.044582,3.1104,1,1,0.025862,C00315,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315,mmu00410+C00315:Spermidine
Terpenoid backbone biosynthesis,19,1,0.06989,2.6608,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phosphonate and phosphinate metabolism,22,1,0.08058,2.5185,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Glutathione metabolism,22,1,0.08058,2.5185,1,1,0.027972,C00315,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315,mmu00480+C00315:Spermidine
Arginine and proline metabolism,35,1,0.12585,2.0727,1,1,0.044118,C00315,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315,mmu00330+C00315:Spermidine
Metabolism of xenobiotics by cytochrome P450,43,1,0.15286,1.8782,1,1,0.011952,C19588,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588,mmu00980+C19588:Aflatoxin B1 diol
Bile secretion,52,1,0.18249,1.701,1,1,0.0091743,C00315,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315,mmu04976+C00315:Spermidine
ABC transporters,59,1,0.205,1.5847,1,1,0.0072464,C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00315,mmu02010+C00315:Spermidine
Glycolysis / Gluconeogenesis,8,1,0.02989,3.5102,1,1,0.037344,C00236,mmu00010,http://www.kegg.jp/pathway/mmu00010+C00236,mmu00010+C00236:3-Phospho-D-glyceroyl phosphate
beta-Alanine metabolism,12,1,0.044582,3.1104,1,1,0.025862,C00315,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315,mmu00410+C00315:Spermidine
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.08058,2.5185,1,1,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Glutathione metabolism,22,1,0.08058,2.5185,1,1,0.027972,C00315,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315,mmu00480+C00315:Spermidine
Arginine and proline metabolism,35,1,0.12585,2.0727,1,1,0.044118,C00315,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315,mmu00330+C00315:Spermidine
Metabolism of xenobiotics by cytochrome P450,43,1,0.15286,1.8782,1,1,0.011952,C19588,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588,mmu00980+C19588:Aflatoxin B1 diol
Bile secretion,52,1,0.18249,1.701,1,1,0.0091743,C00315,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315,mmu04976+C00315:Spermidine
ABC transporters,59,1,0.205,1.5847,1,1,0.0072464,C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00315,mmu02010+C00315:Spermidine
beta-Alanine metabolism,12,1,0.055439,2.8925,1,1,0.025862,C00315,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315,mmu00410+C00315:Spermidine
Terpenoid backbone biosynthesis,19,1,0.086625,2.4462,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phosphonate and phosphinate metabolism,22,1,0.099735,2.3052,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Glutathione metabolism,22,1,0.099735,2.3052,1,1,0.027972,C00315,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315,mmu00480+C00315:Spermidine
Drug metabolism - cytochrome P450,32,1,0.14235,1.9494,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Arginine and proline metabolism,35,1,0.15482,1.8655,1,1,0.044118,C00315,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315,mmu00330+C00315:Spermidine
Metabolism of xenobiotics by cytochrome P450,43,1,0.18735,1.6748,1,1,0.011952,C19588,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588,mmu00980+C19588:Aflatoxin B1 diol
Bile secretion,52,1,0.22275,1.5017,1,1,0.0091743,C00315,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315,mmu04976+C00315:Spermidine
ABC transporters,59,1,0.24942,1.3886,1,1,0.0072464,C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00315,mmu02010+C00315:Spermidine
Glycolysis / Gluconeogenesis,8,1,0.015044,4.1967,1,1,0.037344,C00236,mmu00010,http://www.kegg.jp/pathway/mmu00010+C00236,mmu00010+C00236:3-Phospho-D-glyceroyl phosphate
Phosphonate and phosphinate metabolism,22,1,0.041098,3.1918,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Phosphonate and phosphinate metabolism,22,1,0.020755,3.875,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Glycolysis / Gluconeogenesis,8,1,0.022492,3.7946,1,1,0.037344,C00236,mmu00010,http://www.kegg.jp/pathway/mmu00010+C00236,mmu00010+C00236:3-Phospho-D-glyceroyl phosphate
Phosphonate and phosphinate metabolism,22,1,0.061037,2.7963,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Metabolism of xenobiotics by cytochrome P450,43,1,0.11693,2.1461,1,1,0.011952,C19588,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588,mmu00980+C19588:Aflatoxin B1 diol
beta-Alanine metabolism,12,1,0.022524,3.7932,1,1,0.025862,C00315,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315,mmu00410+C00315:Spermidine
Terpenoid backbone biosynthesis,19,1,0.035544,3.337,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Glutathione metabolism,22,1,0.041098,3.1918,1,1,0.027972,C00315,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315,mmu00480+C00315:Spermidine
Arginine and proline metabolism,35,1,0.064978,2.7337,1,1,0.044118,C00315,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315,mmu00330+C00315:Spermidine
Bile secretion,52,1,0.095751,2.346,1,1,0.0091743,C00315,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315,mmu04976+C00315:Spermidine
ABC transporters,59,1,0.10827,2.2231,1,1,0.0072464,C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00315,mmu02010+C00315:Spermidine
Cholinergic synapse,4,1,0.011289,4.484,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.011289,4.484,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Glycerophospholipid metabolism,12,1,0.033611,3.3929,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.05013,2.9931,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Phenylalanine metabolism,22,1,0.061037,2.7963,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Nicotinate and nicotinamide metabolism,27,1,0.074554,2.5962,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Bile secretion,52,1,0.14019,1.9647,1,1,0.0091743,C00114,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114,mmu04976+C00114:Choline
ABC transporters,59,1,0.158,1.8452,1,1,0.0072464,C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114,mmu02010+C00114:Choline
Glutathione metabolism,22,3,0.00025792,8.2629,0.054936,0.054936,0.083916,C00025;C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00315+C00750,mmu00480+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
Arginine and proline metabolism,35,3,0.0010558,6.8534,0.22383,0.11245,0.11275,C00025;C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00315+C00750,mmu00330+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
beta-Alanine metabolism,12,2,0.0023926,6.0354,0.50484,0.16987,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Bile secretion,52,3,0.0033932,5.686,0.71257,0.18069,0.027523,C00114;C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00315+C00750,mmu04976+C00114:Choline;C00315:Spermidine;C00750:Spermine
ABC transporters,59,3,0.0048901,5.3205,1,0.20094,0.021739,C00025;C00114;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00114+C00315,mmu02010+C00025:L-Glutamate;C00114:Choline;C00315:Spermidine
Spinocerebellar ataxia,1,1,0.0066038,5.0201,1,0.20094,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.0066038,5.0201,1,0.20094,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Long-term potentiation,2,1,0.01317,4.3298,1,0.22084,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Amyotrophic lateral sclerosis,3,1,0.019699,3.9272,1,0.22084,0.055556,C00025,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025,mmu05014+C00025:L-Glutamate
Proximal tubule bicarbonate reclamation,3,1,0.019699,3.9272,1,0.22084,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amphetamine addiction,3,1,0.019699,3.9272,1,0.22084,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.019699,3.9272,1,0.22084,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.019699,3.9272,1,0.22084,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.019699,3.9272,1,0.22084,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.019699,3.9272,1,0.22084,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.019699,3.9272,1,0.22084,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.019699,3.9272,1,0.22084,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.019699,3.9272,1,0.22084,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.019699,3.9272,1,0.22084,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
Phospholipase D signaling pathway,4,1,0.026191,3.6423,1,0.23245,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.026191,3.6423,1,0.23245,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.026191,3.6423,1,0.23245,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Cholinergic synapse,4,1,0.026191,3.6423,1,0.23245,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.026191,3.6423,1,0.23245,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Synaptic vesicle cycle,5,1,0.032646,3.422,1,0.26745,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.032646,3.422,1,0.26745,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Pathways of neurodegeneration - multiple diseases,8,1,0.051792,2.9605,1,0.39399,0.020833,C00025,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025,mmu05022+C00025:L-Glutamate
Retrograde endocannabinoid signaling,8,1,0.051792,2.9605,1,0.39399,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Butanoate metabolism,11,1,0.070613,2.6505,1,0.48518,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
Arginine biosynthesis,11,1,0.070613,2.6505,1,0.48518,0.081761,C00025,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025,mmu00220+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.070613,2.6505,1,0.48518,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Pantothenate and CoA biosynthesis,12,1,0.076814,2.5664,1,0.4958,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.076814,2.5664,1,0.4958,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
Taste transduction,14,1,0.089112,2.4179,1,0.54231,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.089112,2.4179,1,0.54231,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Aminoacyl-tRNA biosynthesis,16,1,0.10127,2.29,1,0.59917,0.017857,C00025,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025,mmu00970+C00025:L-Glutamate
Central carbon metabolism in cancer,17,1,0.10729,2.2322,1,0.61767,0.037736,C00025,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025,mmu05230+C00025:L-Glutamate
"Glycine, serine and threonine metabolism",18,1,0.11329,2.1778,1,0.61871,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Glyoxylate and dicarboxylate metabolism,18,1,0.11329,2.1778,1,0.61871,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Ferroptosis,19,1,0.11924,2.1266,1,0.63497,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
Protein digestion and absorption,21,1,0.13105,2.0322,1,0.68084,0.021277,C00025,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025,mmu04974+C00025:L-Glutamate
Phenylalanine metabolism,22,1,0.13691,1.9884,1,0.69432,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Histidine metabolism,23,1,0.14273,1.9468,1,0.707,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.15999,1.8327,1,0.77449,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
Nicotinate and nicotinamide metabolism,27,1,0.16567,1.7977,1,0.78419,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.20457,1.5869,1,0.94723,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Purine metabolism,51,1,0.29261,1.2289,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Porphyrin and chlorophyll metabolism,54,1,0.30724,1.1801,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
Terpenoid backbone biosynthesis,19,1,0.086625,2.4462,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phenylalanine metabolism,22,1,0.099735,2.3052,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Nicotinate and nicotinamide metabolism,27,1,0.12125,2.1099,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Drug metabolism - cytochrome P450,32,1,0.14235,1.9494,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Purine metabolism,51,1,0.21888,1.5192,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Ferroptosis,19,1,0.017925,4.0216,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Arginine and proline metabolism,35,4,0.0001823,8.6099,0.038829,0.025487,0.15441,C00025;C00062;C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00062+C00315+C00750,mmu00330+C00025:L-Glutamate;C00062:L-Arginine;C00315:Spermidine;C00750:Spermine
Amyotrophic lateral sclerosis,3,2,0.00023931,8.3377,0.050734,0.025487,0.11111,C00025;C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025+C00062,mmu05014+C00025:L-Glutamate;C00062:L-Arginine
Glutathione metabolism,22,3,0.00084903,7.0714,0.17915,0.060281,0.083916,C00025;C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00315+C00750,mmu00480+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
Pathways of neurodegeneration - multiple diseases,8,2,0.0021778,6.1294,0.45735,0.11597,0.041667,C00025;C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025+C00062,mmu05022+C00025:L-Glutamate;C00062:L-Arginine
Arginine biosynthesis,11,2,0.0042135,5.4695,0.88062,0.17859,0.13208,C00025;C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025+C00062,mmu00220+C00025:L-Glutamate;C00062:L-Arginine
beta-Alanine metabolism,12,2,0.0050307,5.2922,1,0.17859,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Aminoacyl-tRNA biosynthesis,16,2,0.0089636,4.7146,1,0.21347,0.035714,C00025;C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025+C00062,mmu00970+C00025:L-Glutamate;C00062:L-Arginine
Spinocerebellar ataxia,1,1,0.009434,4.6634,1,0.21347,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.009434,4.6634,1,0.21347,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Central carbon metabolism in cancer,17,2,0.010107,4.5945,1,0.21347,0.056604,C00025;C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025+C00062,mmu05230+C00025:L-Glutamate;C00062:L-Arginine
Ferroptosis,19,2,0.012581,4.3756,1,0.21347,0.093023,C00025;C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025+C11378,mmu04216+C00025:L-Glutamate;C11378:Ubiquinone-10
ABC transporters,59,3,0.014865,4.2087,1,0.21347,0.021739,C00025;C00062;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00062+C00315,mmu02010+C00025:L-Glutamate;C00062:L-Arginine;C00315:Spermidine
Protein digestion and absorption,21,2,0.015294,4.1803,1,0.21347,0.042553,C00025;C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025+C00062,mmu04974+C00025:L-Glutamate;C00062:L-Arginine
D-Arginine and D-ornithine metabolism,2,1,0.018788,3.9746,1,0.21347,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Long-term potentiation,2,1,0.018788,3.9746,1,0.21347,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Chagas disease,2,1,0.018788,3.9746,1,0.21347,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Proximal tubule bicarbonate reclamation,3,1,0.028062,3.5733,1,0.21347,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amoebiasis,3,1,0.028062,3.5733,1,0.21347,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
Amphetamine addiction,3,1,0.028062,3.5733,1,0.21347,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.028062,3.5733,1,0.21347,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.028062,3.5733,1,0.21347,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.028062,3.5733,1,0.21347,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.028062,3.5733,1,0.21347,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.028062,3.5733,1,0.21347,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.028062,3.5733,1,0.21347,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.028062,3.5733,1,0.21347,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.028062,3.5733,1,0.21347,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
mTOR signaling pathway,3,1,0.028062,3.5733,1,0.21347,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
Phospholipase D signaling pathway,4,1,0.037257,3.2899,1,0.25599,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.037257,3.2899,1,0.25599,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.037257,3.2899,1,0.25599,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Synaptic vesicle cycle,5,1,0.046374,3.071,1,0.29932,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.046374,3.071,1,0.29932,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Retrograde endocannabinoid signaling,8,1,0.07326,2.6137,1,0.45896,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Bile secretion,52,2,0.082551,2.4943,1,0.50238,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
Butanoate metabolism,11,1,0.099463,2.308,1,0.57258,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.099463,2.308,1,0.57258,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Pantothenate and CoA biosynthesis,12,1,0.10805,2.2252,1,0.60563,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Taste transduction,14,1,0.125,2.0795,1,0.6656,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.125,2.0795,1,0.6656,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Glyoxylate and dicarboxylate metabolism,18,1,0.15803,1.845,1,0.82097,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Terpenoid backbone biosynthesis,19,1,0.16611,1.7951,1,0.8424,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phenylalanine metabolism,22,1,0.18993,1.6611,1,0.91944,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.18993,1.6611,1,0.91944,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Histidine metabolism,23,1,0.19774,1.6208,1,0.93595,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.22074,1.5108,1,1,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.27922,1.2757,1,1,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Metabolism of xenobiotics by cytochrome P450,43,1,0.34027,1.078,1,1,0.0039841,C19591,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19591,"mmu00980+C19591:1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal"
Purine metabolism,51,1,0.39058,0.94012,1,1,0.01083,C00360,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360,mmu00230+C00360:dAMP
Porphyrin and chlorophyll metabolism,54,1,0.40854,0.89517,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
Phosphonate and phosphinate metabolism,22,1,0.099735,2.3052,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Nicotinate and nicotinamide metabolism,27,1,0.12125,2.1099,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Drug metabolism - cytochrome P450,32,1,0.14235,1.9494,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Metabolism of xenobiotics by cytochrome P450,43,1,0.18735,1.6748,1,1,0.011952,C19588,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588,mmu00980+C19588:Aflatoxin B1 diol
Purine metabolism,51,1,0.21888,1.5192,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Spinocerebellar ataxia,1,1,0.0037736,5.5797,0.80377,0.17175,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.0037736,5.5797,0.80377,0.17175,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Long-term potentiation,2,1,0.0075365,4.888,1,0.17175,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Amyotrophic lateral sclerosis,3,1,0.011289,4.484,1,0.17175,0.055556,C00025,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025,mmu05014+C00025:L-Glutamate
Proximal tubule bicarbonate reclamation,3,1,0.011289,4.484,1,0.17175,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amphetamine addiction,3,1,0.011289,4.484,1,0.17175,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.011289,4.484,1,0.17175,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.011289,4.484,1,0.17175,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.011289,4.484,1,0.17175,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.011289,4.484,1,0.17175,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.011289,4.484,1,0.17175,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.011289,4.484,1,0.17175,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.011289,4.484,1,0.17175,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.011289,4.484,1,0.17175,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
Phospholipase D signaling pathway,4,1,0.01503,4.1977,1,0.18832,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.01503,4.1977,1,0.18832,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.01503,4.1977,1,0.18832,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Synaptic vesicle cycle,5,1,0.018761,3.976,1,0.21032,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.018761,3.976,1,0.21032,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Pathways of neurodegeneration - multiple diseases,8,1,0.02989,3.5102,1,0.30317,0.020833,C00025,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025,mmu05022+C00025:L-Glutamate
Retrograde endocannabinoid signaling,8,1,0.02989,3.5102,1,0.30317,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Butanoate metabolism,11,1,0.040925,3.196,1,0.36321,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
Arginine biosynthesis,11,1,0.040925,3.196,1,0.36321,0.081761,C00025,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025,mmu00220+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.040925,3.196,1,0.36321,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Taste transduction,14,1,0.051865,2.9591,1,0.42489,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.051865,2.9591,1,0.42489,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Aminoacyl-tRNA biosynthesis,16,1,0.059106,2.8284,1,0.46628,0.017857,C00025,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025,mmu00970+C00025:L-Glutamate
Central carbon metabolism in cancer,17,1,0.062711,2.7692,1,0.47705,0.037736,C00025,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025,mmu05230+C00025:L-Glutamate
Glyoxylate and dicarboxylate metabolism,18,1,0.066305,2.7135,1,0.487,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Ferroptosis,19,1,0.06989,2.6608,1,0.49622,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
Protein digestion and absorption,21,1,0.077027,2.5636,1,0.52011,0.021277,C00025,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025,mmu04974+C00025:L-Glutamate
Phosphonate and phosphinate metabolism,22,1,0.08058,2.5185,1,0.52011,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Glutathione metabolism,22,1,0.08058,2.5185,1,0.52011,0.041958,C00025,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025,mmu00480+C00025:L-Glutamate
Histidine metabolism,23,1,0.084123,2.4755,1,0.52701,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.094691,2.3571,1,0.57626,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.12242,2.1003,1,0.72435,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Arginine and proline metabolism,35,1,0.12585,2.0727,1,0.72447,0.04902,C00025,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025,mmu00330+C00025:L-Glutamate
Metabolism of xenobiotics by cytochrome P450,43,1,0.15286,1.8782,1,0.85681,0.0039841,C19591,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19591,"mmu00980+C19591:1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal"
Purine metabolism,51,1,0.17924,1.719,1,0.97892,0.01083,C00360,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360,mmu00230+C00360:dAMP
Porphyrin and chlorophyll metabolism,54,1,0.18897,1.6662,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
ABC transporters,59,1,0.205,1.5847,1,1,0.0072464,C00025,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025,mmu02010+C00025:L-Glutamate
beta-Alanine metabolism,12,2,0.0050307,5.2922,1,1,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Bile secretion,52,3,0.010472,4.5591,1,1,0.027523,C00114;C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00315+C00750,mmu04976+C00114:Choline;C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.016739,4.09,1,1,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
Pertussis,4,1,0.037257,3.2899,1,1,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Cholinergic synapse,4,1,0.037257,3.2899,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.037257,3.2899,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Arginine and proline metabolism,35,2,0.040371,3.2097,1,1,0.063725,C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315+C00750,mmu00330+C00315:Spermidine;C00750:Spermine
Purine metabolism,51,2,0.079779,2.5285,1,1,0.013409,C00360;C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360+C01345,mmu00230+C00360:dAMP;C01345:dITP
ABC transporters,59,2,0.10281,2.2749,1,1,0.014493,C00114;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114+C00315,mmu02010+C00114:Choline;C00315:Spermidine
Pantothenate and CoA biosynthesis,12,1,0.10805,2.2252,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.10805,2.2252,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.15803,1.845,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Ferroptosis,19,1,0.16611,1.7951,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Phenylalanine metabolism,22,1,0.18993,1.6611,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.18993,1.6611,1,1,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Metabolism of xenobiotics by cytochrome P450,43,1,0.34027,1.078,1,1,0.0039841,C19591,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19591,"mmu00980+C19591:1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal"
Cholinergic synapse,4,1,0.0037736,5.5797,0.80377,0.40189,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.0037736,5.5797,0.80377,0.40189,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Glycerophospholipid metabolism,12,1,0.011321,4.4811,1,0.80377,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.016981,4.0757,1,0.90425,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Bile secretion,52,1,0.049057,3.0148,1,1,0.0091743,C00114,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114,mmu04976+C00114:Choline
ABC transporters,59,1,0.05566,2.8885,1,1,0.0072464,C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114,mmu02010+C00114:Choline
Drug metabolism - cytochrome P450,32,1,0.030189,3.5003,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Ferroptosis,19,1,0.052864,2.94,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Phenylalanine metabolism,22,1,0.061037,2.7963,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Purine metabolism,51,1,0.13763,1.9832,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
beta-Alanine metabolism,12,2,0.0023926,6.0354,0.50962,0.50962,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.0081128,4.8143,1,0.86401,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
Arginine and proline metabolism,35,2,0.02005,3.9095,1,1,0.063725,C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315+C00750,mmu00330+C00315:Spermidine;C00750:Spermine
Bile secretion,52,2,0.042321,3.1625,1,1,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
Pantothenate and CoA biosynthesis,12,1,0.076814,2.5664,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Ferroptosis,19,1,0.11924,2.1266,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Phenylalanine metabolism,22,1,0.13691,1.9884,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.13691,1.9884,1,1,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Metabolism of xenobiotics by cytochrome P450,43,1,0.25228,1.3772,1,1,0.0039841,C19591,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19591,"mmu00980+C19591:1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal"
Purine metabolism,51,1,0.29261,1.2289,1,1,0.01083,C00360,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360,mmu00230+C00360:dAMP
ABC transporters,59,1,0.33106,1.1055,1,1,0.0072464,C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00315,mmu02010+C00315:Spermidine
Ether lipid metabolism,1,1,0.0056604,5.1743,1,1,0.024096,C00670,mmu00565,http://www.kegg.jp/pathway/mmu00565+C00670,mmu00565+C00670:sn-Glycero-3-phosphocholine
Pertussis,4,1,0.022482,3.7951,1,1,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Choline metabolism in cancer,4,1,0.022482,3.7951,1,1,0.11236,C00670,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00670,mmu05231+C00670:sn-Glycero-3-phosphocholine
Glycerophospholipid metabolism,12,1,0.066183,2.7153,1,1,0.025926,C00670,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00670,mmu00564+C00670:sn-Glycero-3-phosphocholine
Ferroptosis,19,1,0.10307,2.2723,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.11851,2.1328,1,1,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Metabolism of xenobiotics by cytochrome P450,43,1,0.22048,1.512,1,1,0.0039841,C19591,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19591,"mmu00980+C19591:1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal"
Purine metabolism,51,1,0.25664,1.3601,1,1,0.01083,C00360,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360,mmu00230+C00360:dAMP
beta-Alanine metabolism,12,2,0.00317,5.754,0.67521,0.67521,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.010681,4.5393,1,1,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
Arginine and proline metabolism,35,2,0.026183,3.6426,1,1,0.063725,C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315+C00750,mmu00330+C00315:Spermidine;C00750:Spermine
Purine metabolism,51,2,0.052779,2.9416,1,1,0.013409,C00360;C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360+C01345,mmu00230+C00360:dAMP;C01345:dITP
Bile secretion,52,2,0.054681,2.9062,1,1,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
Pantothenate and CoA biosynthesis,12,1,0.087335,2.438,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Phenylalanine metabolism,22,1,0.15494,1.8647,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.15494,1.8647,1,1,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Drug metabolism - cytochrome P450,32,1,0.21812,1.5227,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Metabolism of xenobiotics by cytochrome P450,43,1,0.28281,1.263,1,1,0.0039841,C19591,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19591,"mmu00980+C19591:1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal"
ABC transporters,59,1,0.36854,0.99821,1,1,0.0072464,C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00315,mmu02010+C00315:Spermidine
Ether lipid metabolism,1,1,0.0056604,5.1743,1,1,0.024096,C00670,mmu00565,http://www.kegg.jp/pathway/mmu00565+C00670,mmu00565+C00670:sn-Glycero-3-phosphocholine
Pertussis,4,1,0.022482,3.7951,1,1,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Choline metabolism in cancer,4,1,0.022482,3.7951,1,1,0.11236,C00670,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00670,mmu05231+C00670:sn-Glycero-3-phosphocholine
Glycerophospholipid metabolism,12,1,0.066183,2.7153,1,1,0.025926,C00670,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00670,mmu00564+C00670:sn-Glycero-3-phosphocholine
Ferroptosis,19,1,0.10307,2.2723,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.11851,2.1328,1,1,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Metabolism of xenobiotics by cytochrome P450,43,1,0.22048,1.512,1,1,0.0039841,C19591,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19591,"mmu00980+C19591:1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal"
Purine metabolism,51,1,0.25664,1.3601,1,1,0.01083,C00360,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360,mmu00230+C00360:dAMP
Cholinergic synapse,4,1,0.01503,4.1977,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.01503,4.1977,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Glycerophospholipid metabolism,12,1,0.044582,3.1104,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.066305,2.7135,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Ferroptosis,19,1,0.06989,2.6608,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.08058,2.5185,1,1,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Drug metabolism - cytochrome P450,32,1,0.11555,2.158,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Bile secretion,52,1,0.18249,1.701,1,1,0.0091743,C00114,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114,mmu04976+C00114:Choline
ABC transporters,59,1,0.205,1.5847,1,1,0.0072464,C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114,mmu02010+C00114:Choline
Pantothenate and CoA biosynthesis,12,1,0.022524,3.7932,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
beta-Alanine metabolism,12,1,0.022524,3.7932,1,1,0.025862,C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00750,mmu00410+C00750:Spermine
Ferroptosis,19,1,0.035544,3.337,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Glutathione metabolism,22,1,0.041098,3.1918,1,1,0.013986,C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00750,mmu00480+C00750:Spermine
Arginine and proline metabolism,35,1,0.064978,2.7337,1,1,0.019608,C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00750,mmu00330+C00750:Spermine
Bile secretion,52,1,0.095751,2.346,1,1,0.0091743,C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00750,mmu04976+C00750:Spermine
Amyotrophic lateral sclerosis,3,2,0.00048272,7.6361,0.10282,0.084165,0.11111,C00025;C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025+C00062,mmu05014+C00025:L-Glutamate;C00062:L-Arginine
Arginine and proline metabolism,35,4,0.00079029,7.1431,0.16754,0.084165,0.15441,C00025;C00062;C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00062+C00315+C00750,mmu00330+C00025:L-Glutamate;C00062:L-Arginine;C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,3,0.0024395,6.016,0.51473,0.1732,0.083916,C00025;C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00315+C00750,mmu00480+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
Pathways of neurodegeneration - multiple diseases,8,2,0.0043377,5.4404,0.91092,0.23098,0.041667,C00025;C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025+C00062,mmu05022+C00025:L-Glutamate;C00062:L-Arginine
Arginine biosynthesis,11,2,0.008329,4.788,1,0.29773,0.13208,C00025;C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025+C00062,mmu00220+C00025:L-Glutamate;C00062:L-Arginine
beta-Alanine metabolism,12,2,0.0099195,4.6133,1,0.29773,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Spinocerebellar ataxia,1,1,0.013208,4.327,1,0.29773,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.013208,4.327,1,0.29773,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Metabolism of xenobiotics by cytochrome P450,43,3,0.016567,4.1004,1,0.29773,0.01992,C19588;C19591;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588+C19591+C19594,"mmu00980+C19588:Aflatoxin B1 diol;C19591:1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal;C19594:Aflatoxin-M1-8,9-epoxide"
Aminoacyl-tRNA biosynthesis,16,2,0.017498,4.0457,1,0.29773,0.035714,C00025;C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025+C00062,mmu00970+C00025:L-Glutamate;C00062:L-Arginine
Central carbon metabolism in cancer,17,2,0.019681,3.9281,1,0.29773,0.056604,C00025;C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025+C00062,mmu05230+C00025:L-Glutamate;C00062:L-Arginine
D-Arginine and D-ornithine metabolism,2,1,0.026253,3.64,1,0.29773,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Long-term potentiation,2,1,0.026253,3.64,1,0.29773,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Chagas disease,2,1,0.026253,3.64,1,0.29773,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Protein digestion and absorption,21,2,0.029486,3.5239,1,0.29773,0.042553,C00025;C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025+C00062,mmu04974+C00025:L-Glutamate;C00062:L-Arginine
ABC transporters,59,3,0.038456,3.2582,1,0.29773,0.021739,C00025;C00062;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00062+C00315,mmu02010+C00025:L-Glutamate;C00062:L-Arginine;C00315:Spermidine
Proximal tubule bicarbonate reclamation,3,1,0.039138,3.2407,1,0.29773,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amoebiasis,3,1,0.039138,3.2407,1,0.29773,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
Amphetamine addiction,3,1,0.039138,3.2407,1,0.29773,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.039138,3.2407,1,0.29773,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.039138,3.2407,1,0.29773,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.039138,3.2407,1,0.29773,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.039138,3.2407,1,0.29773,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.039138,3.2407,1,0.29773,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.039138,3.2407,1,0.29773,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.039138,3.2407,1,0.29773,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.039138,3.2407,1,0.29773,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
mTOR signaling pathway,3,1,0.039138,3.2407,1,0.29773,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
Phospholipase D signaling pathway,4,1,0.051865,2.9591,1,0.34522,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.051865,2.9591,1,0.34522,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.051865,2.9591,1,0.34522,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Pertussis,4,1,0.051865,2.9591,1,0.34522,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Synaptic vesicle cycle,5,1,0.064435,2.7421,1,0.40366,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.064435,2.7421,1,0.40366,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Retrograde endocannabinoid signaling,8,1,0.10122,2.2904,1,0.61601,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Butanoate metabolism,11,1,0.13666,1.9902,1,0.78674,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.13666,1.9902,1,0.78674,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Purine metabolism,51,2,0.1429,1.9456,1,0.78909,0.013409,C00360;C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360+C01345,mmu00230+C00360:dAMP;C01345:dITP
Bile secretion,52,2,0.14751,1.9138,1,0.78909,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
Pantothenate and CoA biosynthesis,12,1,0.14819,1.9093,1,0.78909,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Taste transduction,14,1,0.1708,1.7672,1,0.86621,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.1708,1.7672,1,0.86621,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Glyoxylate and dicarboxylate metabolism,18,1,0.21437,1.54,1,1,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Terpenoid backbone biosynthesis,19,1,0.22493,1.492,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Ferroptosis,19,1,0.22493,1.492,1,1,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
Phenylalanine metabolism,22,1,0.25581,1.3633,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.25581,1.3633,1,1,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Histidine metabolism,23,1,0.26585,1.3248,1,1,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.29521,1.2201,1,1,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
Nicotinate and nicotinamide metabolism,27,1,0.30475,1.1883,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.36827,0.99895,1,1,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Porphyrin and chlorophyll metabolism,54,1,0.52129,0.65144,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
Amyotrophic lateral sclerosis,3,2,0.00014909,8.8109,0.031757,0.031757,0.11111,C00025;C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025+C00062,mmu05014+C00025:L-Glutamate;C00062:L-Arginine
Pathways of neurodegeneration - multiple diseases,8,2,0.0013654,6.5963,0.28947,0.14542,0.041667,C00025;C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025+C00062,mmu05022+C00025:L-Glutamate;C00062:L-Arginine
Arginine biosynthesis,11,2,0.0026517,5.9325,0.55952,0.18827,0.13208,C00025;C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025+C00062,mmu00220+C00025:L-Glutamate;C00062:L-Arginine
Aminoacyl-tRNA biosynthesis,16,2,0.0056768,5.1714,1,0.2083,0.035714,C00025;C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025+C00062,mmu00970+C00025:L-Glutamate;C00062:L-Arginine
Central carbon metabolism in cancer,17,2,0.0064093,5.05,1,0.2083,0.056604,C00025;C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025+C00062,mmu05230+C00025:L-Glutamate;C00062:L-Arginine
Spinocerebellar ataxia,1,1,0.0075472,4.8866,1,0.2083,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.0075472,4.8866,1,0.2083,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Protein digestion and absorption,21,2,0.0097473,4.6308,1,0.2083,0.042553,C00025;C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025+C00062,mmu04974+C00025:L-Glutamate;C00062:L-Arginine
D-Arginine and D-ornithine metabolism,2,1,0.015044,4.1967,1,0.2083,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Long-term potentiation,2,1,0.015044,4.1967,1,0.2083,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Chagas disease,2,1,0.015044,4.1967,1,0.2083,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Proximal tubule bicarbonate reclamation,3,1,0.022492,3.7946,1,0.2083,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amoebiasis,3,1,0.022492,3.7946,1,0.2083,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
Amphetamine addiction,3,1,0.022492,3.7946,1,0.2083,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.022492,3.7946,1,0.2083,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.022492,3.7946,1,0.2083,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.022492,3.7946,1,0.2083,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.022492,3.7946,1,0.2083,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.022492,3.7946,1,0.2083,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.022492,3.7946,1,0.2083,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.022492,3.7946,1,0.2083,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.022492,3.7946,1,0.2083,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
mTOR signaling pathway,3,1,0.022492,3.7946,1,0.2083,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
Arginine and proline metabolism,35,2,0.026183,3.6426,1,0.22738,0.090686,C00025;C00062,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00062,mmu00330+C00025:L-Glutamate;C00062:L-Arginine
Phospholipase D signaling pathway,4,1,0.02989,3.5102,1,0.22738,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.02989,3.5102,1,0.22738,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.02989,3.5102,1,0.22738,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Pertussis,4,1,0.02989,3.5102,1,0.22738,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Synaptic vesicle cycle,5,1,0.03724,3.2904,1,0.2644,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.03724,3.2904,1,0.2644,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Metabolism of xenobiotics by cytochrome P450,43,2,0.038541,3.256,1,0.26482,0.0079681,C19591;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19591+C19594,"mmu00980+C19591:1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal;C19594:Aflatoxin-M1-8,9-epoxide"
Retrograde endocannabinoid signaling,8,1,0.058996,2.8303,1,0.39269,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
ABC transporters,59,2,0.068691,2.6781,1,0.44337,0.014493,C00025;C00062,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00062,mmu02010+C00025:L-Glutamate;C00062:L-Arginine
Butanoate metabolism,11,1,0.080321,2.5217,1,0.48881,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.080321,2.5217,1,0.48881,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Taste transduction,14,1,0.10122,2.2904,1,0.58271,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.10122,2.2904,1,0.58271,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Glyoxylate and dicarboxylate metabolism,18,1,0.12844,2.0523,1,0.71996,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Ferroptosis,19,1,0.13513,2.0015,1,0.73804,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.15494,1.8647,1,0.80493,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Glutathione metabolism,22,1,0.15494,1.8647,1,0.80493,0.041958,C00025,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025,mmu00480+C00025:L-Glutamate
Histidine metabolism,23,1,0.16145,1.8235,1,0.8188,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.18073,1.7108,1,0.89524,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
Drug metabolism - cytochrome P450,32,1,0.21812,1.5227,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.23025,1.4686,1,1,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Purine metabolism,51,1,0.32687,1.1182,1,1,0.01083,C00360,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360,mmu00230+C00360:dAMP
Porphyrin and chlorophyll metabolism,54,1,0.34277,1.0707,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
beta-Alanine metabolism,12,2,0.00317,5.754,0.67521,0.67521,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.010681,4.5393,1,1,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
Arginine and proline metabolism,35,2,0.026183,3.6426,1,1,0.063725,C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315+C00750,mmu00330+C00315:Spermidine;C00750:Spermine
Metabolism of xenobiotics by cytochrome P450,43,2,0.038541,3.256,1,1,0.0079681,C19591;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19591+C19594,"mmu00980+C19591:1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal;C19594:Aflatoxin-M1-8,9-epoxide"
Bile secretion,52,2,0.054681,2.9062,1,1,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
Pantothenate and CoA biosynthesis,12,1,0.087335,2.438,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Terpenoid backbone biosynthesis,19,1,0.13513,2.0015,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phenylalanine metabolism,22,1,0.15494,1.8647,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Nicotinate and nicotinamide metabolism,27,1,0.18707,1.6763,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Purine metabolism,51,1,0.32687,1.1182,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
ABC transporters,59,1,0.36854,0.99821,1,1,0.0072464,C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00315,mmu02010+C00315:Spermidine
Glutathione metabolism,22,3,0.00025792,8.2629,0.054936,0.054936,0.083916,C00025;C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00315+C00750,mmu00480+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
Arginine and proline metabolism,35,3,0.0010558,6.8534,0.22383,0.11245,0.11275,C00025;C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00315+C00750,mmu00330+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
beta-Alanine metabolism,12,2,0.0023926,6.0354,0.50484,0.16987,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Bile secretion,52,3,0.0033932,5.686,0.71257,0.18069,0.027523,C00114;C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00315+C00750,mmu04976+C00114:Choline;C00315:Spermidine;C00750:Spermine
ABC transporters,59,3,0.0048901,5.3205,1,0.20094,0.021739,C00025;C00114;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00114+C00315,mmu02010+C00025:L-Glutamate;C00114:Choline;C00315:Spermidine
Spinocerebellar ataxia,1,1,0.0066038,5.0201,1,0.20094,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.0066038,5.0201,1,0.20094,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Long-term potentiation,2,1,0.01317,4.3298,1,0.22084,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Amyotrophic lateral sclerosis,3,1,0.019699,3.9272,1,0.22084,0.055556,C00025,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025,mmu05014+C00025:L-Glutamate
Proximal tubule bicarbonate reclamation,3,1,0.019699,3.9272,1,0.22084,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amphetamine addiction,3,1,0.019699,3.9272,1,0.22084,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.019699,3.9272,1,0.22084,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.019699,3.9272,1,0.22084,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.019699,3.9272,1,0.22084,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.019699,3.9272,1,0.22084,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.019699,3.9272,1,0.22084,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.019699,3.9272,1,0.22084,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.019699,3.9272,1,0.22084,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.019699,3.9272,1,0.22084,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
Phospholipase D signaling pathway,4,1,0.026191,3.6423,1,0.23245,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.026191,3.6423,1,0.23245,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.026191,3.6423,1,0.23245,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Cholinergic synapse,4,1,0.026191,3.6423,1,0.23245,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.026191,3.6423,1,0.23245,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Synaptic vesicle cycle,5,1,0.032646,3.422,1,0.26745,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.032646,3.422,1,0.26745,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Pathways of neurodegeneration - multiple diseases,8,1,0.051792,2.9605,1,0.39399,0.020833,C00025,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025,mmu05022+C00025:L-Glutamate
Retrograde endocannabinoid signaling,8,1,0.051792,2.9605,1,0.39399,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Butanoate metabolism,11,1,0.070613,2.6505,1,0.48518,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
Arginine biosynthesis,11,1,0.070613,2.6505,1,0.48518,0.081761,C00025,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025,mmu00220+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.070613,2.6505,1,0.48518,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Pantothenate and CoA biosynthesis,12,1,0.076814,2.5664,1,0.4958,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.076814,2.5664,1,0.4958,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
Taste transduction,14,1,0.089112,2.4179,1,0.54231,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.089112,2.4179,1,0.54231,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Aminoacyl-tRNA biosynthesis,16,1,0.10127,2.29,1,0.59917,0.017857,C00025,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025,mmu00970+C00025:L-Glutamate
Central carbon metabolism in cancer,17,1,0.10729,2.2322,1,0.61767,0.037736,C00025,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025,mmu05230+C00025:L-Glutamate
"Glycine, serine and threonine metabolism",18,1,0.11329,2.1778,1,0.61871,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Glyoxylate and dicarboxylate metabolism,18,1,0.11329,2.1778,1,0.61871,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Ferroptosis,19,1,0.11924,2.1266,1,0.63497,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
Protein digestion and absorption,21,1,0.13105,2.0322,1,0.68084,0.021277,C00025,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025,mmu04974+C00025:L-Glutamate
Phenylalanine metabolism,22,1,0.13691,1.9884,1,0.69432,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Histidine metabolism,23,1,0.14273,1.9468,1,0.707,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.15999,1.8327,1,0.77449,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
Nicotinate and nicotinamide metabolism,27,1,0.16567,1.7977,1,0.78419,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.20457,1.5869,1,0.94723,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Purine metabolism,51,1,0.29261,1.2289,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Porphyrin and chlorophyll metabolism,54,1,0.30724,1.1801,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
Drug metabolism - cytochrome P450,32,1,0.030189,3.5003,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.041098,3.1918,1,1,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Drug metabolism - cytochrome P450,32,1,0.059494,2.8219,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Ferroptosis,19,1,0.06989,2.6608,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Phenylalanine metabolism,22,1,0.08058,2.5185,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Nicotinate and nicotinamide metabolism,27,1,0.098193,2.3208,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Purine metabolism,51,1,0.17924,1.719,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Glutathione metabolism,22,2,0.0024076,6.0291,0.51281,0.15028,0.06993,C00025;C00315,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00315,mmu00480+C00025:L-Glutamate;C00315:Spermidine
Spinocerebellar ataxia,1,1,0.0037736,5.5797,0.8,0.15028,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.0037736,5.5797,0.8,0.15028,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Arginine and proline metabolism,35,2,0.0060991,5.0996,1,0.15028,0.093137,C00025;C00315,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00315,mmu00330+C00025:L-Glutamate;C00315:Spermidine
Long-term potentiation,2,1,0.0075365,4.888,1,0.15028,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Amyotrophic lateral sclerosis,3,1,0.011289,4.484,1,0.15028,0.055556,C00025,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025,mmu05014+C00025:L-Glutamate
Proximal tubule bicarbonate reclamation,3,1,0.011289,4.484,1,0.15028,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amphetamine addiction,3,1,0.011289,4.484,1,0.15028,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.011289,4.484,1,0.15028,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.011289,4.484,1,0.15028,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.011289,4.484,1,0.15028,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.011289,4.484,1,0.15028,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.011289,4.484,1,0.15028,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.011289,4.484,1,0.15028,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.011289,4.484,1,0.15028,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.011289,4.484,1,0.15028,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
Phospholipase D signaling pathway,4,1,0.01503,4.1977,1,0.1685,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.01503,4.1977,1,0.1685,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.01503,4.1977,1,0.1685,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
ABC transporters,59,2,0.017003,4.0744,1,0.18108,0.014493,C00025;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00315,mmu02010+C00025:L-Glutamate;C00315:Spermidine
Synaptic vesicle cycle,5,1,0.018761,3.976,1,0.18164,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.018761,3.976,1,0.18164,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Pathways of neurodegeneration - multiple diseases,8,1,0.02989,3.5102,1,0.26528,0.020833,C00025,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025,mmu05022+C00025:L-Glutamate
Retrograde endocannabinoid signaling,8,1,0.02989,3.5102,1,0.26528,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Butanoate metabolism,11,1,0.040925,3.196,1,0.32285,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
Arginine biosynthesis,11,1,0.040925,3.196,1,0.32285,0.081761,C00025,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025,mmu00220+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.040925,3.196,1,0.32285,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
beta-Alanine metabolism,12,1,0.044582,3.1104,1,0.33914,0.025862,C00315,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315,mmu00410+C00315:Spermidine
Taste transduction,14,1,0.051865,2.9591,1,0.36824,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.051865,2.9591,1,0.36824,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Aminoacyl-tRNA biosynthesis,16,1,0.059106,2.8284,1,0.40611,0.017857,C00025,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025,mmu00970+C00025:L-Glutamate
Central carbon metabolism in cancer,17,1,0.062711,2.7692,1,0.41742,0.037736,C00025,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025,mmu05230+C00025:L-Glutamate
Glyoxylate and dicarboxylate metabolism,18,1,0.066305,2.7135,1,0.42533,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Terpenoid backbone biosynthesis,19,1,0.06989,2.6608,1,0.42533,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Ferroptosis,19,1,0.06989,2.6608,1,0.42533,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
Protein digestion and absorption,21,1,0.077027,2.5636,1,0.45574,0.021277,C00025,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025,mmu04974+C00025:L-Glutamate
Phosphonate and phosphinate metabolism,22,1,0.08058,2.5185,1,0.46388,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Histidine metabolism,23,1,0.084123,2.4755,1,0.47153,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.094691,2.3571,1,0.51716,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.12242,2.1003,1,0.65191,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Bile secretion,52,1,0.18249,1.701,1,0.94807,0.0091743,C00315,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315,mmu04976+C00315:Spermidine
Porphyrin and chlorophyll metabolism,54,1,0.18897,1.6662,1,0.95835,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
Pantothenate and CoA biosynthesis,12,1,0.055439,2.8925,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
beta-Alanine metabolism,12,1,0.055439,2.8925,1,1,0.025862,C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00750,mmu00410+C00750:Spermine
Terpenoid backbone biosynthesis,19,1,0.086625,2.4462,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phenylalanine metabolism,22,1,0.099735,2.3052,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Glutathione metabolism,22,1,0.099735,2.3052,1,1,0.013986,C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00750,mmu00480+C00750:Spermine
Nicotinate and nicotinamide metabolism,27,1,0.12125,2.1099,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Arginine and proline metabolism,35,1,0.15482,1.8655,1,1,0.019608,C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00750,mmu00330+C00750:Spermine
Metabolism of xenobiotics by cytochrome P450,43,1,0.18735,1.6748,1,1,0.0039841,C19591,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19591,"mmu00980+C19591:1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal"
Bile secretion,52,1,0.22275,1.5017,1,1,0.0091743,C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00750,mmu04976+C00750:Spermine
Metabolism of xenobiotics by cytochrome P450,43,2,0.0047019,5.3598,1,1,0.0079681,C19591;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19591+C19594,"mmu00980+C19591:1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal;C19594:Aflatoxin-M1-8,9-epoxide"
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.061037,2.7963,1,1,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Amyotrophic lateral sclerosis,3,2,0.00014909,8.8109,0.031757,0.031757,0.11111,C00025;C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025+C00062,mmu05014+C00025:L-Glutamate;C00062:L-Arginine
Pathways of neurodegeneration - multiple diseases,8,2,0.0013654,6.5963,0.28947,0.14542,0.041667,C00025;C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025+C00062,mmu05022+C00025:L-Glutamate;C00062:L-Arginine
Arginine biosynthesis,11,2,0.0026517,5.9325,0.55952,0.18827,0.13208,C00025;C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025+C00062,mmu00220+C00025:L-Glutamate;C00062:L-Arginine
Aminoacyl-tRNA biosynthesis,16,2,0.0056768,5.1714,1,0.18928,0.035714,C00025;C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025+C00062,mmu00970+C00025:L-Glutamate;C00062:L-Arginine
Central carbon metabolism in cancer,17,2,0.0064093,5.05,1,0.18928,0.056604,C00025;C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025+C00062,mmu05230+C00025:L-Glutamate;C00062:L-Arginine
Ether lipid metabolism,1,1,0.0075472,4.8866,1,0.18928,0.024096,C00670,mmu00565,http://www.kegg.jp/pathway/mmu00565+C00670,mmu00565+C00670:sn-Glycero-3-phosphocholine
Spinocerebellar ataxia,1,1,0.0075472,4.8866,1,0.18928,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.0075472,4.8866,1,0.18928,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Ferroptosis,19,2,0.0079977,4.8286,1,0.18928,0.093023,C00025;C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025+C11378,mmu04216+C00025:L-Glutamate;C11378:Ubiquinone-10
Protein digestion and absorption,21,2,0.0097473,4.6308,1,0.19163,0.042553,C00025;C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025+C00062,mmu04974+C00025:L-Glutamate;C00062:L-Arginine
D-Arginine and D-ornithine metabolism,2,1,0.015044,4.1967,1,0.19163,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Long-term potentiation,2,1,0.015044,4.1967,1,0.19163,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Chagas disease,2,1,0.015044,4.1967,1,0.19163,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Proximal tubule bicarbonate reclamation,3,1,0.022492,3.7946,1,0.19163,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amoebiasis,3,1,0.022492,3.7946,1,0.19163,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
Amphetamine addiction,3,1,0.022492,3.7946,1,0.19163,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.022492,3.7946,1,0.19163,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.022492,3.7946,1,0.19163,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.022492,3.7946,1,0.19163,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.022492,3.7946,1,0.19163,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.022492,3.7946,1,0.19163,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.022492,3.7946,1,0.19163,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.022492,3.7946,1,0.19163,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.022492,3.7946,1,0.19163,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
mTOR signaling pathway,3,1,0.022492,3.7946,1,0.19163,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
Arginine and proline metabolism,35,2,0.026183,3.6426,1,0.20538,0.090686,C00025;C00062,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00062,mmu00330+C00025:L-Glutamate;C00062:L-Arginine
Phospholipase D signaling pathway,4,1,0.02989,3.5102,1,0.20538,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.02989,3.5102,1,0.20538,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.02989,3.5102,1,0.20538,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Pertussis,4,1,0.02989,3.5102,1,0.20538,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Choline metabolism in cancer,4,1,0.02989,3.5102,1,0.20538,0.11236,C00670,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00670,mmu05231+C00670:sn-Glycero-3-phosphocholine
Synaptic vesicle cycle,5,1,0.03724,3.2904,1,0.24037,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.03724,3.2904,1,0.24037,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Retrograde endocannabinoid signaling,8,1,0.058996,2.8303,1,0.36959,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
ABC transporters,59,2,0.068691,2.6781,1,0.41803,0.014493,C00025;C00062,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00062,mmu02010+C00025:L-Glutamate;C00062:L-Arginine
Butanoate metabolism,11,1,0.080321,2.5217,1,0.46239,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.080321,2.5217,1,0.46239,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Glycerophospholipid metabolism,12,1,0.087335,2.438,1,0.48954,0.025926,C00670,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00670,mmu00564+C00670:sn-Glycero-3-phosphocholine
Taste transduction,14,1,0.10122,2.2904,1,0.53901,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.10122,2.2904,1,0.53901,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Glyoxylate and dicarboxylate metabolism,18,1,0.12844,2.0523,1,0.66728,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.15494,1.8647,1,0.76749,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Glutathione metabolism,22,1,0.15494,1.8647,1,0.76749,0.041958,C00025,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025,mmu00480+C00025:L-Glutamate
Histidine metabolism,23,1,0.16145,1.8235,1,0.78158,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.18073,1.7108,1,0.85545,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.23025,1.4686,1,1,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Metabolism of xenobiotics by cytochrome P450,43,1,0.28281,1.263,1,1,0.0039841,C19591,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19591,"mmu00980+C19591:1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal"
Purine metabolism,51,1,0.32687,1.1182,1,1,0.01083,C00360,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360,mmu00230+C00360:dAMP
Porphyrin and chlorophyll metabolism,54,1,0.34277,1.0707,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
beta-Alanine metabolism,12,2,0.0050307,5.2922,1,1,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.016739,4.09,1,1,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
Arginine and proline metabolism,35,2,0.040371,3.2097,1,1,0.063725,C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315+C00750,mmu00330+C00315:Spermidine;C00750:Spermine
Metabolism of xenobiotics by cytochrome P450,43,2,0.058837,2.833,1,1,0.0079681,C19591;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19591+C19594,"mmu00980+C19591:1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal;C19594:Aflatoxin-M1-8,9-epoxide"
Bile secretion,52,2,0.082551,2.4943,1,1,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
Pantothenate and CoA biosynthesis,12,1,0.10805,2.2252,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Terpenoid backbone biosynthesis,19,1,0.16611,1.7951,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phenylalanine metabolism,22,1,0.18993,1.6611,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Phosphonate and phosphinate metabolism,22,1,0.18993,1.6611,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Nicotinate and nicotinamide metabolism,27,1,0.22828,1.4772,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Drug metabolism - cytochrome P450,32,1,0.26499,1.3281,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Purine metabolism,51,1,0.39058,0.94012,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
ABC transporters,59,1,0.43741,0.82687,1,1,0.0072464,C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00315,mmu02010+C00315:Spermidine
beta-Alanine metabolism,12,2,0.0023926,6.0354,0.50962,0.36137,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Bile secretion,52,3,0.0033932,5.686,0.71935,0.36137,0.027523,C00114;C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00315+C00750,mmu04976+C00114:Choline;C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.0081128,4.8143,1,0.57601,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
Arginine and proline metabolism,35,2,0.02005,3.9095,1,0.92979,0.063725,C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315+C00750,mmu00330+C00315:Spermidine;C00750:Spermine
Cholinergic synapse,4,1,0.026191,3.6423,1,0.92979,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.026191,3.6423,1,0.92979,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
ABC transporters,59,2,0.053397,2.93,1,1,0.014493,C00114;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114+C00315,mmu02010+C00114:Choline;C00315:Spermidine
Pantothenate and CoA biosynthesis,12,1,0.076814,2.5664,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.076814,2.5664,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.11329,2.1778,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Terpenoid backbone biosynthesis,19,1,0.11924,2.1266,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Nicotinate and nicotinamide metabolism,27,1,0.16567,1.7977,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Drug metabolism - cytochrome P450,32,1,0.19362,1.6419,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Metabolism of xenobiotics by cytochrome P450,43,1,0.25228,1.3772,1,1,0.0039841,C19591,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19591,"mmu00980+C19591:1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal"
Spinocerebellar ataxia,1,1,0.0075472,4.8866,1,0.31939,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.0075472,4.8866,1,0.31939,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Ferroptosis,19,2,0.0079977,4.8286,1,0.31939,0.093023,C00025;C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025+C11378,mmu04216+C00025:L-Glutamate;C11378:Ubiquinone-10
Long-term potentiation,2,1,0.015044,4.1967,1,0.31939,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Amyotrophic lateral sclerosis,3,1,0.022492,3.7946,1,0.31939,0.055556,C00025,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025,mmu05014+C00025:L-Glutamate
Proximal tubule bicarbonate reclamation,3,1,0.022492,3.7946,1,0.31939,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amphetamine addiction,3,1,0.022492,3.7946,1,0.31939,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.022492,3.7946,1,0.31939,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.022492,3.7946,1,0.31939,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.022492,3.7946,1,0.31939,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.022492,3.7946,1,0.31939,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.022492,3.7946,1,0.31939,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.022492,3.7946,1,0.31939,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.022492,3.7946,1,0.31939,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.022492,3.7946,1,0.31939,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
Phospholipase D signaling pathway,4,1,0.02989,3.5102,1,0.3537,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.02989,3.5102,1,0.3537,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.02989,3.5102,1,0.3537,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Synaptic vesicle cycle,5,1,0.03724,3.2904,1,0.3966,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.03724,3.2904,1,0.3966,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Caffeine metabolism,7,1,0.051792,2.9605,1,0.511,0.029412,C07481,mmu00232,http://www.kegg.jp/pathway/mmu00232+C07481,mmu00232+C07481:Caffeine
Purine metabolism,51,2,0.052779,2.9416,1,0.511,0.013409,C00360;C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360+C01345,mmu00230+C00360:dAMP;C01345:dITP
Pathways of neurodegeneration - multiple diseases,8,1,0.058996,2.8303,1,0.52359,0.020833,C00025,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025,mmu05022+C00025:L-Glutamate
Retrograde endocannabinoid signaling,8,1,0.058996,2.8303,1,0.52359,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Butanoate metabolism,11,1,0.080321,2.5217,1,0.63365,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
Arginine biosynthesis,11,1,0.080321,2.5217,1,0.63365,0.081761,C00025,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025,mmu00220+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.080321,2.5217,1,0.63365,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Taste transduction,14,1,0.10122,2.2904,1,0.74346,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.10122,2.2904,1,0.74346,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Aminoacyl-tRNA biosynthesis,16,1,0.11492,2.1635,1,0.81596,0.017857,C00025,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025,mmu00970+C00025:L-Glutamate
Central carbon metabolism in cancer,17,1,0.12171,2.1061,1,0.83624,0.037736,C00025,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025,mmu05230+C00025:L-Glutamate
Glyoxylate and dicarboxylate metabolism,18,1,0.12844,2.0523,1,0.85495,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Protein digestion and absorption,21,1,0.14838,1.908,1,0.94292,0.021277,C00025,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025,mmu04974+C00025:L-Glutamate
Phenylalanine metabolism,22,1,0.15494,1.8647,1,0.94292,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Glutathione metabolism,22,1,0.15494,1.8647,1,0.94292,0.041958,C00025,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025,mmu00480+C00025:L-Glutamate
Histidine metabolism,23,1,0.16145,1.8235,1,0.95526,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.18073,1.7108,1,1,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
Nicotinate and nicotinamide metabolism,27,1,0.18707,1.6763,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.23025,1.4686,1,1,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Arginine and proline metabolism,35,1,0.23625,1.4429,1,1,0.04902,C00025,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025,mmu00330+C00025:L-Glutamate
Metabolism of xenobiotics by cytochrome P450,43,1,0.28281,1.263,1,1,0.0039841,C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19594,"mmu00980+C19594:Aflatoxin-M1-8,9-epoxide"
Porphyrin and chlorophyll metabolism,54,1,0.34277,1.0707,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
ABC transporters,59,1,0.36854,0.99821,1,1,0.0072464,C00025,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025,mmu02010+C00025:L-Glutamate
beta-Alanine metabolism,12,2,0.0011538,6.7647,0.24576,0.24576,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.0039622,5.531,0.83998,0.42197,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
Arginine and proline metabolism,35,2,0.0099545,4.6097,1,0.70677,0.063725,C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315+C00750,mmu00330+C00315:Spermidine;C00750:Spermine
Bile secretion,52,2,0.021469,3.8412,1,1,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
Caffeine metabolism,7,1,0.032646,3.422,1,1,0.029412,C07481,mmu00232,http://www.kegg.jp/pathway/mmu00232+C07481,mmu00232+C07481:Caffeine
Pantothenate and CoA biosynthesis,12,1,0.055439,2.8925,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Nicotinate and nicotinamide metabolism,27,1,0.12125,2.1099,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Purine metabolism,51,1,0.21888,1.5192,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
ABC transporters,59,1,0.24942,1.3886,1,1,0.0072464,C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00315,mmu02010+C00315:Spermidine
Pertussis,4,1,0.01503,4.1977,1,1,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Pantothenate and CoA biosynthesis,12,1,0.044582,3.1104,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
beta-Alanine metabolism,12,1,0.044582,3.1104,1,1,0.025862,C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00750,mmu00410+C00750:Spermine
Terpenoid backbone biosynthesis,19,1,0.06989,2.6608,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Glutathione metabolism,22,1,0.08058,2.5185,1,1,0.013986,C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00750,mmu00480+C00750:Spermine
Arginine and proline metabolism,35,1,0.12585,2.0727,1,1,0.019608,C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00750,mmu00330+C00750:Spermine
Metabolism of xenobiotics by cytochrome P450,43,1,0.15286,1.8782,1,1,0.0039841,C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19594,"mmu00980+C19594:Aflatoxin-M1-8,9-epoxide"
Bile secretion,52,1,0.18249,1.701,1,1,0.0091743,C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00750,mmu04976+C00750:Spermine
Glycolysis / Gluconeogenesis,8,1,0.0075472,4.8866,1,1,0.037344,C00236,mmu00010,http://www.kegg.jp/pathway/mmu00010+C00236,mmu00010+C00236:3-Phospho-D-glyceroyl phosphate
beta-Alanine metabolism,12,2,0.0040501,5.509,0.86267,0.80848,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Bile secretion,52,3,0.0075914,4.8807,1,0.80848,0.027523,C00114;C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00315+C00750,mmu04976+C00114:Choline;C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.013561,4.3006,1,0.96283,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
Arginine and proline metabolism,35,2,0.032972,3.4121,1,1,0.063725,C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315+C00750,mmu00330+C00315:Spermidine;C00750:Spermine
Pertussis,4,1,0.033579,3.3939,1,1,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Cholinergic synapse,4,1,0.033579,3.3939,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.033579,3.3939,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
ABC transporters,59,2,0.085223,2.4625,1,1,0.014493,C00114;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114+C00315,mmu02010+C00114:Choline;C00315:Spermidine
Pantothenate and CoA biosynthesis,12,1,0.097746,2.3254,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.097746,2.3254,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.14336,1.9424,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Terpenoid backbone biosynthesis,19,1,0.15075,1.8921,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phenylalanine metabolism,22,1,0.17261,1.7567,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Nicotinate and nicotinamide metabolism,27,1,0.20793,1.5705,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Drug metabolism - cytochrome P450,32,1,0.24191,1.4192,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Purine metabolism,51,1,0.3595,1.023,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Terpenoid backbone biosynthesis,19,1,0.017925,4.0216,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Bile secretion,52,3,0.0010403,6.8683,0.22158,0.12288,0.027523,C00114;C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00315+C00750,mmu04976+C00114:Choline;C00315:Spermidine;C00750:Spermine
beta-Alanine metabolism,12,2,0.0011538,6.7647,0.24461,0.12288,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.0039622,5.531,0.83601,0.28131,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
Arginine and proline metabolism,35,2,0.0099545,4.6097,1,0.53008,0.063725,C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315+C00750,mmu00330+C00315:Spermidine;C00750:Spermine
Cholinergic synapse,4,1,0.018761,3.976,1,0.66602,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.018761,3.976,1,0.66602,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
ABC transporters,59,2,0.027328,3.5998,1,0.83157,0.014493,C00114;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114+C00315,mmu02010+C00114:Choline;C00315:Spermidine
Pantothenate and CoA biosynthesis,12,1,0.055439,2.8925,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.055439,2.8925,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.082221,2.4983,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Phenylalanine metabolism,22,1,0.099735,2.3052,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Drug metabolism - cytochrome P450,32,1,0.14235,1.9494,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
beta-Alanine metabolism,12,2,0.00317,5.754,0.67521,0.55823,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Bile secretion,52,3,0.0052416,5.2511,1,0.55823,0.027523,C00114;C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00315+C00750,mmu04976+C00114:Choline;C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.010681,4.5393,1,0.75837,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
Arginine and proline metabolism,35,2,0.026183,3.6426,1,1,0.063725,C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315+C00750,mmu00330+C00315:Spermidine;C00750:Spermine
Cholinergic synapse,4,1,0.02989,3.5102,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.02989,3.5102,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
ABC transporters,59,2,0.068691,2.6781,1,1,0.014493,C00114;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114+C00315,mmu02010+C00114:Choline;C00315:Spermidine
Pantothenate and CoA biosynthesis,12,1,0.087335,2.438,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.087335,2.438,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.12844,2.0523,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Ferroptosis,19,1,0.13513,2.0015,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Terpenoid backbone biosynthesis,19,1,0.13513,2.0015,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phenylalanine metabolism,22,1,0.15494,1.8647,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Nicotinate and nicotinamide metabolism,27,1,0.18707,1.6763,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Purine metabolism,51,1,0.32687,1.1182,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
beta-Alanine metabolism,12,2,0.0023926,6.0354,0.50962,0.50962,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.0081128,4.8143,1,0.86401,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
Arginine and proline metabolism,35,2,0.02005,3.9095,1,1,0.063725,C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315+C00750,mmu00330+C00315:Spermidine;C00750:Spermine
Bile secretion,52,2,0.042321,3.1625,1,1,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
Pantothenate and CoA biosynthesis,12,1,0.076814,2.5664,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Ferroptosis,19,1,0.11924,2.1266,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Terpenoid backbone biosynthesis,19,1,0.11924,2.1266,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phenylalanine metabolism,22,1,0.13691,1.9884,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Nicotinate and nicotinamide metabolism,27,1,0.16567,1.7977,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Metabolism of xenobiotics by cytochrome P450,43,1,0.25228,1.3772,1,1,0.011952,C19588,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588,mmu00980+C19588:Aflatoxin B1 diol
ABC transporters,59,1,0.33106,1.1055,1,1,0.0072464,C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00315,mmu02010+C00315:Spermidine
Ether lipid metabolism,1,1,0.010377,4.5681,1,1,0.024096,C00670,mmu00565,http://www.kegg.jp/pathway/mmu00565+C00670,mmu00565+C00670:sn-Glycero-3-phosphocholine
D-Arginine and D-ornithine metabolism,2,1,0.020657,3.8797,1,1,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Chagas disease,2,1,0.020657,3.8797,1,1,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Amyotrophic lateral sclerosis,3,1,0.030839,3.479,1,1,0.055556,C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00062,mmu05014+C00062:L-Arginine
Amoebiasis,3,1,0.030839,3.479,1,1,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
mTOR signaling pathway,3,1,0.030839,3.479,1,1,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
Pertussis,4,1,0.040925,3.196,1,1,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Choline metabolism in cancer,4,1,0.040925,3.196,1,1,0.11236,C00670,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00670,mmu05231+C00670:sn-Glycero-3-phosphocholine
Arginine and proline metabolism,35,2,0.048332,3.0297,1,1,0.085784,C00062;C00315,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00062+C00315,mmu00330+C00062:L-Arginine;C00315:Spermidine
Metabolism of xenobiotics by cytochrome P450,43,2,0.070094,2.6579,1,1,0.015936,C19588;C19591,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588+C19591,"mmu00980+C19588:Aflatoxin B1 diol;C19591:1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal"
Pathways of neurodegeneration - multiple diseases,8,1,0.080321,2.5217,1,1,0.020833,C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00062,mmu05022+C00062:L-Arginine
Purine metabolism,51,2,0.094579,2.3583,1,1,0.013409,C00360;C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360+C01345,mmu00230+C00360:dAMP;C01345:dITP
Arginine biosynthesis,11,1,0.1089,2.2174,1,1,0.050314,C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00062,mmu00220+C00062:L-Arginine
beta-Alanine metabolism,12,1,0.11824,2.135,1,1,0.025862,C00315,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315,mmu00410+C00315:Spermidine
Glycerophospholipid metabolism,12,1,0.11824,2.135,1,1,0.025926,C00670,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00670,mmu00564+C00670:sn-Glycero-3-phosphocholine
ABC transporters,59,2,0.12129,2.1095,1,1,0.014493,C00062;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00062+C00315,mmu02010+C00062:L-Arginine;C00315:Spermidine
Aminoacyl-tRNA biosynthesis,16,1,0.15473,1.866,1,1,0.017857,C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00062,mmu00970+C00062:L-Arginine
Central carbon metabolism in cancer,17,1,0.16364,1.8101,1,1,0.018868,C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00062,mmu05230+C00062:L-Arginine
Ferroptosis,19,1,0.1812,1.7082,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Terpenoid backbone biosynthesis,19,1,0.1812,1.7082,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Protein digestion and absorption,21,1,0.19842,1.6174,1,1,0.021277,C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00062,mmu04974+C00062:L-Arginine
Glutathione metabolism,22,1,0.2069,1.5755,1,1,0.027972,C00315,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315,mmu00480+C00315:Spermidine
Nicotinate and nicotinamide metabolism,27,1,0.24812,1.3938,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Bile secretion,52,1,0.4265,0.85214,1,1,0.0091743,C00315,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315,mmu04976+C00315:Spermidine
Arginine and proline metabolism,35,3,0.0024206,6.0237,0.51559,0.43133,0.10539,C00062;C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00062+C00315+C00750,mmu00330+C00062:L-Arginine;C00315:Spermidine;C00750:Spermine
beta-Alanine metabolism,12,2,0.0040501,5.509,0.85862,0.43133,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.013561,4.3006,1,0.67307,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
D-Arginine and D-ornithine metabolism,2,1,0.016917,4.0794,1,0.67307,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Chagas disease,2,1,0.016917,4.0794,1,0.67307,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Amyotrophic lateral sclerosis,3,1,0.02528,3.6778,1,0.67307,0.055556,C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00062,mmu05014+C00062:L-Arginine
Amoebiasis,3,1,0.02528,3.6778,1,0.67307,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
mTOR signaling pathway,3,1,0.02528,3.6778,1,0.67307,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
Pathways of neurodegeneration - multiple diseases,8,1,0.066152,2.7158,1,1,0.020833,C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00062,mmu05022+C00062:L-Arginine
Bile secretion,52,2,0.068135,2.6863,1,1,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
ABC transporters,59,2,0.085223,2.4625,1,1,0.014493,C00062;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00062+C00315,mmu02010+C00062:L-Arginine;C00315:Spermidine
Arginine biosynthesis,11,1,0.089938,2.4086,1,1,0.050314,C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00062,mmu00220+C00062:L-Arginine
Pantothenate and CoA biosynthesis,12,1,0.097746,2.3254,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Aminoacyl-tRNA biosynthesis,16,1,0.12839,2.0527,1,1,0.017857,C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00062,mmu00970+C00062:L-Arginine
Central carbon metabolism in cancer,17,1,0.1359,1.9958,1,1,0.018868,C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00062,mmu05230+C00062:L-Arginine
Terpenoid backbone biosynthesis,19,1,0.15075,1.8921,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Protein digestion and absorption,21,1,0.16538,1.7995,1,1,0.021277,C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00062,mmu04974+C00062:L-Arginine
Phenylalanine metabolism,22,1,0.17261,1.7567,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Phosphonate and phosphinate metabolism,22,1,0.17261,1.7567,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Nicotinate and nicotinamide metabolism,27,1,0.20793,1.5705,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Metabolism of xenobiotics by cytochrome P450,43,1,0.31213,1.1643,1,1,0.011952,C19588,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588,mmu00980+C19588:Aflatoxin B1 diol
Purine metabolism,51,1,0.3595,1.023,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Ether lipid metabolism,1,1,0.0066038,5.0201,1,1,0.024096,C00670,mmu00565,http://www.kegg.jp/pathway/mmu00565+C00670,mmu00565+C00670:sn-Glycero-3-phosphocholine
Pertussis,4,1,0.026191,3.6423,1,1,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Choline metabolism in cancer,4,1,0.026191,3.6423,1,1,0.11236,C00670,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00670,mmu05231+C00670:sn-Glycero-3-phosphocholine
Glycerophospholipid metabolism,12,1,0.076814,2.5664,1,1,0.025926,C00670,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00670,mmu00564+C00670:sn-Glycero-3-phosphocholine
Ferroptosis,19,1,0.11924,2.1266,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Phosphonate and phosphinate metabolism,22,1,0.13691,1.9884,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Drug metabolism - cytochrome P450,32,1,0.19362,1.6419,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Metabolism of xenobiotics by cytochrome P450,43,1,0.25228,1.3772,1,1,0.0039841,C19591,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19591,"mmu00980+C19591:1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal"
Purine metabolism,51,1,0.29261,1.2289,1,1,0.01083,C00360,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360,mmu00230+C00360:dAMP
Ether lipid metabolism,1,1,0.004717,5.3566,1,1,0.024096,C00670,mmu00565,http://www.kegg.jp/pathway/mmu00565+C00670,mmu00565+C00670:sn-Glycero-3-phosphocholine
Choline metabolism in cancer,4,1,0.018761,3.976,1,1,0.11236,C00670,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00670,mmu05231+C00670:sn-Glycero-3-phosphocholine
beta-Alanine metabolism,12,1,0.055439,2.8925,1,1,0.025862,C00315,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315,mmu00410+C00315:Spermidine
Glycerophospholipid metabolism,12,1,0.055439,2.8925,1,1,0.025926,C00670,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00670,mmu00564+C00670:sn-Glycero-3-phosphocholine
Ferroptosis,19,1,0.086625,2.4462,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Phosphonate and phosphinate metabolism,22,1,0.099735,2.3052,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Glutathione metabolism,22,1,0.099735,2.3052,1,1,0.027972,C00315,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315,mmu00480+C00315:Spermidine
Drug metabolism - cytochrome P450,32,1,0.14235,1.9494,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Arginine and proline metabolism,35,1,0.15482,1.8655,1,1,0.044118,C00315,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315,mmu00330+C00315:Spermidine
Bile secretion,52,1,0.22275,1.5017,1,1,0.0091743,C00315,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315,mmu04976+C00315:Spermidine
ABC transporters,59,1,0.24942,1.3886,1,1,0.0072464,C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00315,mmu02010+C00315:Spermidine
Glutathione metabolism,22,3,0.00025792,8.2629,0.054936,0.054936,0.083916,C00025;C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00315+C00750,mmu00480+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
Arginine and proline metabolism,35,3,0.0010558,6.8534,0.22383,0.11245,0.11275,C00025;C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00315+C00750,mmu00330+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
beta-Alanine metabolism,12,2,0.0023926,6.0354,0.50484,0.16987,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Spinocerebellar ataxia,1,1,0.0066038,5.0201,1,0.24682,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.0066038,5.0201,1,0.24682,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Long-term potentiation,2,1,0.01317,4.3298,1,0.24682,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Amyotrophic lateral sclerosis,3,1,0.019699,3.9272,1,0.24682,0.055556,C00025,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025,mmu05014+C00025:L-Glutamate
Proximal tubule bicarbonate reclamation,3,1,0.019699,3.9272,1,0.24682,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amphetamine addiction,3,1,0.019699,3.9272,1,0.24682,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.019699,3.9272,1,0.24682,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.019699,3.9272,1,0.24682,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.019699,3.9272,1,0.24682,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.019699,3.9272,1,0.24682,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.019699,3.9272,1,0.24682,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.019699,3.9272,1,0.24682,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.019699,3.9272,1,0.24682,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.019699,3.9272,1,0.24682,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
Phospholipase D signaling pathway,4,1,0.026191,3.6423,1,0.27894,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.026191,3.6423,1,0.27894,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.026191,3.6423,1,0.27894,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Synaptic vesicle cycle,5,1,0.032646,3.422,1,0.31608,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.032646,3.422,1,0.31608,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Bile secretion,52,2,0.042321,3.1625,1,0.39193,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
Pathways of neurodegeneration - multiple diseases,8,1,0.051792,2.9605,1,0.43745,0.020833,C00025,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025,mmu05022+C00025:L-Glutamate
Retrograde endocannabinoid signaling,8,1,0.051792,2.9605,1,0.43745,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
ABC transporters,59,2,0.053397,2.93,1,0.43745,0.014493,C00025;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00315,mmu02010+C00025:L-Glutamate;C00315:Spermidine
Butanoate metabolism,11,1,0.070613,2.6505,1,0.51864,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
Arginine biosynthesis,11,1,0.070613,2.6505,1,0.51864,0.081761,C00025,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025,mmu00220+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.070613,2.6505,1,0.51864,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Pantothenate and CoA biosynthesis,12,1,0.076814,2.5664,1,0.54538,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Taste transduction,14,1,0.089112,2.4179,1,0.59315,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.089112,2.4179,1,0.59315,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Aminoacyl-tRNA biosynthesis,16,1,0.10127,2.29,1,0.65364,0.017857,C00025,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025,mmu00970+C00025:L-Glutamate
Central carbon metabolism in cancer,17,1,0.10729,2.2322,1,0.67217,0.037736,C00025,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025,mmu05230+C00025:L-Glutamate
Glyoxylate and dicarboxylate metabolism,18,1,0.11329,2.1778,1,0.68645,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Terpenoid backbone biosynthesis,19,1,0.11924,2.1266,1,0.68645,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Ferroptosis,19,1,0.11924,2.1266,1,0.68645,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
Protein digestion and absorption,21,1,0.13105,2.0322,1,0.73459,0.021277,C00025,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025,mmu04974+C00025:L-Glutamate
Histidine metabolism,23,1,0.14273,1.9468,1,0.77951,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.15999,1.8327,1,0.85194,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
Nicotinate and nicotinamide metabolism,27,1,0.16567,1.7977,1,0.8607,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.20457,1.5869,1,1,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Metabolism of xenobiotics by cytochrome P450,43,1,0.25228,1.3772,1,1,0.0039841,C19591,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19591,"mmu00980+C19591:1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal"
Purine metabolism,51,1,0.29261,1.2289,1,1,0.01083,C00360,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360,mmu00230+C00360:dAMP
Porphyrin and chlorophyll metabolism,54,1,0.30724,1.1801,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
Glutathione metabolism,22,3,0.00025792,8.2629,0.054936,0.054936,0.083916,C00025;C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00315+C00750,mmu00480+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
Arginine and proline metabolism,35,3,0.0010558,6.8534,0.22383,0.11245,0.11275,C00025;C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00315+C00750,mmu00330+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
beta-Alanine metabolism,12,2,0.0023926,6.0354,0.50484,0.16987,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Bile secretion,52,3,0.0033932,5.686,0.71257,0.18069,0.027523,C00114;C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00315+C00750,mmu04976+C00114:Choline;C00315:Spermidine;C00750:Spermine
ABC transporters,59,3,0.0048901,5.3205,1,0.20094,0.021739,C00025;C00114;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00114+C00315,mmu02010+C00025:L-Glutamate;C00114:Choline;C00315:Spermidine
Spinocerebellar ataxia,1,1,0.0066038,5.0201,1,0.20094,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.0066038,5.0201,1,0.20094,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Long-term potentiation,2,1,0.01317,4.3298,1,0.22084,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Amyotrophic lateral sclerosis,3,1,0.019699,3.9272,1,0.22084,0.055556,C00025,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025,mmu05014+C00025:L-Glutamate
Proximal tubule bicarbonate reclamation,3,1,0.019699,3.9272,1,0.22084,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amphetamine addiction,3,1,0.019699,3.9272,1,0.22084,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.019699,3.9272,1,0.22084,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.019699,3.9272,1,0.22084,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.019699,3.9272,1,0.22084,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.019699,3.9272,1,0.22084,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.019699,3.9272,1,0.22084,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.019699,3.9272,1,0.22084,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.019699,3.9272,1,0.22084,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.019699,3.9272,1,0.22084,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
Phospholipase D signaling pathway,4,1,0.026191,3.6423,1,0.23245,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.026191,3.6423,1,0.23245,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.026191,3.6423,1,0.23245,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Cholinergic synapse,4,1,0.026191,3.6423,1,0.23245,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.026191,3.6423,1,0.23245,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Synaptic vesicle cycle,5,1,0.032646,3.422,1,0.26745,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.032646,3.422,1,0.26745,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Pathways of neurodegeneration - multiple diseases,8,1,0.051792,2.9605,1,0.39399,0.020833,C00025,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025,mmu05022+C00025:L-Glutamate
Retrograde endocannabinoid signaling,8,1,0.051792,2.9605,1,0.39399,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Butanoate metabolism,11,1,0.070613,2.6505,1,0.48518,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
Arginine biosynthesis,11,1,0.070613,2.6505,1,0.48518,0.081761,C00025,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025,mmu00220+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.070613,2.6505,1,0.48518,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Pantothenate and CoA biosynthesis,12,1,0.076814,2.5664,1,0.4958,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.076814,2.5664,1,0.4958,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
Taste transduction,14,1,0.089112,2.4179,1,0.54231,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.089112,2.4179,1,0.54231,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Aminoacyl-tRNA biosynthesis,16,1,0.10127,2.29,1,0.59917,0.017857,C00025,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025,mmu00970+C00025:L-Glutamate
Central carbon metabolism in cancer,17,1,0.10729,2.2322,1,0.61767,0.037736,C00025,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025,mmu05230+C00025:L-Glutamate
"Glycine, serine and threonine metabolism",18,1,0.11329,2.1778,1,0.61871,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Glyoxylate and dicarboxylate metabolism,18,1,0.11329,2.1778,1,0.61871,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Ferroptosis,19,1,0.11924,2.1266,1,0.63497,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
Protein digestion and absorption,21,1,0.13105,2.0322,1,0.68084,0.021277,C00025,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025,mmu04974+C00025:L-Glutamate
Phenylalanine metabolism,22,1,0.13691,1.9884,1,0.69432,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Histidine metabolism,23,1,0.14273,1.9468,1,0.707,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.15999,1.8327,1,0.77449,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
Nicotinate and nicotinamide metabolism,27,1,0.16567,1.7977,1,0.78419,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.20457,1.5869,1,0.94723,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Purine metabolism,51,1,0.29261,1.2289,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Porphyrin and chlorophyll metabolism,54,1,0.30724,1.1801,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
Cholinergic synapse,4,1,0.026191,3.6423,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.026191,3.6423,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Caffeine metabolism,7,1,0.045447,3.0912,1,1,0.029412,C07481,mmu00232,http://www.kegg.jp/pathway/mmu00232+C07481,mmu00232+C07481:Caffeine
Glycerophospholipid metabolism,12,1,0.076814,2.5664,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.11329,2.1778,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Phenylalanine metabolism,22,1,0.13691,1.9884,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Phosphonate and phosphinate metabolism,22,1,0.13691,1.9884,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Nicotinate and nicotinamide metabolism,27,1,0.16567,1.7977,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Drug metabolism - cytochrome P450,32,1,0.19362,1.6419,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Purine metabolism,51,1,0.29261,1.2289,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Bile secretion,52,1,0.29752,1.2123,1,1,0.0091743,C00114,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114,mmu04976+C00114:Choline
ABC transporters,59,1,0.33106,1.1055,1,1,0.0072464,C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114,mmu02010+C00114:Choline
Choline metabolism in cancer,4,2,0.00069668,7.2692,0.14839,0.14839,0.32584,C00114;C00670,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114+C00670,mmu05231+C00114:Choline;C00670:sn-Glycero-3-phosphocholine
Glycerophospholipid metabolism,12,2,0.0072858,4.9218,1,0.37679,0.098148,C00114;C00670,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114+C00670,mmu00564+C00114:Choline;C00670:sn-Glycero-3-phosphocholine
Ether lipid metabolism,1,1,0.011321,4.4811,1,0.37679,0.024096,C00670,mmu00565,http://www.kegg.jp/pathway/mmu00565+C00670,mmu00565+C00670:sn-Glycero-3-phosphocholine
Spinocerebellar ataxia,1,1,0.011321,4.4811,1,0.37679,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.011321,4.4811,1,0.37679,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Long-term potentiation,2,1,0.022524,3.7932,1,0.37679,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Glutathione metabolism,22,2,0.02394,3.7322,1,0.37679,0.06993,C00025;C00315,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00315,mmu00480+C00025:L-Glutamate;C00315:Spermidine
ABC transporters,59,3,0.025163,3.6824,1,0.37679,0.021739,C00025;C00114;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00114+C00315,mmu02010+C00025:L-Glutamate;C00114:Choline;C00315:Spermidine
Amyotrophic lateral sclerosis,3,1,0.033611,3.3929,1,0.37679,0.055556,C00025,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025,mmu05014+C00025:L-Glutamate
Proximal tubule bicarbonate reclamation,3,1,0.033611,3.3929,1,0.37679,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amphetamine addiction,3,1,0.033611,3.3929,1,0.37679,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.033611,3.3929,1,0.37679,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.033611,3.3929,1,0.37679,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.033611,3.3929,1,0.37679,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.033611,3.3929,1,0.37679,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.033611,3.3929,1,0.37679,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.033611,3.3929,1,0.37679,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.033611,3.3929,1,0.37679,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.033611,3.3929,1,0.37679,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
Phospholipase D signaling pathway,4,1,0.044582,3.1104,1,0.39566,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.044582,3.1104,1,0.39566,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.044582,3.1104,1,0.39566,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Pertussis,4,1,0.044582,3.1104,1,0.39566,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Cholinergic synapse,4,1,0.044582,3.1104,1,0.39566,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Synaptic vesicle cycle,5,1,0.055439,2.8925,1,0.44821,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.055439,2.8925,1,0.44821,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Arginine and proline metabolism,35,2,0.056815,2.868,1,0.44821,0.093137,C00025;C00315,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00315,mmu00330+C00025:L-Glutamate;C00315:Spermidine
Caffeine metabolism,7,1,0.076814,2.5664,1,0.58434,0.029412,C07481,mmu00232,http://www.kegg.jp/pathway/mmu00232+C07481,mmu00232+C07481:Caffeine
Pathways of neurodegeneration - multiple diseases,8,1,0.087335,2.438,1,0.62008,0.020833,C00025,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025,mmu05022+C00025:L-Glutamate
Retrograde endocannabinoid signaling,8,1,0.087335,2.438,1,0.62008,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Bile secretion,52,2,0.11379,2.1734,1,0.74075,0.018349,C00114;C00315,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00315,mmu04976+C00114:Choline;C00315:Spermidine
Butanoate metabolism,11,1,0.11824,2.135,1,0.74075,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
Arginine biosynthesis,11,1,0.11824,2.135,1,0.74075,0.081761,C00025,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025,mmu00220+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.11824,2.135,1,0.74075,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
beta-Alanine metabolism,12,1,0.12833,2.0532,1,0.78097,0.025862,C00315,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315,mmu00410+C00315:Spermidine
Taste transduction,14,1,0.14819,1.9093,1,0.85307,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.14819,1.9093,1,0.85307,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Aminoacyl-tRNA biosynthesis,16,1,0.16763,1.786,1,0.93959,0.017857,C00025,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025,mmu00970+C00025:L-Glutamate
Central carbon metabolism in cancer,17,1,0.17719,1.7305,1,0.96775,0.037736,C00025,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025,mmu05230+C00025:L-Glutamate
"Glycine, serine and threonine metabolism",18,1,0.18666,1.6785,1,0.96973,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Glyoxylate and dicarboxylate metabolism,18,1,0.18666,1.6785,1,0.96973,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Ferroptosis,19,1,0.19603,1.6295,1,0.99414,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
Protein digestion and absorption,21,1,0.21446,1.5396,1,1,0.021277,C00025,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025,mmu04974+C00025:L-Glutamate
Phenylalanine metabolism,22,1,0.22354,1.4982,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.22354,1.4982,1,1,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Histidine metabolism,23,1,0.23251,1.4588,1,1,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.25888,1.3514,1,1,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
Nicotinate and nicotinamide metabolism,27,1,0.26748,1.3187,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Drug metabolism - cytochrome P450,32,1,0.30913,1.174,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.32517,1.1234,1,1,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Metabolism of xenobiotics by cytochrome P450,43,1,0.39322,0.93338,1,1,0.0039841,C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19594,"mmu00980+C19594:Aflatoxin-M1-8,9-epoxide"
Purine metabolism,51,1,0.44837,0.80213,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Porphyrin and chlorophyll metabolism,54,1,0.46784,0.75963,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
Ferroptosis,19,1,0.017925,4.0216,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Spinocerebellar ataxia,1,1,0.0075472,4.8866,1,0.30317,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.0075472,4.8866,1,0.30317,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Glutathione metabolism,22,2,0.010681,4.5393,1,0.30317,0.055944,C00025;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00750,mmu00480+C00025:L-Glutamate;C00750:Spermine
Long-term potentiation,2,1,0.015044,4.1967,1,0.30317,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Amyotrophic lateral sclerosis,3,1,0.022492,3.7946,1,0.30317,0.055556,C00025,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025,mmu05014+C00025:L-Glutamate
Proximal tubule bicarbonate reclamation,3,1,0.022492,3.7946,1,0.30317,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amphetamine addiction,3,1,0.022492,3.7946,1,0.30317,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.022492,3.7946,1,0.30317,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.022492,3.7946,1,0.30317,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.022492,3.7946,1,0.30317,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.022492,3.7946,1,0.30317,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.022492,3.7946,1,0.30317,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.022492,3.7946,1,0.30317,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.022492,3.7946,1,0.30317,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.022492,3.7946,1,0.30317,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
Arginine and proline metabolism,35,2,0.026183,3.6426,1,0.30317,0.068627,C00025;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00750,mmu00330+C00025:L-Glutamate;C00750:Spermine
Phospholipase D signaling pathway,4,1,0.02989,3.5102,1,0.30317,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.02989,3.5102,1,0.30317,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.02989,3.5102,1,0.30317,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Cholinergic synapse,4,1,0.02989,3.5102,1,0.30317,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.02989,3.5102,1,0.30317,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Synaptic vesicle cycle,5,1,0.03724,3.2904,1,0.34487,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.03724,3.2904,1,0.34487,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Purine metabolism,51,2,0.052779,2.9416,1,0.46542,0.013409,C00360;C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360+C01345,mmu00230+C00360:dAMP;C01345:dITP
Bile secretion,52,2,0.054681,2.9062,1,0.46542,0.018349,C00114;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00750,mmu04976+C00114:Choline;C00750:Spermine
Pathways of neurodegeneration - multiple diseases,8,1,0.058996,2.8303,1,0.46542,0.020833,C00025,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025,mmu05022+C00025:L-Glutamate
Retrograde endocannabinoid signaling,8,1,0.058996,2.8303,1,0.46542,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
ABC transporters,59,2,0.068691,2.6781,1,0.52254,0.014493,C00025;C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00114,mmu02010+C00025:L-Glutamate;C00114:Choline
Butanoate metabolism,11,1,0.080321,2.5217,1,0.54713,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
Arginine biosynthesis,11,1,0.080321,2.5217,1,0.54713,0.081761,C00025,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025,mmu00220+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.080321,2.5217,1,0.54713,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Pantothenate and CoA biosynthesis,12,1,0.087335,2.438,1,0.54713,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
beta-Alanine metabolism,12,1,0.087335,2.438,1,0.54713,0.025862,C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00750,mmu00410+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.087335,2.438,1,0.54713,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
Taste transduction,14,1,0.10122,2.2904,1,0.5989,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.10122,2.2904,1,0.5989,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Aminoacyl-tRNA biosynthesis,16,1,0.11492,2.1635,1,0.66159,0.017857,C00025,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025,mmu00970+C00025:L-Glutamate
Central carbon metabolism in cancer,17,1,0.12171,2.1061,1,0.6822,0.037736,C00025,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025,mmu05230+C00025:L-Glutamate
"Glycine, serine and threonine metabolism",18,1,0.12844,2.0523,1,0.68396,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Glyoxylate and dicarboxylate metabolism,18,1,0.12844,2.0523,1,0.68396,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Terpenoid backbone biosynthesis,19,1,0.13513,2.0015,1,0.68533,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Ferroptosis,19,1,0.13513,2.0015,1,0.68533,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
Protein digestion and absorption,21,1,0.14838,1.908,1,0.73501,0.021277,C00025,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025,mmu04974+C00025:L-Glutamate
Phenylalanine metabolism,22,1,0.15494,1.8647,1,0.75005,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Histidine metabolism,23,1,0.16145,1.8235,1,0.76421,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.18073,1.7108,1,0.83685,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.23025,1.4686,1,1,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Metabolism of xenobiotics by cytochrome P450,43,1,0.28281,1.263,1,1,0.0039841,C19591,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19591,"mmu00980+C19591:1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal"
Porphyrin and chlorophyll metabolism,54,1,0.34277,1.0707,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
Choline metabolism in cancer,4,2,0.0005813,7.4502,0.12382,0.12382,0.32584,C00114;C00670,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114+C00670,mmu05231+C00114:Choline;C00670:sn-Glycero-3-phosphocholine
beta-Alanine metabolism,12,2,0.0061099,5.0978,1,0.43381,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Glycerophospholipid metabolism,12,2,0.0061099,5.0978,1,0.43381,0.098148,C00114;C00670,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114+C00670,mmu00564+C00114:Choline;C00670:sn-Glycero-3-phosphocholine
Ether lipid metabolism,1,1,0.010377,4.5681,1,0.55259,0.024096,C00670,mmu00565,http://www.kegg.jp/pathway/mmu00565+C00670,mmu00565+C00670:sn-Glycero-3-phosphocholine
Bile secretion,52,3,0.013904,4.2756,1,0.59231,0.027523,C00114;C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00315+C00750,mmu04976+C00114:Choline;C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.020203,3.9019,1,0.7172,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
Pertussis,4,1,0.040925,3.196,1,1,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Cholinergic synapse,4,1,0.040925,3.196,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Arginine and proline metabolism,35,2,0.048332,3.0297,1,1,0.063725,C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315+C00750,mmu00330+C00315:Spermidine;C00750:Spermine
Purine metabolism,51,2,0.094579,2.3583,1,1,0.013409,C00360;C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360+C01345,mmu00230+C00360:dAMP;C01345:dITP
Pantothenate and CoA biosynthesis,12,1,0.11824,2.135,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
ABC transporters,59,2,0.12129,2.1095,1,1,0.014493,C00114;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114+C00315,mmu02010+C00114:Choline;C00315:Spermidine
"Glycine, serine and threonine metabolism",18,1,0.17246,1.7576,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Ferroptosis,19,1,0.1812,1.7082,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Phenylalanine metabolism,22,1,0.2069,1.5755,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.2069,1.5755,1,1,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Metabolism of xenobiotics by cytochrome P450,43,1,0.36729,1.0016,1,1,0.0039841,C19591,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19591,"mmu00980+C19591:1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal"
Glutathione metabolism,22,3,0.0030083,5.8064,0.64078,0.44617,0.083916,C00025;C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00315+C00750,mmu00480+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
beta-Alanine metabolism,12,2,0.011373,4.4765,1,0.44617,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Arginine and proline metabolism,35,3,0.011435,4.471,1,0.44617,0.11275,C00025;C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00315+C00750,mmu00330+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
Ether lipid metabolism,1,1,0.014151,4.258,1,0.44617,0.024096,C00670,mmu00565,http://www.kegg.jp/pathway/mmu00565+C00670,mmu00565+C00670:sn-Glycero-3-phosphocholine
Spinocerebellar ataxia,1,1,0.014151,4.258,1,0.44617,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.014151,4.258,1,0.44617,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Metabolism of xenobiotics by cytochrome P450,43,3,0.020129,3.9056,1,0.44617,0.01992,C19588;C19591;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588+C19591+C19594,"mmu00980+C19588:Aflatoxin B1 diol;C19591:1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal;C19594:Aflatoxin-M1-8,9-epoxide"
Ferroptosis,19,2,0.027826,3.5818,1,0.44617,0.093023,C00025;C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025+C11378,mmu04216+C00025:L-Glutamate;C11378:Ubiquinone-10
Long-term potentiation,2,1,0.028115,3.5715,1,0.44617,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Amyotrophic lateral sclerosis,3,1,0.041894,3.1726,1,0.44617,0.055556,C00025,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025,mmu05014+C00025:L-Glutamate
Proximal tubule bicarbonate reclamation,3,1,0.041894,3.1726,1,0.44617,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amphetamine addiction,3,1,0.041894,3.1726,1,0.44617,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.041894,3.1726,1,0.44617,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.041894,3.1726,1,0.44617,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.041894,3.1726,1,0.44617,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.041894,3.1726,1,0.44617,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.041894,3.1726,1,0.44617,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.041894,3.1726,1,0.44617,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.041894,3.1726,1,0.44617,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.041894,3.1726,1,0.44617,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
Phospholipase D signaling pathway,4,1,0.05549,2.8915,1,0.47278,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.05549,2.8915,1,0.47278,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.05549,2.8915,1,0.47278,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Pertussis,4,1,0.05549,2.8915,1,0.47278,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Choline metabolism in cancer,4,1,0.05549,2.8915,1,0.47278,0.11236,C00670,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00670,mmu05231+C00670:sn-Glycero-3-phosphocholine
Synaptic vesicle cycle,5,1,0.068907,2.675,1,0.5436,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.068907,2.675,1,0.5436,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Caffeine metabolism,7,1,0.095208,2.3517,1,0.72426,0.029412,C07481,mmu00232,http://www.kegg.jp/pathway/mmu00232+C07481,mmu00232+C07481:Caffeine
Pathways of neurodegeneration - multiple diseases,8,1,0.1081,2.2247,1,0.76748,0.020833,C00025,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025,mmu05022+C00025:L-Glutamate
Retrograde endocannabinoid signaling,8,1,0.1081,2.2247,1,0.76748,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Butanoate metabolism,11,1,0.14574,1.9259,1,0.9407,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
Arginine biosynthesis,11,1,0.14574,1.9259,1,0.9407,0.081761,C00025,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025,mmu00220+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.14574,1.9259,1,0.9407,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Pantothenate and CoA biosynthesis,12,1,0.15796,1.8454,1,0.94673,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.15796,1.8454,1,0.94673,0.025926,C00670,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00670,mmu00564+C00670:sn-Glycero-3-phosphocholine
Purine metabolism,51,2,0.16001,1.8325,1,0.94673,0.013409,C00360;C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360+C01345,mmu00230+C00360:dAMP;C01345:dITP
Bile secretion,52,2,0.16508,1.8013,1,0.9503,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
Taste transduction,14,1,0.1819,1.7043,1,0.99346,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.1819,1.7043,1,0.99346,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
ABC transporters,59,2,0.20136,1.6027,1,1,0.014493,C00025;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00315,mmu02010+C00025:L-Glutamate;C00315:Spermidine
Aminoacyl-tRNA biosynthesis,16,1,0.20521,1.5837,1,1,0.017857,C00025,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025,mmu00970+C00025:L-Glutamate
Central carbon metabolism in cancer,17,1,0.21663,1.5296,1,1,0.037736,C00025,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025,mmu05230+C00025:L-Glutamate
Glyoxylate and dicarboxylate metabolism,18,1,0.22789,1.4789,1,1,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Terpenoid backbone biosynthesis,19,1,0.23901,1.4313,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Protein digestion and absorption,21,1,0.26079,1.344,1,1,0.021277,C00025,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025,mmu04974+C00025:L-Glutamate
Phenylalanine metabolism,22,1,0.27146,1.3039,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.27146,1.3039,1,1,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Histidine metabolism,23,1,0.28199,1.2659,1,1,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.31273,1.1624,1,1,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.3888,0.94469,1,1,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Porphyrin and chlorophyll metabolism,54,1,0.54601,0.60513,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
Amyotrophic lateral sclerosis,3,2,0.00048272,7.6361,0.10282,0.084165,0.11111,C00025;C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025+C00062,mmu05014+C00025:L-Glutamate;C00062:L-Arginine
Arginine and proline metabolism,35,4,0.00079029,7.1431,0.16754,0.084165,0.15441,C00025;C00062;C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025+C00062+C00315+C00750,mmu00330+C00025:L-Glutamate;C00062:L-Arginine;C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,3,0.0024395,6.016,0.51473,0.1732,0.083916,C00025;C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025+C00315+C00750,mmu00480+C00025:L-Glutamate;C00315:Spermidine;C00750:Spermine
Pathways of neurodegeneration - multiple diseases,8,2,0.0043377,5.4404,0.91092,0.23098,0.041667,C00025;C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025+C00062,mmu05022+C00025:L-Glutamate;C00062:L-Arginine
Arginine biosynthesis,11,2,0.008329,4.788,1,0.29773,0.13208,C00025;C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025+C00062,mmu00220+C00025:L-Glutamate;C00062:L-Arginine
beta-Alanine metabolism,12,2,0.0099195,4.6133,1,0.29773,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Spinocerebellar ataxia,1,1,0.013208,4.327,1,0.29773,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.013208,4.327,1,0.29773,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Metabolism of xenobiotics by cytochrome P450,43,3,0.016567,4.1004,1,0.29773,0.01992,C19588;C19591;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588+C19591+C19594,"mmu00980+C19588:Aflatoxin B1 diol;C19591:1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal;C19594:Aflatoxin-M1-8,9-epoxide"
Aminoacyl-tRNA biosynthesis,16,2,0.017498,4.0457,1,0.29773,0.035714,C00025;C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025+C00062,mmu00970+C00025:L-Glutamate;C00062:L-Arginine
Central carbon metabolism in cancer,17,2,0.019681,3.9281,1,0.29773,0.056604,C00025;C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025+C00062,mmu05230+C00025:L-Glutamate;C00062:L-Arginine
D-Arginine and D-ornithine metabolism,2,1,0.026253,3.64,1,0.29773,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Long-term potentiation,2,1,0.026253,3.64,1,0.29773,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Chagas disease,2,1,0.026253,3.64,1,0.29773,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Protein digestion and absorption,21,2,0.029486,3.5239,1,0.29773,0.042553,C00025;C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025+C00062,mmu04974+C00025:L-Glutamate;C00062:L-Arginine
ABC transporters,59,3,0.038456,3.2582,1,0.29773,0.021739,C00025;C00062;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025+C00062+C00315,mmu02010+C00025:L-Glutamate;C00062:L-Arginine;C00315:Spermidine
Proximal tubule bicarbonate reclamation,3,1,0.039138,3.2407,1,0.29773,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amoebiasis,3,1,0.039138,3.2407,1,0.29773,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
Amphetamine addiction,3,1,0.039138,3.2407,1,0.29773,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.039138,3.2407,1,0.29773,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.039138,3.2407,1,0.29773,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.039138,3.2407,1,0.29773,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.039138,3.2407,1,0.29773,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.039138,3.2407,1,0.29773,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.039138,3.2407,1,0.29773,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.039138,3.2407,1,0.29773,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.039138,3.2407,1,0.29773,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
mTOR signaling pathway,3,1,0.039138,3.2407,1,0.29773,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
Phospholipase D signaling pathway,4,1,0.051865,2.9591,1,0.34522,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.051865,2.9591,1,0.34522,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.051865,2.9591,1,0.34522,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Pertussis,4,1,0.051865,2.9591,1,0.34522,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Synaptic vesicle cycle,5,1,0.064435,2.7421,1,0.40366,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.064435,2.7421,1,0.40366,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Retrograde endocannabinoid signaling,8,1,0.10122,2.2904,1,0.61601,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Butanoate metabolism,11,1,0.13666,1.9902,1,0.78674,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.13666,1.9902,1,0.78674,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Purine metabolism,51,2,0.1429,1.9456,1,0.78909,0.013409,C00360;C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360+C01345,mmu00230+C00360:dAMP;C01345:dITP
Bile secretion,52,2,0.14751,1.9138,1,0.78909,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
Pantothenate and CoA biosynthesis,12,1,0.14819,1.9093,1,0.78909,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Taste transduction,14,1,0.1708,1.7672,1,0.86621,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.1708,1.7672,1,0.86621,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Glyoxylate and dicarboxylate metabolism,18,1,0.21437,1.54,1,1,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Terpenoid backbone biosynthesis,19,1,0.22493,1.492,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Ferroptosis,19,1,0.22493,1.492,1,1,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
"Phenylalanine, tyrosine and tryptophan biosynthesis",22,1,0.25581,1.3633,1,1,0.026316,C20710,mmu00400,http://www.kegg.jp/pathway/mmu00400+C20710,"mmu00400+C20710:(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate"
Histidine metabolism,23,1,0.26585,1.3248,1,1,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.29521,1.2201,1,1,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
Nicotinate and nicotinamide metabolism,27,1,0.30475,1.1883,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Drug metabolism - cytochrome P450,32,1,0.35069,1.0478,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.36827,0.99895,1,1,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Porphyrin and chlorophyll metabolism,54,1,0.52129,0.65144,1,1,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
Choline metabolism in cancer,4,2,0.00069668,7.2692,0.14839,0.14839,0.32584,C00114;C00670,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114+C00670,mmu05231+C00114:Choline;C00670:sn-Glycero-3-phosphocholine
beta-Alanine metabolism,12,2,0.0072858,4.9218,1,0.51729,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Glycerophospholipid metabolism,12,2,0.0072858,4.9218,1,0.51729,0.098148,C00114;C00670,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114+C00670,mmu00564+C00114:Choline;C00670:sn-Glycero-3-phosphocholine
Ether lipid metabolism,1,1,0.011321,4.4811,1,0.60283,0.024096,C00670,mmu00565,http://www.kegg.jp/pathway/mmu00565+C00670,mmu00565+C00670:sn-Glycero-3-phosphocholine
Bile secretion,52,3,0.017903,4.0228,1,0.76267,0.027523,C00114;C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00315+C00750,mmu04976+C00114:Choline;C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.02394,3.7322,1,0.84989,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
Pertussis,4,1,0.044582,3.1104,1,1,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Cholinergic synapse,4,1,0.044582,3.1104,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Arginine and proline metabolism,35,2,0.056815,2.868,1,1,0.063725,C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315+C00750,mmu00330+C00315:Spermidine;C00750:Spermine
Purine metabolism,51,2,0.1101,2.2064,1,1,0.013409,C00360;C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360+C01345,mmu00230+C00360:dAMP;C01345:dITP
Pantothenate and CoA biosynthesis,12,1,0.12833,2.0532,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
ABC transporters,59,2,0.14052,1.9624,1,1,0.014493,C00114;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114+C00315,mmu02010+C00114:Choline;C00315:Spermidine
"Glycine, serine and threonine metabolism",18,1,0.18666,1.6785,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Ferroptosis,19,1,0.19603,1.6295,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Terpenoid backbone biosynthesis,19,1,0.19603,1.6295,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phenylalanine metabolism,22,1,0.22354,1.4982,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Nicotinate and nicotinamide metabolism,27,1,0.26748,1.3187,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Metabolism of xenobiotics by cytochrome P450,43,1,0.39322,0.93338,1,1,0.0039841,C19591,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19591,"mmu00980+C19591:1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal"
Choline metabolism in cancer,4,2,0.00069668,7.2692,0.14839,0.14839,0.32584,C00114;C00670,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114+C00670,mmu05231+C00114:Choline;C00670:sn-Glycero-3-phosphocholine
beta-Alanine metabolism,12,2,0.0072858,4.9218,1,0.51729,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Glycerophospholipid metabolism,12,2,0.0072858,4.9218,1,0.51729,0.098148,C00114;C00670,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114+C00670,mmu00564+C00114:Choline;C00670:sn-Glycero-3-phosphocholine
Ether lipid metabolism,1,1,0.011321,4.4811,1,0.60283,0.024096,C00670,mmu00565,http://www.kegg.jp/pathway/mmu00565+C00670,mmu00565+C00670:sn-Glycero-3-phosphocholine
Bile secretion,52,3,0.017903,4.0228,1,0.76267,0.027523,C00114;C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00315+C00750,mmu04976+C00114:Choline;C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.02394,3.7322,1,0.84989,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
Pertussis,4,1,0.044582,3.1104,1,1,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Cholinergic synapse,4,1,0.044582,3.1104,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Arginine and proline metabolism,35,2,0.056815,2.868,1,1,0.063725,C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315+C00750,mmu00330+C00315:Spermidine;C00750:Spermine
Caffeine metabolism,7,1,0.076814,2.5664,1,1,0.029412,C07481,mmu00232,http://www.kegg.jp/pathway/mmu00232+C07481,mmu00232+C07481:Caffeine
Purine metabolism,51,2,0.1101,2.2064,1,1,0.013409,C00360;C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360+C01345,mmu00230+C00360:dAMP;C01345:dITP
Pantothenate and CoA biosynthesis,12,1,0.12833,2.0532,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
ABC transporters,59,2,0.14052,1.9624,1,1,0.014493,C00114;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114+C00315,mmu02010+C00114:Choline;C00315:Spermidine
"Glycine, serine and threonine metabolism",18,1,0.18666,1.6785,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Terpenoid backbone biosynthesis,19,1,0.19603,1.6295,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phenylalanine metabolism,22,1,0.22354,1.4982,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Nicotinate and nicotinamide metabolism,27,1,0.26748,1.3187,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Metabolism of xenobiotics by cytochrome P450,43,1,0.39322,0.93338,1,1,0.0039841,C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19594,"mmu00980+C19594:Aflatoxin-M1-8,9-epoxide"
Pertussis,4,1,0.02989,3.5102,1,1,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Cholinergic synapse,4,1,0.02989,3.5102,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.02989,3.5102,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Bile secretion,52,2,0.054681,2.9062,1,1,0.018349,C00114;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00750,mmu04976+C00114:Choline;C00750:Spermine
Pantothenate and CoA biosynthesis,12,1,0.087335,2.438,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
beta-Alanine metabolism,12,1,0.087335,2.438,1,1,0.025862,C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00750,mmu00410+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.087335,2.438,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
"Glycine, serine and threonine metabolism",18,1,0.12844,2.0523,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Ferroptosis,19,1,0.13513,2.0015,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Terpenoid backbone biosynthesis,19,1,0.13513,2.0015,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phenylalanine metabolism,22,1,0.15494,1.8647,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Glutathione metabolism,22,1,0.15494,1.8647,1,1,0.013986,C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00750,mmu00480+C00750:Spermine
Nicotinate and nicotinamide metabolism,27,1,0.18707,1.6763,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Arginine and proline metabolism,35,1,0.23625,1.4429,1,1,0.019608,C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00750,mmu00330+C00750:Spermine
Purine metabolism,51,1,0.32687,1.1182,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
ABC transporters,59,1,0.36854,0.99821,1,1,0.0072464,C00114,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114,mmu02010+C00114:Choline
beta-Alanine metabolism,12,2,0.0040501,5.509,0.86267,0.86267,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.013561,4.3006,1,1,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
Arginine and proline metabolism,35,2,0.032972,3.4121,1,1,0.063725,C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315+C00750,mmu00330+C00315:Spermidine;C00750:Spermine
Pertussis,4,1,0.033579,3.3939,1,1,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Bile secretion,52,2,0.068135,2.6863,1,1,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
Pantothenate and CoA biosynthesis,12,1,0.097746,2.3254,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Terpenoid backbone biosynthesis,19,1,0.15075,1.8921,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phenylalanine metabolism,22,1,0.17261,1.7567,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Nicotinate and nicotinamide metabolism,27,1,0.20793,1.5705,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Drug metabolism - cytochrome P450,32,1,0.24191,1.4192,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Metabolism of xenobiotics by cytochrome P450,43,1,0.31213,1.1643,1,1,0.0039841,C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19594,"mmu00980+C19594:Aflatoxin-M1-8,9-epoxide"
Purine metabolism,51,1,0.3595,1.023,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
ABC transporters,59,1,0.40395,0.90645,1,1,0.0072464,C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00315,mmu02010+C00315:Spermidine
Spinocerebellar ataxia,1,1,0.0018868,6.2729,0.40189,0.086037,0.14286,C00025,mmu05017,http://www.kegg.jp/pathway/mmu05017+C00025,mmu05017+C00025:L-Glutamate
Huntington disease,1,1,0.0018868,6.2729,0.40189,0.086037,0.16667,C00025,mmu05016,http://www.kegg.jp/pathway/mmu05016+C00025,mmu05016+C00025:L-Glutamate
Long-term potentiation,2,1,0.0037718,5.5802,0.79585,0.086037,0.14286,C00025,mmu04720,http://www.kegg.jp/pathway/mmu04720+C00025,mmu04720+C00025:L-Glutamate
Amyotrophic lateral sclerosis,3,1,0.005655,5.1752,1,0.086037,0.055556,C00025,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00025,mmu05014+C00025:L-Glutamate
Proximal tubule bicarbonate reclamation,3,1,0.005655,5.1752,1,0.086037,0.070796,C00025,mmu04964,http://www.kegg.jp/pathway/mmu04964+C00025,mmu04964+C00025:L-Glutamate
Amphetamine addiction,3,1,0.005655,5.1752,1,0.086037,0.076923,C00025,mmu05031,http://www.kegg.jp/pathway/mmu05031+C00025,mmu05031+C00025:L-Glutamate
Cocaine addiction,3,1,0.005655,5.1752,1,0.086037,0.090909,C00025,mmu05030,http://www.kegg.jp/pathway/mmu05030+C00025,mmu05030+C00025:L-Glutamate
Nitrogen metabolism,3,1,0.005655,5.1752,1,0.086037,0.090909,C00025,mmu00910,http://www.kegg.jp/pathway/mmu00910+C00025,mmu00910+C00025:L-Glutamate
Circadian entrainment,3,1,0.005655,5.1752,1,0.086037,0.11111,C00025,mmu04713,http://www.kegg.jp/pathway/mmu04713+C00025,mmu04713+C00025:L-Glutamate
Long-term depression,3,1,0.005655,5.1752,1,0.086037,0.11111,C00025,mmu04730,http://www.kegg.jp/pathway/mmu04730+C00025,mmu04730+C00025:L-Glutamate
Nicotine addiction,3,1,0.005655,5.1752,1,0.086037,0.14286,C00025,mmu05033,http://www.kegg.jp/pathway/mmu05033+C00025,mmu05033+C00025:L-Glutamate
D-Glutamine and D-glutamate metabolism,3,1,0.005655,5.1752,1,0.086037,0.14286,C00025,mmu00471,http://www.kegg.jp/pathway/mmu00471+C00025,mmu00471+C00025:L-Glutamate
FoxO signaling pathway,3,1,0.005655,5.1752,1,0.086037,0.2,C00025,mmu04068,http://www.kegg.jp/pathway/mmu04068+C00025,mmu04068+C00025:L-Glutamate
Glutamatergic synapse,3,1,0.005655,5.1752,1,0.086037,0.2,C00025,mmu04724,http://www.kegg.jp/pathway/mmu04724+C00025,mmu04724+C00025:L-Glutamate
Phospholipase D signaling pathway,4,1,0.0075365,4.888,1,0.094428,0.047619,C00025,mmu04072,http://www.kegg.jp/pathway/mmu04072+C00025,mmu04072+C00025:L-Glutamate
Alcoholism,4,1,0.0075365,4.888,1,0.094428,0.071429,C00025,mmu05034,http://www.kegg.jp/pathway/mmu05034+C00025,mmu05034+C00025:L-Glutamate
Gap junction,4,1,0.0075365,4.888,1,0.094428,0.090909,C00025,mmu04540,http://www.kegg.jp/pathway/mmu04540+C00025,mmu04540+C00025:L-Glutamate
Synaptic vesicle cycle,5,1,0.0094161,4.6653,1,0.10556,0.083333,C00025,mmu04721,http://www.kegg.jp/pathway/mmu04721+C00025,mmu04721+C00025:L-Glutamate
GABAergic synapse,5,1,0.0094161,4.6653,1,0.10556,0.23529,C00025,mmu04727,http://www.kegg.jp/pathway/mmu04727+C00025,mmu04727+C00025:L-Glutamate
Caffeine metabolism,7,1,0.01317,4.3298,1,0.14026,0.029412,C07481,mmu00232,http://www.kegg.jp/pathway/mmu00232+C07481,mmu00232+C07481:Caffeine
Pathways of neurodegeneration - multiple diseases,8,1,0.015044,4.1967,1,0.14566,0.020833,C00025,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00025,mmu05022+C00025:L-Glutamate
Retrograde endocannabinoid signaling,8,1,0.015044,4.1967,1,0.14566,0.052632,C00025,mmu04723,http://www.kegg.jp/pathway/mmu04723+C00025,mmu04723+C00025:L-Glutamate
Butanoate metabolism,11,1,0.020657,3.8797,1,0.176,0.036765,C00025,mmu00650,http://www.kegg.jp/pathway/mmu00650+C00025,mmu00650+C00025:L-Glutamate
Arginine biosynthesis,11,1,0.020657,3.8797,1,0.176,0.081761,C00025,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00025,mmu00220+C00025:L-Glutamate
"Alanine, aspartate and glutamate metabolism",11,1,0.020657,3.8797,1,0.176,0.17045,C00025,mmu00250,http://www.kegg.jp/pathway/mmu00250+C00025,mmu00250+C00025:L-Glutamate
Taste transduction,14,1,0.026253,3.64,1,0.20711,0.026316,C00025,mmu04742,http://www.kegg.jp/pathway/mmu04742+C00025,mmu04742+C00025:L-Glutamate
Taurine and hypotaurine metabolism,14,1,0.026253,3.64,1,0.20711,0.029412,C00025,mmu00430,http://www.kegg.jp/pathway/mmu00430+C00025,mmu00430+C00025:L-Glutamate
Aminoacyl-tRNA biosynthesis,16,1,0.029975,3.5074,1,0.22802,0.017857,C00025,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00025,mmu00970+C00025:L-Glutamate
Central carbon metabolism in cancer,17,1,0.031833,3.4472,1,0.23381,0.037736,C00025,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00025,mmu05230+C00025:L-Glutamate
Glyoxylate and dicarboxylate metabolism,18,1,0.03369,3.3906,1,0.2392,0.033333,C00025,mmu00630,http://www.kegg.jp/pathway/mmu00630+C00025,mmu00630+C00025:L-Glutamate
Ferroptosis,19,1,0.035544,3.337,1,0.24422,0.069767,C00025,mmu04216,http://www.kegg.jp/pathway/mmu04216+C00025,mmu04216+C00025:L-Glutamate
Protein digestion and absorption,21,1,0.039248,3.2378,1,0.26125,0.021277,C00025,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00025,mmu04974+C00025:L-Glutamate
Glutathione metabolism,22,1,0.041098,3.1918,1,0.26527,0.041958,C00025,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00025,mmu00480+C00025:L-Glutamate
Histidine metabolism,23,1,0.042945,3.1478,1,0.26904,0.032,C00025,mmu00340,http://www.kegg.jp/pathway/mmu00340+C00025,mmu00340+C00025:L-Glutamate
Neuroactive ligand-receptor interaction,26,1,0.048478,3.0267,1,0.29502,0.019231,C00025,mmu04080,http://www.kegg.jp/pathway/mmu04080+C00025,mmu04080+C00025:L-Glutamate
"Neomycin, kanamycin and gentamicin biosynthesis",34,1,0.063151,2.7622,1,0.37365,0.012048,C00025,mmu00524,http://www.kegg.jp/pathway/mmu00524+C00025,mmu00524+C00025:L-Glutamate
Arginine and proline metabolism,35,1,0.064978,2.7337,1,0.37406,0.04902,C00025,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00025,mmu00330+C00025:L-Glutamate
Porphyrin and chlorophyll metabolism,54,1,0.099337,2.3092,1,0.55681,0.0039216,C00025,mmu00860,http://www.kegg.jp/pathway/mmu00860+C00025,mmu00860+C00025:L-Glutamate
ABC transporters,59,1,0.10827,2.2231,1,0.59133,0.0072464,C00025,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00025,mmu02010+C00025:L-Glutamate
Caffeine metabolism,7,1,0.019699,3.9272,1,1,0.029412,C07481,mmu00232,http://www.kegg.jp/pathway/mmu00232+C07481,mmu00232+C07481:Caffeine
Pantothenate and CoA biosynthesis,12,1,0.033611,3.3929,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
beta-Alanine metabolism,12,1,0.033611,3.3929,1,1,0.025862,C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00750,mmu00410+C00750:Spermine
Glutathione metabolism,22,1,0.061037,2.7963,1,1,0.013986,C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00750,mmu00480+C00750:Spermine
Nicotinate and nicotinamide metabolism,27,1,0.074554,2.5962,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Arginine and proline metabolism,35,1,0.095909,2.3444,1,1,0.019608,C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00750,mmu00330+C00750:Spermine
Bile secretion,52,1,0.14019,1.9647,1,1,0.0091743,C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00750,mmu04976+C00750:Spermine
Pantothenate and CoA biosynthesis,12,1,0.055439,2.8925,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
beta-Alanine metabolism,12,1,0.055439,2.8925,1,1,0.025862,C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00750,mmu00410+C00750:Spermine
Ferroptosis,19,1,0.086625,2.4462,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Phenylalanine metabolism,22,1,0.099735,2.3052,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Glutathione metabolism,22,1,0.099735,2.3052,1,1,0.013986,C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00750,mmu00480+C00750:Spermine
Nicotinate and nicotinamide metabolism,27,1,0.12125,2.1099,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Arginine and proline metabolism,35,1,0.15482,1.8655,1,1,0.019608,C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00750,mmu00330+C00750:Spermine
Purine metabolism,51,1,0.21888,1.5192,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Bile secretion,52,1,0.22275,1.5017,1,1,0.0091743,C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00750,mmu04976+C00750:Spermine
beta-Alanine metabolism,12,2,0.0017198,6.3655,0.36632,0.36632,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.0058685,5.1382,1,0.625,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
Arginine and proline metabolism,35,2,0.014623,4.2251,1,1,0.063725,C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315+C00750,mmu00330+C00315:Spermidine;C00750:Spermine
Bile secretion,52,2,0.031199,3.4674,1,1,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
Pantothenate and CoA biosynthesis,12,1,0.066183,2.7153,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Terpenoid backbone biosynthesis,19,1,0.10307,2.2723,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phenylalanine metabolism,22,1,0.11851,2.1328,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Nicotinate and nicotinamide metabolism,27,1,0.14374,1.9397,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Purine metabolism,51,1,0.25664,1.3601,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
ABC transporters,59,1,0.29139,1.2331,1,1,0.0072464,C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00315,mmu02010+C00315:Spermidine
Ether lipid metabolism,1,1,0.0084906,4.7688,1,0.79471,0.024096,C00670,mmu00565,http://www.kegg.jp/pathway/mmu00565+C00670,mmu00565+C00670:sn-Glycero-3-phosphocholine
D-Arginine and D-ornithine metabolism,2,1,0.016917,4.0794,1,0.79471,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Chagas disease,2,1,0.016917,4.0794,1,0.79471,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Amyotrophic lateral sclerosis,3,1,0.02528,3.6778,1,0.79471,0.055556,C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00062,mmu05014+C00062:L-Arginine
Amoebiasis,3,1,0.02528,3.6778,1,0.79471,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
mTOR signaling pathway,3,1,0.02528,3.6778,1,0.79471,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
Arginine and proline metabolism,35,2,0.032972,3.4121,1,0.79471,0.061275,C00062;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00062+C00750,mmu00330+C00062:L-Arginine;C00750:Spermine
Pertussis,4,1,0.033579,3.3939,1,0.79471,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Choline metabolism in cancer,4,1,0.033579,3.3939,1,0.79471,0.11236,C00670,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00670,mmu05231+C00670:sn-Glycero-3-phosphocholine
Caffeine metabolism,7,1,0.058102,2.8456,1,1,0.029412,C07481,mmu00232,http://www.kegg.jp/pathway/mmu00232+C07481,mmu00232+C07481:Caffeine
Purine metabolism,51,2,0.065806,2.721,1,1,0.013409,C00360;C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360+C01345,mmu00230+C00360:dAMP;C01345:dITP
Pathways of neurodegeneration - multiple diseases,8,1,0.066152,2.7158,1,1,0.020833,C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00062,mmu05022+C00062:L-Arginine
Arginine biosynthesis,11,1,0.089938,2.4086,1,1,0.050314,C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00062,mmu00220+C00062:L-Arginine
Pantothenate and CoA biosynthesis,12,1,0.097746,2.3254,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
beta-Alanine metabolism,12,1,0.097746,2.3254,1,1,0.025862,C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00750,mmu00410+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.097746,2.3254,1,1,0.025926,C00670,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00670,mmu00564+C00670:sn-Glycero-3-phosphocholine
Aminoacyl-tRNA biosynthesis,16,1,0.12839,2.0527,1,1,0.017857,C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00062,mmu00970+C00062:L-Arginine
Central carbon metabolism in cancer,17,1,0.1359,1.9958,1,1,0.018868,C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00062,mmu05230+C00062:L-Arginine
Ferroptosis,19,1,0.15075,1.8921,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Protein digestion and absorption,21,1,0.16538,1.7995,1,1,0.021277,C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00062,mmu04974+C00062:L-Arginine
Glutathione metabolism,22,1,0.17261,1.7567,1,1,0.013986,C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00750,mmu00480+C00750:Spermine
Nicotinate and nicotinamide metabolism,27,1,0.20793,1.5705,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Bile secretion,52,1,0.36521,1.0073,1,1,0.0091743,C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00750,mmu04976+C00750:Spermine
ABC transporters,59,1,0.40395,0.90645,1,1,0.0072464,C00062,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00062,mmu02010+C00062:L-Arginine
Arginine and proline metabolism,35,3,0.0033799,5.6899,0.71992,0.53577,0.10539,C00062;C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00062+C00315+C00750,mmu00330+C00062:L-Arginine;C00315:Spermidine;C00750:Spermine
beta-Alanine metabolism,12,2,0.0050307,5.2922,1,0.53577,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.016739,4.09,1,0.74715,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
D-Arginine and D-ornithine metabolism,2,1,0.018788,3.9746,1,0.74715,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Chagas disease,2,1,0.018788,3.9746,1,0.74715,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Amyotrophic lateral sclerosis,3,1,0.028062,3.5733,1,0.74715,0.055556,C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00062,mmu05014+C00062:L-Arginine
Amoebiasis,3,1,0.028062,3.5733,1,0.74715,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
mTOR signaling pathway,3,1,0.028062,3.5733,1,0.74715,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
Metabolism of xenobiotics by cytochrome P450,43,2,0.058837,2.833,1,1,0.015936,C19588;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588+C19594,"mmu00980+C19588:Aflatoxin B1 diol;C19594:Aflatoxin-M1-8,9-epoxide"
Pathways of neurodegeneration - multiple diseases,8,1,0.07326,2.6137,1,1,0.020833,C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00062,mmu05022+C00062:L-Arginine
Bile secretion,52,2,0.082551,2.4943,1,1,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
Arginine biosynthesis,11,1,0.099463,2.308,1,1,0.050314,C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00062,mmu00220+C00062:L-Arginine
ABC transporters,59,2,0.10281,2.2749,1,1,0.014493,C00062;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00062+C00315,mmu02010+C00062:L-Arginine;C00315:Spermidine
Pantothenate and CoA biosynthesis,12,1,0.10805,2.2252,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Aminoacyl-tRNA biosynthesis,16,1,0.14165,1.9544,1,1,0.017857,C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00062,mmu00970+C00062:L-Arginine
Central carbon metabolism in cancer,17,1,0.14988,1.8979,1,1,0.018868,C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00062,mmu05230+C00062:L-Arginine
Terpenoid backbone biosynthesis,19,1,0.16611,1.7951,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Protein digestion and absorption,21,1,0.18206,1.7034,1,1,0.021277,C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00062,mmu04974+C00062:L-Arginine
Phenylalanine metabolism,22,1,0.18993,1.6611,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Phosphonate and phosphinate metabolism,22,1,0.18993,1.6611,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Nicotinate and nicotinamide metabolism,27,1,0.22828,1.4772,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Purine metabolism,51,1,0.39058,0.94012,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Ether lipid metabolism,1,1,0.0066038,5.0201,1,1,0.024096,C00670,mmu00565,http://www.kegg.jp/pathway/mmu00565+C00670,mmu00565+C00670:sn-Glycero-3-phosphocholine
Pertussis,4,1,0.026191,3.6423,1,1,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Choline metabolism in cancer,4,1,0.026191,3.6423,1,1,0.11236,C00670,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00670,mmu05231+C00670:sn-Glycero-3-phosphocholine
Caffeine metabolism,7,1,0.045447,3.0912,1,1,0.029412,C07481,mmu00232,http://www.kegg.jp/pathway/mmu00232+C07481,mmu00232+C07481:Caffeine
Glycolysis / Gluconeogenesis,8,1,0.051792,2.9605,1,1,0.037344,C00236,mmu00010,http://www.kegg.jp/pathway/mmu00010+C00236,mmu00010+C00236:3-Phospho-D-glyceroyl phosphate
Glycerophospholipid metabolism,12,1,0.076814,2.5664,1,1,0.025926,C00670,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00670,mmu00564+C00670:sn-Glycero-3-phosphocholine
Phosphonate and phosphinate metabolism,22,1,0.13691,1.9884,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Drug metabolism - cytochrome P450,32,1,0.19362,1.6419,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Purine metabolism,51,1,0.29261,1.2289,1,1,0.01083,C00360,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360,mmu00230+C00360:dAMP
Ferroptosis,19,1,0.035544,3.337,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Metabolism of xenobiotics by cytochrome P450,43,1,0.079523,2.5317,1,1,0.011952,C19588,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588,mmu00980+C19588:Aflatoxin B1 diol
Pertussis,4,1,0.02989,3.5102,1,1,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Glycolysis / Gluconeogenesis,8,1,0.058996,2.8303,1,1,0.037344,C00236,mmu00010,http://www.kegg.jp/pathway/mmu00010+C00236,mmu00010+C00236:3-Phospho-D-glyceroyl phosphate
Pantothenate and CoA biosynthesis,12,1,0.087335,2.438,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
beta-Alanine metabolism,12,1,0.087335,2.438,1,1,0.025862,C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00750,mmu00410+C00750:Spermine
Ferroptosis,19,1,0.13513,2.0015,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Terpenoid backbone biosynthesis,19,1,0.13513,2.0015,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Glutathione metabolism,22,1,0.15494,1.8647,1,1,0.013986,C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00750,mmu00480+C00750:Spermine
Phosphonate and phosphinate metabolism,22,1,0.15494,1.8647,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Drug metabolism - cytochrome P450,32,1,0.21812,1.5227,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Arginine and proline metabolism,35,1,0.23625,1.4429,1,1,0.019608,C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00750,mmu00330+C00750:Spermine
Metabolism of xenobiotics by cytochrome P450,43,1,0.28281,1.263,1,1,0.011952,C19588,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588,mmu00980+C19588:Aflatoxin B1 diol
Bile secretion,52,1,0.33221,1.102,1,1,0.0091743,C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00750,mmu04976+C00750:Spermine
beta-Alanine metabolism,12,2,0.0061099,5.0978,1,1,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Bile secretion,52,3,0.013904,4.2756,1,1,0.027523,C00114;C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00114+C00315+C00750,mmu04976+C00114:Choline;C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.020203,3.9019,1,1,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
Pertussis,4,1,0.040925,3.196,1,1,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Cholinergic synapse,4,1,0.040925,3.196,1,1,0.16667,C00114,mmu04725,http://www.kegg.jp/pathway/mmu04725+C00114,mmu04725+C00114:Choline
Choline metabolism in cancer,4,1,0.040925,3.196,1,1,0.21348,C00114,mmu05231,http://www.kegg.jp/pathway/mmu05231+C00114,mmu05231+C00114:Choline
Arginine and proline metabolism,35,2,0.048332,3.0297,1,1,0.063725,C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315+C00750,mmu00330+C00315:Spermidine;C00750:Spermine
Glycolysis / Gluconeogenesis,8,1,0.080321,2.5217,1,1,0.037344,C00236,mmu00010,http://www.kegg.jp/pathway/mmu00010+C00236,mmu00010+C00236:3-Phospho-D-glyceroyl phosphate
Pantothenate and CoA biosynthesis,12,1,0.11824,2.135,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Glycerophospholipid metabolism,12,1,0.11824,2.135,1,1,0.072222,C00114,mmu00564,http://www.kegg.jp/pathway/mmu00564+C00114,mmu00564+C00114:Choline
ABC transporters,59,2,0.12129,2.1095,1,1,0.014493,C00114;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00114+C00315,mmu02010+C00114:Choline;C00315:Spermidine
"Glycine, serine and threonine metabolism",18,1,0.17246,1.7576,1,1,0.0062112,C00114,mmu00260,http://www.kegg.jp/pathway/mmu00260+C00114,mmu00260+C00114:Choline
Ferroptosis,19,1,0.1812,1.7082,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Terpenoid backbone biosynthesis,19,1,0.1812,1.7082,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phenylalanine metabolism,22,1,0.2069,1.5755,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Phosphonate and phosphinate metabolism,22,1,0.2069,1.5755,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Nicotinate and nicotinamide metabolism,27,1,0.24812,1.3938,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Purine metabolism,51,1,0.42018,0.86707,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Terpenoid backbone biosynthesis,19,1,0.052864,2.94,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phenylalanine metabolism,22,1,0.061037,2.7963,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Phosphonate and phosphinate metabolism,22,1,0.061037,2.7963,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Terpenoid backbone biosynthesis,19,1,0.052864,2.94,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phosphonate and phosphinate metabolism,22,1,0.061037,2.7963,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Drug metabolism - cytochrome P450,32,1,0.08794,2.4311,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Ferroptosis,19,1,0.086625,2.4462,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Terpenoid backbone biosynthesis,19,1,0.086625,2.4462,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phenylalanine metabolism,22,1,0.099735,2.3052,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Nicotinate and nicotinamide metabolism,27,1,0.12125,2.1099,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Purine metabolism,51,1,0.21888,1.5192,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
beta-Alanine metabolism,12,2,0.0023926,6.0354,0.50962,0.50962,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.0081128,4.8143,1,0.86401,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
Arginine and proline metabolism,35,2,0.02005,3.9095,1,1,0.063725,C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00315+C00750,mmu00330+C00315:Spermidine;C00750:Spermine
Bile secretion,52,2,0.042321,3.1625,1,1,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
Pantothenate and CoA biosynthesis,12,1,0.076814,2.5664,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
Ferroptosis,19,1,0.11924,2.1266,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Terpenoid backbone biosynthesis,19,1,0.11924,2.1266,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Phenylalanine metabolism,22,1,0.13691,1.9884,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Phosphonate and phosphinate metabolism,22,1,0.13691,1.9884,1,1,0.014706,C21613,mmu00440,http://www.kegg.jp/pathway/mmu00440+C21613,mmu00440+C21613:(R)-2-(Phosphonomethyl)malate
Nicotinate and nicotinamide metabolism,27,1,0.16567,1.7977,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
ABC transporters,59,1,0.33106,1.1055,1,1,0.0072464,C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00315,mmu02010+C00315:Spermidine
D-Arginine and D-ornithine metabolism,2,1,0.016917,4.0794,1,1,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Chagas disease,2,1,0.016917,4.0794,1,1,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Amyotrophic lateral sclerosis,3,1,0.02528,3.6778,1,1,0.055556,C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00062,mmu05014+C00062:L-Arginine
Amoebiasis,3,1,0.02528,3.6778,1,1,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
mTOR signaling pathway,3,1,0.02528,3.6778,1,1,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
Pertussis,4,1,0.033579,3.3939,1,1,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Metabolism of xenobiotics by cytochrome P450,43,2,0.048294,3.0305,1,1,0.015936,C19588;C19591,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588+C19591,"mmu00980+C19588:Aflatoxin B1 diol;C19591:1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal"
Purine metabolism,51,2,0.065806,2.721,1,1,0.013409,C00360;C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C00360+C01345,mmu00230+C00360:dAMP;C01345:dITP
Pathways of neurodegeneration - multiple diseases,8,1,0.066152,2.7158,1,1,0.020833,C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00062,mmu05022+C00062:L-Arginine
Arginine biosynthesis,11,1,0.089938,2.4086,1,1,0.050314,C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00062,mmu00220+C00062:L-Arginine
Aminoacyl-tRNA biosynthesis,16,1,0.12839,2.0527,1,1,0.017857,C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00062,mmu00970+C00062:L-Arginine
Central carbon metabolism in cancer,17,1,0.1359,1.9958,1,1,0.018868,C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00062,mmu05230+C00062:L-Arginine
Ferroptosis,19,1,0.15075,1.8921,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
Terpenoid backbone biosynthesis,19,1,0.15075,1.8921,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Protein digestion and absorption,21,1,0.16538,1.7995,1,1,0.021277,C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00062,mmu04974+C00062:L-Arginine
Nicotinate and nicotinamide metabolism,27,1,0.20793,1.5705,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Arginine and proline metabolism,35,1,0.26166,1.3407,1,1,0.041667,C00062,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00062,mmu00330+C00062:L-Arginine
ABC transporters,59,1,0.40395,0.90645,1,1,0.0072464,C00062,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00062,mmu02010+C00062:L-Arginine
Arginine and proline metabolism,35,3,0.0045425,5.3943,0.96755,0.65071,0.10539,C00062;C00315;C00750,mmu00330,http://www.kegg.jp/pathway/mmu00330+C00062+C00315+C00750,mmu00330+C00062:L-Arginine;C00315:Spermidine;C00750:Spermine
beta-Alanine metabolism,12,2,0.0061099,5.0978,1,0.65071,0.051724,C00315;C00750,mmu00410,http://www.kegg.jp/pathway/mmu00410+C00315+C00750,mmu00410+C00315:Spermidine;C00750:Spermine
Glutathione metabolism,22,2,0.020203,3.9019,1,0.82109,0.041958,C00315;C00750,mmu00480,http://www.kegg.jp/pathway/mmu00480+C00315+C00750,mmu00480+C00315:Spermidine;C00750:Spermine
D-Arginine and D-ornithine metabolism,2,1,0.020657,3.8797,1,0.82109,0.066667,C00062,mmu00472,http://www.kegg.jp/pathway/mmu00472+C00062,mmu00472+C00062:L-Arginine
Chagas disease,2,1,0.020657,3.8797,1,0.82109,0.16667,C00062,mmu05142,http://www.kegg.jp/pathway/mmu05142+C00062,mmu05142+C00062:L-Arginine
Amyotrophic lateral sclerosis,3,1,0.030839,3.479,1,0.82109,0.055556,C00062,mmu05014,http://www.kegg.jp/pathway/mmu05014+C00062,mmu05014+C00062:L-Arginine
Amoebiasis,3,1,0.030839,3.479,1,0.82109,0.076923,C00062,mmu05146,http://www.kegg.jp/pathway/mmu05146+C00062,mmu05146+C00062:L-Arginine
mTOR signaling pathway,3,1,0.030839,3.479,1,0.82109,0.25,C00062,mmu04150,http://www.kegg.jp/pathway/mmu04150+C00062,mmu04150+C00062:L-Arginine
Pertussis,4,1,0.040925,3.196,1,0.96855,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Metabolism of xenobiotics by cytochrome P450,43,2,0.070094,2.6579,1,1,0.015936,C19588;C19594,mmu00980,http://www.kegg.jp/pathway/mmu00980+C19588+C19594,"mmu00980+C19588:Aflatoxin B1 diol;C19594:Aflatoxin-M1-8,9-epoxide"
Pathways of neurodegeneration - multiple diseases,8,1,0.080321,2.5217,1,1,0.020833,C00062,mmu05022,http://www.kegg.jp/pathway/mmu05022+C00062,mmu05022+C00062:L-Arginine
Bile secretion,52,2,0.097806,2.3248,1,1,0.018349,C00315;C00750,mmu04976,http://www.kegg.jp/pathway/mmu04976+C00315+C00750,mmu04976+C00315:Spermidine;C00750:Spermine
Arginine biosynthesis,11,1,0.1089,2.2174,1,1,0.050314,C00062,mmu00220,http://www.kegg.jp/pathway/mmu00220+C00062,mmu00220+C00062:L-Arginine
Pantothenate and CoA biosynthesis,12,1,0.11824,2.135,1,1,0.0089286,C00750,mmu00770,http://www.kegg.jp/pathway/mmu00770+C00750,mmu00770+C00750:Spermine
ABC transporters,59,2,0.12129,2.1095,1,1,0.014493,C00062;C00315,mmu02010,http://www.kegg.jp/pathway/mmu02010+C00062+C00315,mmu02010+C00062:L-Arginine;C00315:Spermidine
Aminoacyl-tRNA biosynthesis,16,1,0.15473,1.866,1,1,0.017857,C00062,mmu00970,http://www.kegg.jp/pathway/mmu00970+C00062,mmu00970+C00062:L-Arginine
Central carbon metabolism in cancer,17,1,0.16364,1.8101,1,1,0.018868,C00062,mmu05230,http://www.kegg.jp/pathway/mmu05230+C00062,mmu05230+C00062:L-Arginine
Terpenoid backbone biosynthesis,19,1,0.1812,1.7082,1,1,0.052288,C01107,mmu00900,http://www.kegg.jp/pathway/mmu00900+C01107,mmu00900+C01107:(R)-5-Phosphomevalonate
Protein digestion and absorption,21,1,0.19842,1.6174,1,1,0.021277,C00062,mmu04974,http://www.kegg.jp/pathway/mmu04974+C00062,mmu04974+C00062:L-Arginine
Phenylalanine metabolism,22,1,0.2069,1.5755,1,1,0.011905,C12624,mmu00360,http://www.kegg.jp/pathway/mmu00360+C12624,mmu00360+C12624:2-Hydroxy-6-ketononatrienedioate
Nicotinate and nicotinamide metabolism,27,1,0.24812,1.3938,1,1,0.0046512,C16152,mmu00760,http://www.kegg.jp/pathway/mmu00760+C16152,mmu00760+C16152:Blue pigment
Drug metabolism - cytochrome P450,32,1,0.28739,1.2469,1,1,0.025641,C16586,mmu00982,http://www.kegg.jp/pathway/mmu00982+C16586,"mmu00982+C16586:2-Phenyl-1,3-propanediol monocarbamate"
Purine metabolism,51,1,0.42018,0.86707,1,1,0.0025786,C01345,mmu00230,http://www.kegg.jp/pathway/mmu00230+C01345,mmu00230+C01345:dITP
Pertussis,4,1,0.0075365,4.888,1,1,0.1,C12505,mmu05133,http://www.kegg.jp/pathway/mmu05133+C12505,mmu05133+C12505:Magnesium sulfate
Ferroptosis,19,1,0.035544,3.337,1,1,0.023256,C11378,mmu04216,http://www.kegg.jp/pathway/mmu04216+C11378,mmu04216+C11378:Ubiquinone-10
